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ABSTRACT 
 
This work aimed at the development of novel affinity pairs “tag-receptor” as generic platforms for 
the purification of recombinant proteins. Five different hexapeptides with the sequences 
RWRWRW, WFWFWF, NWNWNW, RKRKRK and NNNNNN were selected as affinity tags to 
be fused to Green Fluorescent Protein (GFP). The respective DNA fragments were designed, 
cloned in pET21c expression vector and expressed in Escherichia coli host as soluble proteins 
except for the WFWFWF tagged GFP. A solid phase combinatorial library based on the Ugi 
reaction was synthesized with 64 affinity ligands displaying complementarity functionalities 
towards the designed tags. The library was screened by microscale affinity chromatography in a 
96-well format for binding to GFP and GFP-tagged proteins, leading to the selection of four 
putative lead ligands A4C8, A3C4, A7C1, and A4C7 for WFWFWF, NWNWNW and RKRKRK 
fusion proteins and non-tagged GFP, respectively. The affinity pair WFWFWF tagged GFP – 
A4C8 was explored for matrix assisted refolding. The affinity pair NWNWNW tagged GFP-A3C4 
revealed extremely low protein recovery. The affinity pair RKRKRK tagged GFP-A7C1 emerged 
as a promising pair, as the ligand yielded 30% of protein recovery with a purity of 50% by using 
arginine as competitor agent. Additionally, the pair displays a Ka of 2.45x10
5
 M
-1 
and a Qmax of 
0.5 mg GFP-tagged per gram of moist gel. A novel strategy for the purification of non-tagged 
GFP or GFP fusion proteins was also accomplished with ligand A4C7 that allowed a selective 
recovery of GFP with 92% yield and 94% purity. Moreover, the pair displayed a suitable Ka of 
2.3x10
5
 M
-1 
and a Qmax of 1 mg of GFP.per gram of moist gel.  
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RESUMO 
 
O objetivo desta tese consistiu no desenvolvimento de pares de afinidade “etiqueta-recetor” 
para a purificação por afinidade de proteínas recombinantes. Cinco hexapéptidos com 
sequências RWRWRW, WFWFWF, NWNWNW, RKRKRK and NNNNNN foram selecionados 
como etiquetas de afinidade para serem utilizadas como proteínas de fusão com a “Green 
Fluorescent Protein” (GFP). Os respetivos fragmentos de ADN foram desenhados, clonados no 
vetor de expressão pET21c e produzidos em Escherichia coli sob a forma solúvel, à exceção 
de WFWFWF-GFP. A biblioteca combinatorial foi sintetizada em fase sólida, tendo por base a 
reação de Ugi, apresentando 64 ligandos de afinidade com funcionalidades complementares 
para as etiquetas desenhadas. A avaliação da interação da biblioteca para a GFP e proteínas 
de fusão com a GFP foi efetuada através de cromatografia de afinidade em micro-escala, 
resultando na seleção de quatro ligandos de afinidade A4C8, A3C4, A7C1 e A4C7 para as 
proteínas de fusão marcadas com WFWFWF, NWNWNW, RKRKRK e GFP não marcada, 
respetivamente. A proteína WFWFWF-GFP foi explorada para estudos de enrolamento 
utilizando a matriz de afinidade com o ligando A4C8. O par de afinidade NWNWNW- GFP e 
A3C4 revelou baixos rendimentos na recuperação da proteína de fusão. O par de afinidade 
RKRKRK -GFP e A7C1 emergiu como um par promissor, tendo o ligando permitido uma 
recuperação de 30% da proteína de fusão com uma pureza de 50%, utilizando arginina como 
agente competidor. Adicionalmente, o par de afinidade apresentou um Ka de 2.45x10
5
 M
-1 
e um 
Qmax de 0.5 mg/g de resina. Uma nova estratégia para a purificação de GFP foi também 
desenvolvida, sendo que adsorventes com o ligando A4C7 permitiram uma recuperação 
seletiva de GFP com 92% de rendimento e 94% de pureza, apresentando um Ka de 2.3x10
5
 M
-
e Qmax de 1 mg GFP/g resina 
 
PALAVRAS CHAVE- Proteína de fusão, Etiqueta de afinidade, Ligando biomimético, 
Cromatografia de afinidade, GFP 
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BACKGROUND 
 
 
The market of therapeutic proteins represents one of the fastest-growing segments of 
pharmaceutical industry and the most prominent best-selling classes include monoclonal 
antibodies, hormones and growth factors [1-2]. With the advances on genetic engineering it 
became possible the production of the therapeutic proteins in different microorganisms where 
Escherichia coli represents the most widely used platform, covering 30% of the total production 
of recombinant proteins among mammalian, insect and yeast cells [2]. Along with these 
advances, regulatory demands on purity became stricter, and the cost-effectiveness of the end 
product has been a driving force for the development of more efficient downstream processes 
[3-5]. 
 
Currently, there is not a universal strategy for the purification of recombinant proteins, as the 
individual biochemical and biophysical properties of each target protein dictate the production 
and the purification process. Affinity chromatography is considered the most widely used 
chromatographic method on the downstream processing due to the high yields of recovered 
protein with purity over 90% [3, 6], but there is a lack of suitable affinity ligands for a wide range 
of proteins. Moreover, the diversity of proteins makes the development of general purification 
and capturing strategies difficult. Therefore, the incorporation of a genetically encoded 
purification affinity tag is an attractive choice for the purification of recombinant proteins, while 
contributing for a reduction on the number of chromatographic processes involved in a 
purification scheme [7-8].  
 
The use of purification affinity tags requires a respective binding receptor immobilized onto a 
chromatographic matrix and their use is dependent on the molecular recognition mediated by 
the non-covalent interactions and the complementarity between the pair tag-receptor [9]. To 
date, the purification affinity tags commercially available and those referred in the literature, are 
not specifically designed to the receptor. The common receptors comprise biological and 
structural ligands that are able to recognize peptides or proteins used as purification affinity 
tags. One group of tags includes native or engineered proteins: enzymes (e.g. Gluthathione-S-
transferase), protein binding domains (e.g. protein A and Z domain) and carbohydrate binding 
domains (e.g. maltose-binding protein) [7-8, 10-11]. The other group of purification tags 
encloses peptides: antigenic epitopes (e.g. FLAG), protein-binding peptides (e.g. calmodulin-
binding peptide), streptadivin-binding peptides (e.g. Strep-tag), charged peptides (e.g. poly-
arginines), and metallo-binding peptides (e.g. poly-histidine) [7-8, 10-11]. Short peptide tags 
present several advantages over larger tags (as proteins) as they are less likely to interfere with 
the expression, structure and function of the target recombinant protein and the cloning 
procedure is facilitated [8]. 
 
xxvi 
 
The corresponding capturing affinity ligands comprise biological ligands (e.g. complementary 
monoclonal antibodies or haptens) and structural ligands (e.g. ion-exchange resins, metal-
chelate) [7-8, 10-11]. In general, biological ligands tend to have high binding and specificity 
capacities, but also high associated costs, low stability and re-usability [12-14]. Available 
structural ligands are usually inexpensive to produce but display low selectivities and as a 
consequence the purity of the final protein can be compromised, in particular when using metal 
chelator ligands which are more prone to leaching [15-17].  
 
A class of synthetic affinity ligands denominated as biomimetic ligands have been employed in 
the affinity purification of specific proteins such as immunoglobulins, [18-20], glycoproteins [21-
22], prion proteins [23], human recombinant factor VII, [24] and elastases [25]. These can be de 
novo rationally designed for a specific target to better mimic the structure and binding of natural 
biological ligands [12-14, 26], and can present high selectivity combined with low production 
costs. Additionally, the biomimetic ligands are highly robust and can operate over a wide range 
of chemical conditions (e.g. pH, buffer composition, ionic strength) making cleaning in place and 
matrix re-utilization possible [12-14].  
To date, there is no purification process based on the use of an affinity pair that combines a 
biomimetic ligand as a binding partner for a specific affinity tag.  
 
Therefore, this project aims the development of a new “tag-receptor” to be used as 
generic platform for recombinant protein purification. The novelty of this work is the de 
novo creation of a tailor-made affinity pair, where the tag will be a small peptide and the 
receptor a biomimetic synthetic affinity ligand designed target the tag. 
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CHAPTER 1 
AFFINITY PAIRS TAG-LIGAND FOR THE PURIFICATION OF RECOMBINANT PROTEINS 
 
 
 
 
 
 
SUMMARY 
 
 
The purification of recombinant proteins based on affinity chromatography is one of the most 
efficient purification strategies that allows high recovery yields of and purity of the target protein.  
However, this strategy is dependent on the availability of affinity adsorbents. Adsorbents 
comprising synthetic affinity ligands which combine the selectivity of biological ligands with the 
cost-efectiveness of structural ligands are promising viable options. The diversity of proteins 
requires a generic platform for the purification of recombinant proteins. Therefore, genetically 
encoded affinity tags are an attractive and viable option, which only requires specific receptors 
for capturing the fusion protein through the affinity tag tail. There is a wide range of available 
affinity pairs “tag-receptor” combining biological or structural ligands with respective binding 
partners such as peptide or proteins tags  
Although current affinity pairs are well established for purification purposes there is still a lack of 
compromise between high selectivity and affordable costs within the affinity pairs so far 
developed.  
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1.1 AFFINITY LIGANDS FOR RECOMBINANT PROTEIN PURIFICATION 
 
Recombinant proteins produced through recombinant DNA technology present one of the major 
classes of biopharmaceuticals and include erythropoietin, insulin, interferons, colony-stimulating 
factors, blood factors and growth hormones, employed in the treatment of cancer, diabetes, 
auto-immune and growth disturbances, among many others [3, 27]. In 2009, therapeutic 
proteins were the leaders of the global biopharmaceutical industry with a market size of 50 
billion Euros, and by 2016, the market is estimated to reach 120 billion Euros [27]. The 
manufacturing of biopharmaceuticals is constantly evolving to reach higher productivity, quality, 
and lower production costs [4-5, 28]. Upstream and downstream processing are intimately 
linked, where the former deals with the production and the latter with the separation steps to 
ensure a highly purified final product [5]. Downstream processing costs can be as high as 80% 
of the total production cost of a therapeutic recombinant protein [29-30]. This is mainly a 
consequence of the several purification steps needed, combined with the strict regulatory 
demands on purity, and the required optimization processes for each particular biologic target 
[3-5, 29]. Chromatography is a well established platform for downstream bioprocesses, being 
currently economically feasible and yielding recovery of bioproducts with purities as high as 97-
99% [3, 5, 31-32]. Among the several chromatographic techniques available for bioseparation 
purposes, affinity chromatography is extremely popular [6] due to its high selectivity and 
reduction of process steps [5, 29, 33]. 
 
The concept of affinity chromatography emerged in the 1970’s and exploits the reversible and 
selective interaction between two entities: an affinity ligand immobilized on a solid support, and 
a target biomolecule to purify [14, 29-30, 34-35]. The solid supports most widely used in affinity 
purification are composed of cross-linked agarose, polymethacrylate, polycrylamide, cellulose, 
and silica, and include porous and non-porous particulates, membranes and monoliths [14, 34-
37]. The properties required for an efficient and effective affinity separation matrix include 
chemical inertness, mechanical and chemical stability, proper pore and particle size [14, 34, 36-
37]. The chemical inertness of the matrix is related with the minimization of nonspecific 
interactions between the matrix material and the target protein to be purified [34, 37]. As the 
support should interact in a minimal way with the mobile phase, the matrix support should be 
hydrophilic and non-charged to minimize the formation of ionic interactions [37]. Concerning the 
stability of the material, the matrix must be physically and chemically stable under a wide range 
of conditions including those employed during surface modification, protein adsorption, elution, 
regeneration, matrix sterilization in place (SIP) and cleaning in place (CIP). These conditions 
include extreme pH values, high and low temperatures and the use of organic solvents, 
enzymes in the sample, detergents and disruptive eluent conditions [14, 34, 36-37].  
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Matrix selectivity can be introduced through the chemical functionalization of the solid support 
with desired affinity ligands, which can be divided into three main categories: biological, 
structural and synthetic ligands (Table 1.1 and Fig 1.1) 
 
Figure 1.1 Overview of the classes of affinity ligands employed on affinity chromatography, where 
(A) is a biological ligand( staphylococcal protein A, PDB: 1DEE), (B) a structural ligand (metal chelate such 
as iminodiacetic acid cheated to Ni
2+
) and (C) a synthetic biomimetic ligand (ligand A3C1 specific for 
immunoglobulins [38]. The solid support is representing agarose beads ( ). 
 
Biological ligands comprise of biomolecules obtained from natural biological sources and from 
in vitro selection techniques. The former include natural receptors with high selectivity and 
affinity for their target, such as peptides, antibodies, antigens and receptor proteins [13, 39-40], 
but usually associated with high costs of production and purification, poor stabilization under 
SIP and CIP conditions, as well as potential leakage and end-product contamination. Examples 
of common affinity biological ligands include immunoglobulins against a target protein (antigen), 
bacterial immunoglobulin-binding domains such as staphylococcal proteins A, G and L [41-45], 
natural lectins targeting glycoproteins [46]. Novel biological affinity ligands can be obtained 
through in vitro selection techniques as phage, ribosome or yeast display [47], being phage 
display the most popular for these purposes. 
 
Structural ligands are produced at affordable prices with relatively easy chemistries, and 
possess high resistance to harsh conditions. These ligands comprise ion-exchange [48-50], 
hydrophobic [51], metal chelate [16], thiophilic ligands [13-14, 52], boronate ligands [53-57], and 
mixed-mode affinity ligands [58-62]. The multimodal affinity chromatography relies on multiple 
forms of interactions and the respective mixed-mode affinity ligands usually combine a 
hydrophobic moiety with ionic and hydrophilic groups [58]. However, their limited selectivity and 
low affinity for specific targets usually obliges the design of multi-step purification schemes.  
 
Synthetic affinity ligands have been developed in an attempt to overcome disadvantages of 
natural and structural ligands, by combining the best of two worlds: affinity molecular recognition 
features associated with high resistance to chemical and biological degradation, high scalability, 
as well as low costs and low toxicity [30, 39-40].  Synthetic ligands have been well established 
since the 90´s being mostly represented by biomimetic ligands or de novo designed ligands 
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tailor-made for a specific target protein [13]. The research strategy followed for the development 
of these ligands involves ligand design using in silico molecular modelling tools as a first step 
[13, 63], followed by on-bead combinatorial synthesis and high-throughput screening (HTS) of 
ligand libraries, with the aim of testing enough diversity of compounds while reducing costs and 
time [64], and further ligand optimization. Different scaffolds were already used for the 
development of synthetic ligands. The triazine scaffold is a well-established technique by Lowe 
and co-workers. This scaffold was in the basis of alternatives of proteins A, G and L for the 
purification of antibodies[18, 20, 65], on the development of an artificial lectin for purification of 
glycoproteins [21-22], as well as other protein targets such as prion proteins [23], human 
recombinant factor VII, [24] and elastases [25].  This strategy was also considered by other 
authors for the purification of alkaline phosphatase [66] and human tissue plasminogen activator 
[67]. More recently, a different scaffold based on the Ugi reaction was exploited by the Lowe 
group [38]. The Ugi reaction is a multicomponent reaction that involves four main compounds, 
an aldehyde, an amine, a carboxylic acid and an isocyanine. So far, this strategy has been 
mainly used for the development of antibody–binding ligands [38, 68-69]. 
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Table 1.1 Comparison the affinity ligands employed on purification of proteins through affinity 
chromatography. The affinity ligands can be divided as biological, structural, and synthetic (biomimetic).  
. 
 
 
 
 
 
 
 
 
 
AFFINITY LIGANDS 
 
BIOLOGICAL 
 
 
STRUCTURAL 
 
 
SYNTHETIC – BIOMIMETIC 
 
A
D
V
A
N
T
A
G
E
S
 
 
- High Selectivity 
- Well-established 
- Optimized 
 
 
- Robustness 
- Cost-effectiveness 
-  Stability to sterilization and 
cleaning in place  
- Scalability 
- Reusability 
 
 
 
 
 
- High Selectivity 
- Robustness 
- Cost-effectiveness 
- Scalability 
- Resistance to chemical and 
biological degradation 
- Stability to sterilization and 
cleaning in place 
- Reusability 
D
IS
A
D
V
A
N
T
A
G
E
S
 
 
- Poor stability 
- Leakage 
- End product 
contamination 
- Limited lifespan 
- Low scale-up potential 
- High costs 
 
 
- Reduced Selectivity 
- Leaching (e.g. Metal chelate) 
- Toxicity (e.g. Metal chelate) 
 
 
 
 
- Potential toxicity 
- Limited availability 
 
 
 
1.2. PURIFICATION OF FUSION PROTEINS BY TAG-AFFINITY LIGAND STRATEGIES 
 
The diversity of proteins and their biochemical properties makes the development of universal 
purification and capturing strategies difficult. Most proteins of interest lack a suitable, specific 
and robust affinity ligand for capture on a solid matrix. Genetically encoded affinity tags are a 
viable and common option for the purification of recombinant fusion proteins and also represent 
important tools for structural and functional proteomics initiatives. This approach requires the 
existence and availability of specific receptors for capturing the fusion protein through an 
encoded affinity tag tail (Fig. 1.2), denominated as affinity pairs tag-receptor. Currently available 
affinity pairs tag-receptor fall within one of the categories: protein-protein, protein-small 
biological ligands, peptide-protein or peptide-metal chelating ligands. 
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Affinity tags display different size ranges from a single amino acid to entire proteins, and can be 
genetically fused to the N- or C-terminal of the target biomolecule [7-8, 10-11, 70-71]. Apart 
from facilitating the purification process, affinity tags can also enhance protein solubility and 
stability, increase expression levels [72-73] and allow labelling for cellular localization and 
imaging studies [70]. An overview of the main advantages and disadvantages associated with 
different affinity tags are presented in Table 1.2., and have been already thoroughly discussed 
on literature [7-8, 10-11, 70, 72-75]. In general, shorter affinity tags (peptides) are more 
attractive as they are less likely to interfere with the expression, structure and function of the 
target protein. Due to their smaller size, the peptides represent a smaller burden for the host 
during fusion protein production and might interfere less with the tertiary structure and biological 
activity of the target fused protein [8, 74-75]. Therefore, the removal of the peptide tags can be 
exempt, decreasing thus the overall costs of the purification process based on affinity peptide 
tags [8, 75]. For certain proteins, mainly those with applications in therapy, the presence of the 
affinity tag can compromise protein properties and tag removal is usually compulsory [8, 10-11, 
70, 76], which will be further discussed.  
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Figure 1.2 Overview of a recombinant fusion protein purification process through the use of affinity 
tags fused to the target protein. The process comprises several stages as gene construction of the 
fusion protein, where the gene that encodes the affinity tag is fused to the nucleotide sequence of the 
target protein. Then the fusion protein is expressed in the selected host and purified by affinity 
chromatography, through the molecular recognition between the tag and the ligand. After protein recovery, 
the tag might be removed leading to a pure target protein.  
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Table 1.2 Comparison of the general properties of proteins and peptides used as affinity tags 
 
 
 
 
 
 
 
 
 
 
AFFINITY TAGS 
 
PROTEIN 
 
PEPTIDE 
A
D
V
A
N
T
A
G
E
S
 
- Enhance protein solubility and 
stability 
-Genetically fused to N- or C-terminal 
of the target protein 
- Facilitate protein purification 
- Molecular diversity 
 
 
 
 
 
- Easy cloning 
- Genetically fused to N- or C-terminal of 
the target protein 
- Minimal effect on tertiary structure and 
biological activity 
- Less burden for the host 
- Enhance protein solubility and yield 
- Facilitate protein purification 
- Useful for matrix-assisted protein refolding 
- Tag removal might not be required 
- Allows accessibility to tag removal 
D
IS
A
D
V
A
N
T
A
G
E
S
 
 
- Large size and complex structure 
- Cysteine content 
- Interference with tertiary structure 
and biological activity of the target 
protein 
- High energy consumption by the 
host 
- Low scale-up potential 
 
 
 
- Can be buried within the internal structure 
of the protein 
- Mask functional binding sites 
- A wide range of the respective binding 
partners  are biological ligands 
- High costs of the matrix resin 
 
 
1.2.1. Biological ligands as binding partners of affinity tags 
 
Biological ligands involved on the molecular recognition with a partner affinity tag include 
peptides, protein and carbohydrates (Table 1.3 and 1.4). 
Immunoglobulin-based adsorbents for affinity chromatography purposes are usually very 
selective for the target proteins but the costs incurred are very high. The first affinity tag 
developed was based on the intrinsic selectivity and affinity between the bacterial 
immunoglobulin-binding domain staphylococcal protein A (SpA) and the Fc region of 
mammalian IgG [77]. SpA is well-known as a biological adsorbent for the purification of 
immunoglobulins, but it can be also used as an affinity tag for fusion to target proteins, as 
alkaline phosphatase [78]. In these situations, the purification of the fusion target protein was 
conducted on a single step of IgG based affinity chromatography with protein recovery at acidic 
pH [78]. According to Nilsson et al [77], SpA presents five homologous domains (E, D, A, B and 
C) where IgG binds preferentially to B domain. A mutated version of B domain was developed 
and denominated as Z domain to improve resistance towards tag removal by chemical methods 
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[79]. The bacterial immunoglobulin-binding domain staphylococcal protein G (SpG) has been 
also studied as a fusion partner due to its bifunctional behaviour – SpG is composed of different 
domains (A, B, C and D) with affinity for both IgG and human serum albumin (HSA) [80-81] – 
allowing the purification of SpG tagged proteins through HSA and IgG affinity chromatography 
[8, 71, 80-81].  
 
Other affinity tags recognizing immunoglobulins based adsorbents include the peptide epitopes 
FLAG, c-myc, T7, hemaglutinin antigen (HA) and Sogtags [8, 11]. The FLAG tag is the most 
popular, and has been employed on the purification of several recombinant proteins such as 
immunoglobulins, cytokines, gene-regulatory proteins [82]. It is a hydrophilic peptide with the 
sequence DYKDDDDK with high affinity for the monoclonal antibodies M1 and M2, being M1 
binding calcium dependent [82-85]. Therefore, the elution of FLAG fusion proteins from M1 
resins can be carried out under mild conditions in the presence of metal chelators such as 
EDTA, whereas elution from M2 resins requires a decrease in pH [82-85]. An attractive feature 
of FLAG tag is the possibility of simultaneous purification and removal by enterokinase which 
recognises the DDDDK sequence [82, 84]. The c-myc is a product of a proto-oncogene which 
epitope presents high affinity for the monoclonal antibody 9E10 [86]. This affinity pair has been 
mostly used as a tool for the detection of recombinant proteins through immnunoblotting assays 
rather than for purification processes [75, 86-87]. The affinity tags T7 and HA are mostly used 
on immune-detection assays [11, 73], where the T7-tag is a leader peptide of phage T7 with 
eleven amino acid with affinity for the anti-T7 monoclonal antibody [88-89], and the HA tag is a 
peptide epitope of the influenza virus hemaglutinin [90] recognized by the monoclonal antibody 
12 CA5 [91-92]. The epitope tags denominated as Softags are also employed on immunoaffinity 
chromatography by using polyols responsive monoclonal antibodies as biological adsorbents 
[93-94]. According to their designation, these tags allow a soft competitive elution with polyols 
which are low molecular weight compounds [93-94]. There are three Softags, where Softag 1 
corresponds to a thirteen amino acid sequence near the C-terminal of the β’ subunit of E.coli 
RNA polymerase [95]; Softag 2 is a repeat heptapeptide found on C-terminal of RNA 
polymerase I [96]; and Softag3 is an epitope near the N-terminal of human transcription factor 
[94]. 
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Table 1.3 Overview of biological ligands involved as binding partners of affinity tags  
 
 
BIOLOGICAL LIGAND 
 
TAG 
 
TAG SIZE 
 
 
APPLICATION 
 
REFERENCE 
P
E
P
T
ID
E
S
 A
N
D
 P
R
O
T
E
IN
S
 
Glutathione GST 26 kDa 
Purification 
and solubility 
[97] 
 
Calmodulin 
 
CBP
 
 
26 aa 
 
Purification 
 
[98] 
S protein 
(S-fragment RNAse A) 
S-tag 15 aa Purification [99] 
 
Streptavidin 
Strep-tag, Strep-
tag II 
9 aa 
Detection and 
purification 
[100-101] 
Nano tag 9-15 aa [102] 
SBP
 
38 aa [103] 
Strep-Tactin 
(modified streptavidin) 
Strep tag II 8 aa [104] 
NeutraAvidin AviD-tag 6 aa [105] 
 
 IgG 
Protein A (SpA) 
14-31 
kDa Purification 
[78] 
Z domain 7 kDa [79] 
IgG / HSA Protein G (SpG) 28 kDa Purification [81] 
Monoclonal antibody M1, M2 FLAG 8 aa Purification [85] 
Monoclonal antibody 9E10 c-myc
 
10 aa Purification [86] 
Anti-T7 monoclonal antibody T7 tag 11 aa 
Detection and 
Purification 
[106] 
Monoclonal antibody 12 CA5 HA tag 9 aa 
Detection and 
Purification 
[91] 
Polyol responsive monoclonal 
antibodies 
Softag 1/2/3 13/7/8 aa 
Detection and 
Purification 
[94, 96, 107-
108] 
C
A
R
B
O
H
Y
D
R
A
T
E
S
 
 
Cross-linked amylose 
MBP 42 kDa 
Purification 
and solubility 
[109] 
Cellulose 
Cellulose 
binding protein 
100 kDa Purification [110] 
Chitin 
Chitin binding 
domain 
5 kDa Purification [111] 
Starch 
Starch binding 
domain 
133 aa Purification [112] 
GST- Gluthatione-S-transferase; CBP- calmodulin binding peptide; SPB- strepdavidin-binding peptide; IgG 
–immunoglobulin G; HSA- human serum albumin; HA- hemaglutinin antigen; MPB- maltose binding protein 
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Table 1.4 Examples of a peptide and protein affinity tags and their respective biological ligands 
employed on the purification of fusion proteins based on affinity chromatography. The peptide tag 
is the Strep-tag, an eight amino acid sequence, with the affinity for streptavidin protein (PDB: 1RST), whilst 
the example of a protein used as an affinity tag is related with the staphylococcal protein G and the 
respective biological ligand, the Fc fragment of immunoglobulin G (PDB:1FCC). 
 
A
F
F
IN
IT
Y
 T
A
G
 
 
 
 
 
 
 
PEPTIDE 
 
 
 
 
 
 
 
 
BIOLOGICAL LIGAND 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROTEIN 
 
 
 
 
 
 
 
Another important group of biological affinity ligands includes streptavidin, where the tag-
receptor system is based on the selective natural binding pair avidin-biotin with a dissociation 
constant of 10
-15
 M [113]. The first tag with affinity for streptavidin was Strep-tag, a nine amino 
acid peptide selected from a random peptide library [100],  generally fused to the C-terminal of 
the target protein. According to structural studies, this affinity tag binds to the same pocket of 
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biotin, the natural partner of streptavidin [101]. The main advantages of Strep-tag are related to 
the resistance to proteolysis in vivo, the lack of interference with expression in E.coli and the 
mild elution conditions employed which include competitive elution with a biotin or analogue 
compound such as iminibiotin [100]. However, a limitation of the Strep-tag is the restriction to C-
terminal fusion and an improved version of Strep-tag was developed and denominated as 
Strep-tag II with equilibrium dissociation constant of 37 µM [101]. Also, at the same time, an 
engineered streptadividin chromatographic support (Strep-Tactin) was developed to improve the 
binding capacity towards Strep-tag II. This new version of streptavidin was generated from 
random mutagenesis on the amino acids 44-47 located at the flexible loop region near the 
binding site [114]. The affinity pair Strep-tag II – Strep tactin has been extensively used on a 
variety of applications [114], still affinity tags with higher affinity for streptavidin matrices were 
searched: The strepdavidin-binding peptide (SPB) tag comprising a 38 amino acid sequence 
with an equilibrium dissociation constant of 2.5 nM was selected from a peptide library screened 
against immobilized streptavidin [103]; The Nano-tag combining the small size of Strep-tag II 
and a namolar dissociation constant of 4 nM [102].  This tag is a 15 amino acid peptide and was 
selected from a synthetic library based on the heart fatty acid-binding protein by ribosome 
display [115]. The AviD-tag is another affinity tag based on Strep-tag displaying affinity for 
neutravidin, a neutral form of avidin rather for streptavidin [105]. The AviD-tag is composed by a 
6-amino acid cyclic peptide that was selected through phage display technique with a 
dissociation constant of 12 µM for both Neutravidin and avidin [105].  
 
Calmodulin is a small (17 kDa) and stable peptide employed as an affinity ligand on the 
purification of calmodulin binding peptide (CBP) fusion proteins. CBP is a 26 amino acid 
sequence derived from the carboxyl-terminal of rabbit skeletal muscle myosin light chain kinase 
[98, 116], displaying a dissociation constant of 10
-9
 M for calmodulin, calcium dependent [98, 
116-117]. CBP has been fused on N-terminal of a wide range of recombinant proteins that were 
further produced with high levels of expression. The size and stability of calmodulin ligands 
allows the production of calmodulin affinity resins at affordable prices. In addition, protein elution 
can be carried out at mild conditions with calcium chelating agents such as 
ethylenediaminetetraacetic acid (EDTA) and ethylene glycol tetraacetic acid (EGTA) [98, 116-
117].   
 
Another example of tag-biological ligand includes biological ligand for tag-ligand pairs include 
the S peptide tag and S-protein derived from the enzymatic cleavage of ribonuclease A by the 
protease subtilisin [118]. The S-peptide, a fifteen amino acid sequence, is used as an affinity tag 
recognized by the S-protein immobilized on resin [99]. The major advantages are related with 
the small size of the affinity tag and the nanomolar dissociation affinity constant of the affinity 
pair [99].  
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Glutathione-S-transferase (GST) is a monomeric protein (26 kDa) originated from Schistosoma 
japonicum and belongs to a family of enzymes that catalyze the reaction between a nucleophile, 
reduced glutathione and electrophilic compounds [119-120]. The complementary GST tag acts 
both as a purification anchoring point and as solubility/stability enhancer [97], which justifies the 
popularity of this tag-ligand system [121-122]. In addition, GST resins are cost effective and the 
elution conditions are mild as reduced glutathione can be employed as a competitive agent 
[120]. However, if reducing conditions are not guaranteed, the fusion protein can undergo 
oxidative aggregation due to the existence of four cysteine residues exposed at the surface of 
GST tag [123]. Also, fusion proteins with higher molecular weights than 100 kDa can lead to 
partially or completely insoluble proteins [122].  
 
The other class of biological ligands that recognize affinity ligands include carbohydrate based 
ligands, including cross-linked amylose, cellulose, and chitin, among others. The greatest 
advantages of these affinity ligands is that carbohydrates display high affinity for their respective 
affinity tags, the affinity matrices are inexpensive and prepared in a simple manner, which 
contributes for the ease of scaling-up the process. 
 
The maltose-binding protein (MBP) is a 42 kDa periplasmic protein engaged with the transport 
of maltose and maltodextrins across the bacterial cytoplasmic membrane [124-125]. The MPB 
tag fused on the N-terminal of target proteins can be purified in one-single step with a cross-
linked amylose affinity resin [126]. The MBP tag presents a high affinity for amylose, a maltose 
analogue, with a similar dissociation constant (10
-6
 M) to maltose, the competitive elution agent 
[124, 127]. This presents one of the greastest advantages of this affinity pair because the 
elution of the target fusion protein can be carried out under mild conditions with 10 mM of 
maltose [126]. In addition, the MBP tag is an extremely efficient solubilizing agent when 
compared to GST and thioredoxin (Trx) [128], and does not present any cysteine residue, thus 
not interfering with disulfide bonds of the target protein [10, 126].  
 
The cellulose and chitin binding proteins present high affinity for the polysaccharides cellulose 
and chitin, respectively, which act as affinity ligands for purification purposes. Polysaccharides 
represent extremely interesting adsorbents for affinity based purification as they tend to be non-
toxic, inert and stable [110, 112, 129]. Cellulose binding proteins can be found in a wide range 
of carbohydrolases, display considerable dissociation constants in the low micromolar range for 
cellulosic supports, and vary on size from small (33-36 aa) to large domains with more than 180 
amino acids [110]. For the particular application of fusion protein expression and purification, 
smaller domains are preferred. Cellulosic supports are commercially available in a wide range of 
geometries including fibers, beads, membranes and hydrogels, with a diverse extent of porosity, 
polymerization and functionalization. Chitin binding domains present high affinity for chitin, the 
second most abundant polymer after cellulose, and are part of the enzymes involved on the 
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biodegradation of chitin and chitosan [129]. Starch binding domains have also been explored as 
affinity tags, where these domains were fused to N-terminal of β-galactosidase which was then 
purified by using  starch granules [112]. 
 
 
1.2.2. Structural ligands as binding partners of affinity tags 
 
Structural affinity ligands, mainly cation and anion-exchange, metal chelate and hydrophobic 
ligands are extremely popular as binding partners of affinity tags and widely employed on the 
affinity purification of fusion proteins (Table 1.5). So far, synthetic ligands have been only tailor-
made for the purification of specific biomolecules and not regarded as universal purification 
adsorbents for fusion proteins.  
 
The more implemented are the metal chelate ligands complementary to the affinity tag His-tag 
(6xHis), where purification of the fusion protein is performed by immobilized metal affinity 
chromatography (IMAC) and has been comprehensively reviewed in the literature [15-17, 130-
131]. The concept of IMAC was developed by Porath and co-workers in 1975, through the 
exploitation of the affinity between proteins and heavy metal ions (Zn
2+
, Cu
2+
, Ni
2+
), in 
particularly zinc and copper metal which strongly adsorb polypeptides containing histidine and 
cysteine residues in aqueous solutions [132]. Based on this principle, the same authors coupled 
iminodiacetic acid (IDA) on to agarose to bind metal ions and further chelate proteins through 
histidine and cysteine residues [133]. Later, nitrilotriacetic acid (NTA), another highly stable 
quadridentate chelating adsorbent, was found to bind strongly to Ni
2+
 and Cu
2+ 
and to further 
chelate adjacent histidine residues [134]. NTA technology was then reported for the production 
and purification of a recombinant protein. The hexapeptide 6xHis was genetically fused to the 
N-terminal of mouse dihydrofolate reductase protein, produced in E. coli and then purified by 
IMAC using a Ni
2+
-NTA adsorbent. Subsequently, the fusion protein was eluted by different 
attempts such as a pH gradient (pH 8-5) in presence of denaturant agents (e.g. guanidine-HCl), 
and the tag was removed by carboxypeptidase  A cleavage [134]. However, the major drawback 
on this pioneer purification study was the employment of denaturing conditions, which triggered 
the improvement of the procedure by conducting binding under native conditions and elution 
with low concentrations of competitor imidazole, or EDTA [135-136]. In addition to the 
advantages associated to structural ligands and to small affinity tags already discussed, the 
compatibility of His-tag with denaturing agents can be a benefit for recombinant proteins 
produced as inclusion bodies, as they require steps of solubilization with chaotropic agents prior 
binding to column [134]. The main disadvantages of IMAC adsorbents are metal leaching [137], 
that contribute for an end-product contamination and additional steps of purification with 
increased costs. In addition, IMAC adsorbents can bind to native histidine patches in proteins or 
to other amino acids (Glutamic and Aspartic acid, Tyrosine, Cysteine, Arginine, and Methionine) 
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resulting in a low selectivity. Other disadvantages are related with the evidences that the 
imidazoyl side chain groups of histidine can interfere with protein expression and folding and 
also mask the biological activity of the protein [74]. Nonetheless, the universe of application for 
the IMAC/His-tag system has surmounted protein purification and is extended to matrix-assisted 
refolding [138], detection and immobilization, protein microarrays [139-141], and to the 
development of other affinity tag technologies. The HAT tag is one of these examples and 
comprises a polyhistidine peptide sequence that can be fused on both ends of the target 
protein. The purification can be carried out under the same conditions as for His-tag, however 
the adsorbent used is based on carboxymethylaspartate (CMA) complexed with Co
2+
, 
presenting high capacity [142].  Novel metal chelating agents based on 1,4,7-triazacyclononane 
(TACN) complexed with Ni
2+ 
were developed in an attempt to overcome the limitations such as 
leaching, stability and lack of selectivity non-specific [143]. The respective affinity tags 
correspond to random heptapeptide sequences displaying multiple histidine, tryptophan, and/or 
tyrosine residues selected from a phage display library [143]. The selected peptide tag 
(HHHNSWD) was fused to N—terminal of Green Fluorescent Protein (GFP), produced in E.coli 
and then purified under physiological conditions with high salt concentration. Recovery was 
done with imidazole due to the presence of three histidine residues [143]. 
 
Ion-exchange chromatographic resins are also used as structural ligands with affinity for several 
tags, which comprise charged amino acids to promote electrostatic interactions with opposite 
charges on the matrices. The polyarginine-tag (polyArg) is an example that consists of six 
arginine residues and correspondent fusion proteins have been purified on cationic exchange 
resins. A great advantage on using cation-exchange chromatography for purification of 
recombinant proteins produced in E.coli is that most host proteins are neutral or acidic, which 
can contribute for the reduction of non-specific interactions as these proteins do not bind to 
cationic resins at physiological and alkaline pH [48, 74]. The first reported example was the 
production and two-step purification of human urogastrone fused to the polyArg tail, with protein 
eluted under a NaCl linear gradient at alkaline pH, with 44% yield and purity higher than 95% 
[144]. The polyArg-tag has also been successfully employed on refolding studies of a target 
protein upon immobilization, [145-146]. This affinity tag system shows low selectivity and 
promotes aggregation due to charge-charge interactions [8]. Poly-anionic affinity tails from one 
to eight glutamic residues were used in alternative to purify functional human growth hormone 
[147] and virus-like particles [148] produced in E.coli. Negatively charged affinity tags based on 
aspartates residues also yielded to stable fusion proteins with unaltered activity [149]. 
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Table 1.5 Overview of the structural ligands involved as binding partners of affinity tags 
 
 
STRUCTURAL LIGANDS 
 
TAG 
 
TAG SIZE 
 
 
TAG TYPE 
 
REFERENCE 
M
E
T
A
L
 C
H
E
L
A
T
E
 
Ni
2+
-NTA / Ni
2+
- IDA 
 
Histidine residues 
(His tag) 
6 aa 
Purification 
[132, 134] 
Co
2+
- CMA HAT 18 aa [142] 
Ni
2+
-TACN 
peptide phage 
display library 
7 aa [143] 
IO
N
 E
X
C
H
A
N
G
E
 (
IE
X
) Cation-exchange 
 
Arginine residues 
 
5-15 aa 
Purification 
And 
Refolding 
[144] 
Z basic 7 kDa [49] 
Anion-exchange 
Aspartic acid 
residues  
5-16 aa Purification [149] 
Glutamic acid 
residues 
1-8 aa Purification [148] 
Z acidic 7 kDa Purification [50] 
 
M
U
L
T
IP
U
R
P
O
S
E
 –
 
IE
X
, 
IM
A
C
 A
N
D
 
H
IC
 
 
Ni
2+
-NTA (IMAC) 
Phenyl agarose 
(HIC) 
 
Multifunctional tag 6 aa Purification [150] 
 
The Z domain, a variant of the B domain of SpA, has been engineered to create a highly 
charged Z domain - Zbasic - through the introduction of charged residues at specific positions, to 
allow interaction with negatively charged matrices at physiological conditions [48-49]. The Z 
domain was proved to be an excellent protein scaffold for engineering as it is soluble, does not 
display disulfide bonds and presents a reversible folding after exposure to chaotropic agents 
[49]. Due to its excellent properties, the Zbasic was explored for matrix assisted refolding of fusion 
proteins solubilised with chaotropic agents after being produced as inclusion bodies. This 
successful strategy is more advantageous over the common solubilization and refolding 
procedures based on dialysis, contributing for an effective, less expensive and time-consuming 
procedure. The Z domain was also on the basis of Zacidic, engineered to have negatively charged 
and therefore to be purified by anion-exchange chromatography [50].   
In order to combine several functionalities, a multipurpose peptide tag with the sequence 
HYDHYD that comprises a bi-repetition of the tripeptide constituted by a histidine, tyrosine and 
aspartate residues was developed [150]. Due to these functionalities, this peptide can be fused 
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on N-or C-terminal of the target proteins enabling the purification by a combination of several 
techniques such as IMAC, IEX, aqueous two phase system (ATPS) and hydrophobic interaction 
chromatography (HIC). This versatile affinity tag has proven to have multifunctional purification 
capabilities and was employed for the purification of GFP, lactate dehydrogenase and human 
haemoglobin [150]. 
 
Overall, the purification of recombinant proteins through affinity pairs “tag-receptor” have been 
extensively used and there is a broad range of commercially available purification supports, 
both biological (Table 1.6) and structural (Table 1.7). 
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Table 1.6 Examples of commercially available affinity tags and respective purification supports 
based on biological ligands 
 
BIOLOGICAL 
LIGANDS 
AFFINITY SOLID SUPPORT AND SUPPLIER 
AFFINITY 
TAG 
CAPACITY 
(MG/ML) 
P
E
P
T
ID
E
S
 A
N
D
 P
R
O
T
E
IN
S
 
 
- Glutathione Sepharose (GE Healthcare) 
- Glutahione Superflow (Clontech) 
- Glutathione HiCap matrix (Qiagen) 
- Pierce Glutahione agarose / magnetic beads (Thermo 
Scientific) 
-Glutahione agarose and magnetic agarose 
beads(Sigma) 
GST tag 
10 
10 
20 
40 / 5-10 
 
5-10/ 15 
- Calmodulin resin (VWR) 
- MagneZoom
TM
 – CAM (bioWorld) 
- Calmodulin resin (G Biosciences( 
CMP 
3 
na 
3 
- S protein Agarose (Novagen-EMD Millipore  S-tag na 
- StrepTactin
TM
 (GE Healthcare) 
- Strep-Tactin Superflow /  Magnetic Beads  (Qiagen) 
-Strep-Tactin Superflow (Novagen- EMD Millipore  
Strep-tag II 
6 
9 / 0.3 
3 
- IgG Agarose (GE Healthcare) 
- IgG Agarose (Sigma) 
Protein A/G 
tag 
2 
1 
-Anti-FLAG M1, M2 resin (Sigma-Aldrich) 
-Anti-FLAG antibody agarose/ magnetic beads 
(Clontech) 
Flag-tag 
0.6 
na/ 1.3 
- EZview
TM 
red Anti-myc resin (Sigma) 
- Anti-c-myc agarose (Sigma-Aldrich) 
- Anti c-myc antibody agarose (Clontech) 
- Anti-Myc-tag mAb-Magnetic beads (MBL) 
- Pierce c-Myc-Tag IP (Thermo Scientific) 
c-myc tag 
0.05 
0.2 
0.5 
na 
na 
- T7 Tag® antibody agarose (EMD Millipore) 
- T7 tag antibody agarose (Genetex) 
- Anti-T7 tag® antibody agarose (Abcam) 
T7-tag 
0.3 
0.5 
na 
- Pierce Anti-HA Agarose (Thermo Scientific) 
- Pierce Anti-HA Magnetic Beads (Thermo Scientific) 
- Ezview
TM
 anti-HÁ affinity gel (Sigma) 
- Anti-HÁ Affinity Matrix (3F10) (Roche) 
- Anti-HA-tag mAb-Magnetic beads (MBL) 
HA tag 
150nmol/ml 
10 µg/g 
0.4 
9 nmol/ml 
na 
-Softag immune affinity resin (Neoclone) Softag 1/2/3 
0.3 
na- data not available 
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Table 1.6 Examples of commercially available affinity tags and respective purification supports 
based on biological ligands – Continuation 
 
BIOLOGICAL 
LIGANDS 
AFFINITY SOLID SUPPORT AND SUPPLIER AFFINITY TAG 
CAPACITY 
(MG/ML) 
C
A
R
N
O
H
Y
D
R
A
T
E
S
 
 
-  Amylose resin/ magnetic beads (New England 
Biolabs) 
 
MBP 
7-10 / 0.01 
- Cellulose (Sigma) 
Cellulose 
Binding domain 
15 
- Chitin agarose (New England Biolabs) 
Chitin Binding 
domain 
3 
 
 
Table 1.7 Examples of commercially available affinity tags and respective purification supports 
based on structuralligands 
 
STRUCTURAL 
LIGANDS 
 AFFINITY SOLID SUPPORT AND SUPPLIER 
AFFINITY 
TAG 
CAPACITY 
(MG/ML) 
M
E
T
A
L
 C
H
E
L
A
T
E
 
 
- Ni-sepharose  high perfomarnce (GE Healthcare) 
- His Mag Sepharose (GE Healthcare) 
- TALON® Superflow™ (GE Healthcare) 
- HisPur Ni-NTA resin/ magnetic beads (Thermo Scientific) 
- HisPur Cobalt Superflow agarose (Thermo Scientific) 
- His60 Ni resin / magnetic beads (Clontech) 
- TALLON® resin / magnetic beads (Clontech) 
- Ni-NTA agarose (Invitrogen) 
- Dynabeads® His-Tag (Invitrogen) 
- NTA-Agarose / Magnetic Agarose Beads (Qiagen) 
- Profinity
TM
 IMAC Nickel Charged resin (BIORAD) 
- IMAC HyperCel
TM
 (PALL) 
His-tag 
40 
50 
20 
20 /0.5 
 
20 
60 / n.a 
5-18/ n.a 
5-10 
0.04 
50 / 2 
15 
na 
 
-TALLON® metal affinity resin (Clontech) 
 
HAT tag 
 
18 
IO
N
-E
X
C
H
A
N
G
E
 
(I
E
X
) 
-Anion or cation exchange resins(several sources) 
Charged 
peptides 
50-120 
na- data not available 
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1.2.3. Affinity tags with versatile properties 
 
Affinity tags that have been described so far are developed to be the anchoring point for 
purification by affinity chromatography, where the existence of a complementary affinity ligand is 
required. However, affinity tags alone can be auto-sufficient for enhanced fusion protein 
solubility and purification. Examples include the employment of hydrophobic tags based on 
tryptophan, phenylalanine and tyrosine which allow direct purification of the fusion protein 
through aqueous two-phase systems [151]; the Halo-tag, a 34 kDa protein derived from 
bacterial haloalkane dehalogenase that is able to yield pure proteins through the covalent 
binding to chloroalkane [152];  
 
An alternative affinity system relies on the interaction between oil bodies and oleosin fusion 
proteins. Oil bodies are spherical structures that contain a triacylglycerol (TAG) matrix 
surrounded by a phospholipid mono-layer and several proteins, mainly oleosins, caleosins and 
steroleosins [153-155]. Oleosin being the main structural protein of the oil bodies´s membrane 
will work as an affinity tag. The target fusion protein can be easily purified by using a flotation 
centrifugation step, and then the tag can be cleaved by enzymatic methods [154-155]. 
 
Elastin-like polypeptides (ELPs) are composed by repetitions of the pentapeptide VPGXG 
(where X is any amino acid, with the exception of proline) and present as an attractive property 
such as a thermally responsive reversible phase transition [156-158]. Below transition 
temperature (Tt), ELPs are highly water soluble whereas at temperatures higher than Tt, they 
aggregate and become insoluble [156-158]. Due to their unique properties, ELPs have been 
used as tags, and therefore successfully employed on purification of recombinant fusion 
proteins [158-159].  The purification of ELP fusion proteins can be carried out by several cycles 
of salt addition, heating and centrifugation until precipitation [160]. ELP technology eliminates 
the use of chromatographic resins, is a simple methodology with scale-up potential [158].  
 
Self-cleaving tags have also been developed to possess inducible proteolytic activity 
representing an extremely interesting class of affinity tags [161-162]. The intein-based system is 
a well established example where the fusion protein cleavage can be induced by the presence 
of compounds such as β-mercaptoethanol or 1,4-dithiothreitol (DTT), or by a shift on pH or 
temperature [161-162]. Recently, a self-cleaving aggregation tag was constructed by combining 
the attractive properties of ELPs and inteins [160]. The major drawback of using this system is 
related with premature cleaving that can lead to a loss of the target protein and also the 
incompatibility with cleaving conditions [163] . 
 
The production recombinant proteins in bacterial hosts can lead to the formation of protein 
aggregates with unfolded or partially folded structures [164-165], denominated as inclusion 
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bodies (IBs) [166]. When these proteins are fused to solubility affinity tags, solubility is improved 
during protein expression, although the mechanism is not fully understood [10-11, 73]. 
Thioredoxin A (TrxA)[167], small ubiquitins-related modifier (SUMO) [168-169], and N-utilization 
substance A (NusA) [170-171] are examples of widely employed affinity tags with the purpose 
of increasing the solubility of the fusion partner rather than purifying it [10, 73]. As a 
consequence, a purification tag must be also added to the fusion partner to facilitate purification 
through affinity chromatography. The TrxA is a small (12 kDa) oxido-reductase protein with 
intrinsic thermal stability, solubility and robust folding properties that when fused to a target 
protein contributes for high yields of soluble protein [172-173]. The SUMO protein (11kDa) is 
involved in post-translational modification in eukaryotic cells, enhances solubility and stability of 
the binding partner when fused to the N-terminal [169], and allows simultaneous cleavage as it 
is recognized by the SUMO protease (S. cerevisae Ulp1), at the conserved dipeptide glycine-
glycine [168]. However, when used in eukaryotic hosts, the affinity tag can be cleaved due to 
the presence of SUMO proteases in vivo [173-174]. The NusA is a 55 kDa transcription 
elongation and antitermination factor, also known to increase the solubility of fusion proteins, 
however due to their large size can contribute for a high metabolic burn for the host cell [175].  
 
Most affinity tags developed so far present different properties and the choice of selecting the 
best affinity pair is ambiguous and also dependent on the target protein and production system 
employed.  
Novel dual-tagging methods have been developed and the concept of tandem affinity 
chromatography (TAP) has emerged as a generic platform for protein complex purification, 
combined with mass spectrometry that allows the isolation, identification and characterization of 
protein partners in multi-protein complexes [176-177]. 
The original C-terminal TAP tag was developed by Puig et al by using Saccharomyces 
cerevisiae hosts and consists of two IgG binding domains of SpA and a calmodulin binding 
peptide, separated by TEV protease cleavage site [177]. Also the N-terminal version was 
developed, being an inverse version of C-terminal as the SpA needs to be at N-or C-terminal 
end of the fusion protein to facilitate the purification process [177]. The main advantage related 
with this strategy is the highly efficient recovery of target protein [176-178]. Nowadays, the TAP 
strategy have been successfully  employed in main application studies of protein-protein 
interaction studies in prokaryotic and eukaryotic cells, and different TAP tags also have been 
developed [176, 178-181].  
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1.3 TAG REMOVAL 
 
For most applications, affinity tags are innocuous and do not interfere with the structure and 
biological function of the target protein. However, for therapeutic proteins there is a demand for 
tag cleavage to avoid immunological responses and to guarantee authenticity of the protein 
structure. The removal of the affinity tag can be performed by enzymatic cleavage or harsh 
chemical treatments and have been extensively reviewed [7, 74-76]. The chemical methods 
mostly used involve cyanogen bromide or hydroxylamine treatments, which are an inexpensive 
option but with low specificity and stringent conditions deterious to the protein [8, 74]. Therefore, 
enzymatic methods are usually preferred as they operate under milder conditions and present 
higher selectivity as endoproteases recognize specific amino acid sequences or motifs [8, 74, 
76]. The main endoproteases used on tag removal have been extensively reviewed and 
comprise enterokinase [182], tobacco etch virus (TEV) [183] Factor Xa [184], thrombin [184-
185]  and SUMO protease [168]. An attractive feature of enterokinase and factor Xa is that after 
cleavage there is no additional amino acid residues on the protein structure, contributing for an 
intact end product [74, 182, 184]. The main limitations in the use of proteases are related with 
the tag incompatibility under certain tag cleavage conditions (e.g. buffers, temperature), thus 
influencing its operation, and accessibility to the tag cleavage site [76].The high costs 
associated with proteases limit the scalability of the purification process [161]. In order to 
overcome the higher costs, strategies on the reusability of these proteases without losing their 
efficiency have been studied, as recently reported for the immobilization of enterokinase on 
magnetic supports [186]. 
 
 
1.4 CONCLUDING REMARKS AND FUTURE TRENDS  
 
Nowadays there is still a demand to develop processes for recombinant protein purification that 
can combine selectivity at affordable prices. Affinity chromatography is the most frequent choice 
for protein purification; however this technique is dependent on the adsorbents availability. 
Within the range of available affinity ligands, those of biological origin are still the preferred 
option due to the high selectivity. The use of structural ligands is dependent on the properties of 
the target protein and contaminants; however they could be extended to the purification of a 
wide range of proteins at low costs. Nevertheless, the main limitation of these ligands is the lack 
of specificity and the need to employ multi-steps purification protocols. Synthetic ligands raised 
to overcome the high costs associated with biological ligands have been developed to mimic 
naturally occurring interactions and are tailor-made to specific target proteins, fulfilling the lack 
of selectivity of structural ligands. However, most synthetic ligands developed so far have 
focused on high value proteins, as immunoglobulins. As each protein presents different 
biochemical and physical properties, a universal strategy for the purification of recombinant 
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proteins based on the use of affinity ligands tends to be difficult due to the fact that one ligand is 
required to purify one target protein, limiting the purification strategies. As a result, the use of 
affinity pairs “tag-receptor” emerged as an universal purification strategy.  
 
Currently there is a wide range of affinity pairs “tag-receptor” that can be used for the production 
and purification of fusion proteins. Commercial purification supports possess either biological or 
structural ligands are presented inTable 1.6 and 1.7, respectively. The choice of the affinity tag 
should take into account the target protein, the host and production conditions, as well as the 
respective binding partner.  
 
Therefore there is still a need to progress on the development of affinity pairs “tag-receptor” that 
can combine robustness, cost effectivess and selectivity of the affinity ligand (receptor) andf a 
peptide tag and also promotes the solubility and then the proper folding of the target protein. 
Therefore, there is a window of opportunity for the implementation of synthetic ligands de novo 
designed for affinity tags as viable alternatives for recombinant protein purification. 
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2.1 MATERIALS 
 
2.1.1 Chemicals 
 
All chemicals used were at least 98% pure and the solvents were pro-analysis.  
 
1-Pyrene methylamine hydrochloride, 1,4 Diaminobutane, 3-Indoleactic acid, 3-(4-
Hydroxybenzoic acid), 4-Aminobenzamide, 4-Hydroxybezoic acid , 5-Aminoisophthalic acid, 9-
Anthracenecarboxylic acid, Arabic Acid, β-glutamic acid, β-Mercaptoethanol, Bichinchoninic 
Acid (BCA) kit, Citric acid , Coomassie Brilliant Blue R250, cyanuric chloride, DL-Dithiothreitol, 
Ethylenediaminetetraacetic acid (EDTA), epychlorohydrin, Glycerol 99%,  Glutaric acic, 
isopropyl isocyanide, L-Arginine ≥ 98.5%, L-tryptophanol, Nα,Nα-Bis(carboxymethyl)-L-lysine 
hydrate, N-acetil-D-Phenylalanine, N,N-dimethylformamide, Phenylacetic acid, Sodium 
Bicarbonate, Sodium Periodate, Sodium phosphate monobasic monohydrate, Sodium 
phosphate dibasic heptahydrate, Sodium thiosulfate, Succinamic acid, Triton-X100, Tryptamine, 
Urea were purchased from Sigma- Aldrich. 
 
Ethanol absolute PA, Ethanol 96%, Ethylene glycol, Hydrochloric acid 37%, Sodium Chloride, 
Sodium-di-hydrogen Phosphate 1-hydrate, Sodium Hydroxide, (Di) Sodium-hydrogen 
Phosphate 2-hydrate were from Panreac. 
 
β-D-1-thiogalactopyranoside (IPTG) , Agar, Luria Broth, Agarose, Ampicilin, Glycine ultra pure 
for Molecular biology, NZYMiniprep kit, Tris(hydroxymethyl)aminomethane (Tris) Base ultra pure 
for Molecular Biology, SDS Micropellets (Sodium dodecyl sulphate) were acquired from 
NzyTech. The plasmid midi kit was purchased from Omega Bio-Tek 
 
2-propanol, Acetone ≥ 99.5% , Ammonium peroxydisulphate, Bromphenol blue sodium salt, 
Methanol, Tetramethylethylenediamine (TEMED) were obtained from Roth.  
 
Ammonium hydroxide solution and Glycine 98% were obtained from Fluka and ACROS, 
respectively. Silver stain kit which includes fixative enhancer concentrate, silver complex 
solution, reduction moderator solution, image development reagent and development 
accelerator reagent, 30% acrylamide and bis-acrylamide solution 37:5:1 and Sodium dodecyl 
sulphate Solution 10% were purchased from Bio-Rad.The Coomassie Plus (Bradford) assay kit 
and polyvinylidene difluoride (PVDF) membranes were acquired from Thermo Scientific and Life 
Technologies Ltd., respectively. 
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2.1.2 Biochemicals  
 
BSA protein (Albumin from bovine serum) min. 98% and recombinant green fluorescent protein 
rTurboGFP (FP552-Evrogen) were purchased from Sigma and Biocat GmbH respectively.  The 
labelled peptides FITC-RWRWRW peptide (98.31%), FITC-RKRKRK peptide (98.56%), FITC-
NNNNNN (98.48%), FITC-WFWFWF (98.51%) were obtained from Antagen Inc (USA.  
 
The plasmids pET21c containing the DNA fragment respective for the hexapeptides WFWFWF, 
NWNWNW, RKRKRK, NNNNNN fused to GFP and non-tagged GFP were synthesized by 
Geneart (Invitrogen), and the pET21c was kindly provided by Prof. Alice Pereira (Requimte, 
Portugal). The restriction enzymes NheI and EcoRI were obtained from TAKARA. T4 DNA 
ligase, competent cells BL21 (DE3), NZY5α and NZYSTAR, NZYDNA Il and III ladders, low 
molecular weight protein marker were purchased from NZYTech. DNase I was obtained from 
Roche. The E. coli K-12 was kindly provided by Dr Pedro Vidinha and Diana Garcia. 
 
The E-gel® CloneWell agarose gel, Novex® Sharp protein standard marker were obtained from 
Invitrogen. The fusion protein GFP - B. megaterium spore cortex lytic enzyme SleL was kindly 
provided by Dr Isik Ustok, University of Cambridge. The Rabbit PAb to GFP and Goat PAb to 
Rabbit IgG were acquired from Abcam. The Novex HRP Chemiluminescent substrate reagent 
kit was from Life Technologies, Paisley, UK 
 
 
2.1.3 Chromatographic materials 
 
Cross-linked agarose (Sepharose
TM 
CL-6B), PD-10 Columns – Sephadex
TM
 G – 25M and 
HiScale16/20 columns were obtained from GE Healthcare. Captiva 96-well filtration block and 
and empty columns (0.8 x 6.5 cm) were purchased from Varian. Brand Black immunograde 96-
well microplates and 96-well UV half area (Greiner) was supplied from VWR International. The 
96-well transparent microplates were acquired from Sarstedt.  
 
 
2.2 INSTRUMENTATION  
 
The synthesis of the combinatorial library of ligands based on the Ugi reaction was carried out 
in IKA KS 4000 ic control (VWR) incubator. The Fluorescence Microscope Olympus BX 51 with 
an objective U-RFL-T (40x amplification), U-MWB  (λexc= 460-490 nm; λem = 515 -570 nm), an 
Olympus U-RFL-T lamp, an objective Uplam FLN, and Cell F software were employed for 
monitoring the formation of WFWFWF tagged GFP inclusion bodies. Image J was utilised for 
analysis of data obtained from fluorescence microscopy. 
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The measurement of the fluorescence intensity and the absorbance from BCA assay on a 96-
well plate format were conducted on a Microplate Titre Infinite F200 with the respective Tecan 
filters (λexc= 485 – 505 nm; λem= 535 -560 nm and 560 nm, respectively).  
 
The isolation of the plasmids pET21c and pAP001 was carried out in Sigma 3-18K centrifuge 
and the respective hydrolysis of the plasmids was performed on a GRANT dry block. The 
plasmid DNA was analyzed by spectrophotometric analysis on Thermo scientific Evolution 
300UV-VIS and evaluated through gel agarose electrophoresis, by using a Horizon 11.14 
electrophoresis chamber with GE EPS 301 power supply and Safe Imager™ Blue-Light 
Transilluminator from Invitrogen through KODAK 1D 3.6 software for visualization. The DNA 
fragment of pAP001 and double-digested pET21c were purified through E-gel® system using E-
gel® CloneWell agarose gel on E-gel® iBase
TM 
from Invitrogen. The ligation products resultant 
from the molecular cloning between DNA fragment of pAP001 and double-digested pET21c 
were carried out on a GRANT dry block. The sequencing analysis of the positive clones was 
performed by StabVida. The pH adjustment was performed with a pH meter from Hanna 
Instruments.  
 
The expression of GFP-tagged proteins was conducted in OVAN incubator. Cells were collected 
with a Sigma 3-18K centrifuge, lysed with French press from Thermo Scientific, centrifuged with 
the same Sigma 3-18K and then ultracentrifuged in a Beckman Optima LE-80 (rotor 45TI). The 
Mini-Protean Tetra System from BIO-RAD was used for SDS-PAGE gels electrophoresis, and 
revealed with UVITEC Transilluminator through KODAK 1D 3.6 software.  
 
The antimicrobial assays were carried out on Digital Thermo Mixer Vortemp 56, S2056-A, from 
Labnet. The static partition equilibration studies were conducted in a 96-well format in a 
Enduro™ MiniMix™ Nutating Mixe from Labnet.  
 
The scale-up screening between the lead ligands and the respective GFP-tagged and non-
tagged proteins was carried out in the automated system ÄKTA avant 25 from GE Healthcare. 
The western blot was carried out in a Semi Dry Transfer Cell unit from Biorad and revealed in X-
ray film using a developer from GE, Amersham Hyperfilm ECL. 
 
The structures of the lead ligands were drawn in ChemDraw Ultra 11.0 from CambridgeSoft. 
The isolectric point and LogP properties of the affinity tags were estimated by Marvin Sketch 
4.1.6 from ChemAxon. The GFP structure (PDB: 1QYO) was visualized with Pymol from 
DeLano Scientific LLC.  
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2.3 GENERAL METHODS 
2.3.1 Solid phase combinatorial synthesis of the library of Ugi-based affinity ligands 
 
The synthesis of the Ugi-based ligands begins with aldehyde functionalization of agarose 
beads. This functionalization encloses the following stages (i) epoxyactivation of Sepharose
TM
 
CL-6B, (ii) cis-diol activation and (iii) generation of aldehyde groups on the agarose beads (Fig. 
2.1). 
 
 
Figure 2.1 Aldehyde functionalization of agarose beads.  
 
2.3.1.1 Epoxyactivation of agarose beads 
 
The required amount of Sepharose
TM
 CL-6B (100g) was washed with distilled water (10x  
volume of resin’s weight) and then filtered under vacuum, being the last washing filtered under 
gravity. Then the resin was ressuspended in 100 ml of distilled water and 4 ml of 10M NaOH 
(40 ml per 1 Kg of moist gel) were added and the slurry was incubated at 30ºC during 30 min 
with orbital shaking at 200 rpm. Afterwards, 7.2 ml of epichlorohydrin (72 ml per 1kg of moist 
gel) was added to the moist gel and incubated for 3h at 36ºC at 200 rpm. Agarose was then 
extensively washed with distilled water, and the first litter was discarded to halogens waste 
disposal.  
2.3.1.1.1 Quantification of epoxyactivation extension 
 
The extension of epoxyactivation was determined though a titration between OH
-
 groups 
released from epoxy ring opening and hydrochloric acid. Therefore, 3ml of 1.3M of Na2S2O3 
were added to 1g of epoxyactivated agarose and incubated for 20 min at room temperature. 
Released OH
-
 groups were further titrated with 0.1M HCl, until pH reached 7. The volume used 
corresponded to the number of moles of OH
- 
released (10 μmoles per 100 μl added).  Typically, 
epoxyactivation of Sepharose
TM
 CL-6B yielded 20 μmol of epoxy/g of gel. 
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2.3.1.2 Aldehyde functionalization of agarose beads 
 
The cis-diol activation was carried out by adding 97 ml 1M NaOH (1 ml per gram of moist gel) to 
97g of epoxyactivated moist gel and then incubated overnight at 30ºC under orbital agitation at 
200 rpm. Afterwards, the gel was washed as described in 2.3.1.1. 
 
Aldehyde functionalization was performed by adding 97 ml of 0.1 M NaIO4 (with the proportion 
of 1 ml of solvent / g of moist gel) and then incubated during 6h at 45ºC at 200 rpm. After the 
functionalization the washing is performed as described in 2.3.1.1. 
 
2.3.1.2.1 Qualitative evaluation of aldehyde functionalization  
 
To 1g of aldehyde-activated agarose 1 ml of freshly prepared Tollens reagent was added.  The 
presence of a silver mirror or a black precipitate revealed the presence of aldehyde. The 
positive control was performed with1 ml of glutaraldehyde and the negative control with 1 g of 
Sepharose
TM
 CL-6B unmodified. The Tollens reagent was freshly prepared by adding into a test 
tube, (previously cleaned with 3 M NaOH) 2 ml of 0.2 M AgNO3 and a drop of 3 M NaOH. After 
this, the base 2.8 % NH4OH was added dropwise with a constant shaking until almost all 
precipitate of silver oxides has dissolved. In order to remove all the precipitate, a 8.8% NH4OH 
was added dropwise. The Tollens reagent was ready to use.   
 
2.3.1.3 Synthesis of the solid phase combinatorial library  
 
The preparation of the combinatorial library based on the Ugi reaction is described in Fig 2.2. 
The Ugi reaction is a multicomponent reaction that involves four different groups: an aldehyde, 
an amine, an isocyanide and a carboxylic acid.  
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Figure 2.2 Reaction scheme of the multicomponent Ugi reaction synthesized in the solid phase, 
with isopropyl isocyanide being kept constant, whereas amine (R3) and carboxylic acid compounds (R4) 
are variable groups The aldehyde component was attached to the solid phase. 
 
In order to perform the Ugi reaction as shown in Fig. 2.2., the agarose gel functionalized with 
aldehyde was washed with 20% increments of methanol, from 0% (v/v) to 100 % (v/v) methanol 
using gravity without applying any vacuum. For the generation of the first combinatorial library 
comprising 56 affinity ligands, 16 g of the methanol-saturated resin was ressuspended in 16 ml 
of 100% methanol (v/v). Prior the addition of the aldehyde beads in each well of the 96-well 
filtration block, 1-ml pippette tip was cut 4 mm so that the resin slurry was not entrapped in the 
tip, enhancing resin pipetting reproducibility. Therefore, 400 µl of resin slurry aliquots (~250 mg 
of resin) were pipetted in each well of a total of 56 wells (8x7). At this point, the flexible end cap 
of the reaction block was removed in order to drain the solvent and allow resin settling in each 
well. After this, the end cap was again placed for the synthesis of the Ugi based ligands. The 
combinatorial library based on the Ugi reaction presents diversity within all the affinity ligands 
due to the variability introduced by the use of different amines (A3 to A10 columns) (Table 2.1 
and Fig.2.3) and carboxylic acids (C1 to C7 rows) (Table 2.2). The isocyanide and aldehyde 
functionality was kept constant in all affinity ligands by using isopropyl isocyanide and the 
aldehyde groups functionalized in agarose beads.  
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Figure 2.3 Visualization of the 96-well filtration block used for the synthesis of the combinatorial 
libraries based on the Ugi reaction and triazine scaffold (A) from the front and (B) from the top with the 
respective addition of the compounds used on the Ugi reaction. Regarding the triazine library, amines 
were employed in both rows and columns. 
 
Each compound used presented a 5 molar excess of the epoxide-activated resin (§2.3.1.1). 
The synthesis of the Ugi based ligands begins with the addition of the amine compound (Fig. 
2.2), being the addition (250 µl/well) done in each column of the reaction block from A3 (first 
column) until A10 (last column). All the amines were dissolved in 2.5 ml of 100% methanol (v/v), 
however for of amines A2, A3 and A7 that possess both amine and carboxylic acid 
functionalities, the carboxylic acids were also neutralized with 1M NaOH (370 µl for A3 and A7, 
and 555 µl for A2). The neutralization was carried out taking into account also the 5x molar 
excess and the respective number of COOH groups. The amine A4 was also neutralized with 
180 µl of 1M NaOH. The 96-well block was then sealed with the upper cap and left incubating 
for 2h at 60ºC at 180 rpm, in order to guarantee the formation of the imine compound. The next 
compound added was isopropyl isocyanide (2.2 l per each well). Finally, the last compound 
(carboxylic acid) was added (250 l/well). The respective amounts of each carboxylic acid were 
dissolved in 2.5 ml of 100% methanol (v/v) and added according to the following order: C1 in 
first row and C7 in last row of the 96-well filtration block. 
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Table 2.1 List of the amines compounds used on the Ugi reaction for the solid phase combinatorial 
library  
  
NUMBER STRUCTURE CHEMICAL NAME 
A1 
 
 
Tyramine 
A2 
 
 
 
Nα,Nα-Bis(carboxymethyl)-
L-lysine hydrate 
 
A3 
 
 
β – Glutamic Acid 
 
A4 
 
 
 
1-Pyrenemethylamine 
hydrochloride 
 
A5 
 
 
 
4 - Aminobenzamide 
A6 
 
 
 
1,4 - Diaminobutane 
A7 
 
 
5 – Aminoisophthalic acid 
 
A8 
 
 
Tryptamine 
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Table 2.2 List of the carboxylic acid and isocyanide compounds used on the Ugi reaction for the 
solid phase combinatorial library  
 
NUMBER STRUCTURE CHEMICAL NAME 
C1 
 
 
Succinamic acid 
 
C2 
 
 
3-(4-Hydroxyphenyl) 
propionic acid 
 
C3 
 
 
3-Indoleacetic acid 
 
C4 
 
 
 
N-acetyl-D-phenylalanine 
 
C5 
 
 
 
Arabic acid 
 
C6 
 
 
Glutaric Acid 
 
C7 
 
 
Phenylacetic acid 
 
C8 
 
 
 
9-Anthracenecarboxylic 
acid 
 
 
 
 
HO
O
O
NH
2
HO
O
OH
NH
O
OH
HN
O
OH
H
3
C
O
HO
O
OH
OH OH
OH
HO
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After the addition of all components, the upper cap was again fixed on the top of the block, and 
and incubating for 48h at 60ºC at 180 rpm 
At the end of this reaction, the end cap was carefully removed to drain each well and then a 
washing procedure was performed to guarantee that all unreacted reagents were removed. 
Each well was washed with 1 ml of the following reagents: (1) 100 % (v/v) methanol (2) 50% 
DMF : 50 % methanol (v/v) (3) 50% (v/v) DMF (4) water (5) 0,1 M HCl (6) water (7) 0,2 M NaOH 
in 50 % (v/v) isopropanol (8) 2x water and (9) 20% (v/v) ethanol. The washed beads were 
stored with 250 µl of 20% (v/v) ethanol at 4ºC. 
 
Seven identical combinatorial libraries were synthesized to be further screened against the 
respective target: five different fusion proteins with different affinity tags (RWRWRW, 
WFWFWF, NWNWNW, RKRKRK and NNNNN) under physiological conditions, WFWFWF 
tagged GFP in presence of 8M urea and with the negative control, non-tagged GFP. 
 
2.3.2 Production of crude extracts containing GFP-tagged and non-tagged GFP 
 
2.3.2.1 Molecular Cloning of RWRWRW-GFP encoded gene in a pET-21c expression vector 
 
2.3.2.1.1 Preparation of Luria Broth (LB) medium and LB agar plates with ampicilin preparation 
 
The LB medium was prepared for the bacterial culture, where 25 g were added to 1 L of distilled 
water.  The LB agar plates were prepared by dissolving 7.5 g of LB and 4.5 g agar (15 g for 1 L 
distilled water) in 500 mL of distilled water in a Schott flask. Then, the LB and LB agar were 
autoclaved at 120 ºC for 20 min.  Afterwards, the LB agar plates were cooled down without 
medium solidification at room temperature, for the addition of 500 µl of 100 μg/ml ampicilin 
under sterile conditions. The importance of cooling down the LB agar medium before antibiotic 
addition is relevant to avoid degradation of the antibiotic at high temperatures. Once the 
antibiotic was added, the medium was spread in the sterile Petri dishes (~20 ml of medium per 
Petri dish) also under sterile conditions. After the solidification of LB agar, the plated were kept 
at 4 ºC.  The LB liquid medium was kept at room temperature.  
 
2.3.2.1.2 Transformation of the plasmids pAP001 and PET-21C in NZY5α competent cells 
 
The plasmid pAP001 carries the gene that encodes RWRWRW tagged GFP and was 
synthesized by Geneart
 TM
 (Germany). The plasmid (5 µg) was ressuspended in 10 μl 
autoclaved H2O MiliQ. The transformation of the NZY5α competent cells with pAP001 was 
performed according with supplier instructions, NZYTech (Portugal). The NZY5α competent 
cells (60 μl) were thawed on ice. After addition of 2 μl of pAP001, the cells were incubated on 
ice during 30 min. After the cells were subjected to a heat-shock during 30 seconds in a 42 ºC 
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water bath and then immediately placed on ice for 2 minutes. Subsequently, 940 μl of LB 
medium were added to the cells, up to a final volume of 1 ml, at room temperature and were 
shaked at 210 rpm for 1 hour at 37 ºC. Afterward, 50 μl, 100 μl and 200 μl of the transformed 
cells with pAP001 were spread on LB agar plates containing 100 μg/ml ampicilin. Then to 
concentrate the cells, the remaining volume (700 μl) of cell culture was centrifuged for 3 min at 
1850xg, and 600 μl of the supernatant medium was discarded.  The concentrated cells were 
ressuspended in the remaining volume and spread on the LB agar plates. The plates were 
incubated overnight at 37 ºC. Negative and positive controls were performed without adding any 
plasmid and using 1 μl of pUC19 plasmid, respectively, and 20 μl of NZY5α competence cells. 
This procedure was also followed for the transformation of the NZY5α competent cells with pET-
21c plasmid, kindly provided by Prof. Alice Pereira (Requimte, Portugal).  
 
2.3.2.1.3 Isolation and purification of plasmids DNA pAP001 and pET-21c 
 
The isolation and purification of plasmid DNA from pAP001 and pET-21c were carried out using 
a standard procedure from plasmid midi kit according with the supplier instructions (Omega Bio-
Tek). Five pre-inoculum test tubes were prepared: 2x pAP001, 2x pET-21c and a negative 
control. Each tubes containing 6 μl of 100 μg/ml ampicilin, 6 ml of LB medium and one single 
isolated colony from the respective freshly transformed plate (§2.3.2.1.2). In the negative control 
test tube was not added any colony. Then all the test tubes were incubated overnight at 37 ºC at 
210 rpm. After the incubation, 2 ml of each pre-inoculum was used to inoculate 300 ml of LB 
medium with 300 μl of 100 µg/ml ampicilin. This was repeated twice for pAP001 and pET-21c. 
Then, all flasks were incubated overnight at 37 ºC with 210 rpm. The culture was split in Falcon 
tubes of 50 ml and centrifuged during 10 minutes at 11000xg until the total volume has been 
used. After centrifugation, the supernatant was removed and the cell pellet was kept for plasmid 
DNA isolation using the plasmid midi kit (Omega Bio-Tek). The procedure and solution volumes 
were maintained equal as described in the kit instructions for the high-copy plasmid pAP001.  
The isolation of plasmid DNA from low-copy number plasmids requires double of cells and 
volumes of lysis buffers for a more effective isolation. The plasmid pET-21c is considered as 
low-copy plasmid [187].  This kit simplifies the extraction and purification of nucleic acids 
through the binding DNA or RNA into a HiBind® matrix under certain optimal conditions. After 
cell harvest, 2.25 ml of solution I/RNAse A was added to bacterial cell pellet and the cells were 
ressuspended by vortexing. After, the cell suspensions were transferred to 50 ml centrifuge 
tubes, and 2.25 ml of solution II was added, and the centrifuge tubes were covered and mixed 
gently by inverting and rotating the tube 8-10 times to obtain a cleared lysate. The tubes were 
then incubated at room temperature with occasional mixing for 2-3 minutes. Subsequently, 3 ml 
of solution III was added into the tubes, and then gently mixed until a flocculent white 
precipitation has formed. The tubes were incubated at room temperature for 5 minutes and 
afterwards centrifuged at 11000xg for 25 minutes at room temperature, and the cleared 
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supernatant was kept. Meanwhile, a HiBind® DNA Midi column was pre-inserted in a 15 ml 
collection tube and 1 ml of equilibration buffer was added into the column and let sit for 4 
minutes at room temperature to equilibrate the membrane. The columns were centrifuged at 
11000xg for 3 minutes. Then, the cleared supernatant was added by carefully aspirated it into 
the HiBind® DNA Midi column and after centrifuged at 11000xg for 5 minutes until all the 
supernatant has pass through the column. The flow-through was discarded. Subsequently, 3 ml 
of Buffer HB was added to the Midi column and centrifuged as above. The flow-through was 
again discarded, and 3.5 ml of DNA wash buffer (previously warmed at room temperature) and 
then the columns were centrifuged at 11000xg for 5 minutes. The flow-through was again 
discarded and the procedure was repeated. The empty column was centrifuged at 11000xg for 
15 minutes to dry the column matrix and remove the ethanol from the column. The columns 
were placed into a clean 15 ml centrifuge tube. Then, the elution step was carried out by adding 
500 μl of MiliQ water (pre-heated at 65 ºC) onto the column matrix and let it sit at room 
temperature for 2-3 minutes. Then, the columns were centrifuged at 11000xg for 5 minutes. A 
second elution step with 600 μl MiliQ water was performed with the same conditions as first 
elution. Finally, the plasmid DNA concentration was determined.  
 
2.3.2.1.4 Spectrophotometric quantification of plasmid DNA pAP001 and pET-21c 
 
The spectrophotometric analysis allows the quantification of plasmid DNA and evaluation of its 
purity. The eluted fractions (pAP001 and pET-21c) obtained from §2.3.2.1.3 were diluted 1:100 
(10 μl of sample dissolved in 990 μl of MiliQ water) and then a spectrum scan between 220 and 
280 nm was performed in a 1-cm spectrophotometric cuvette. The determination of DNA 
concentration is related with the optical density (OD) at 260 nm, where for 1-cm pathlength, the 
optical density at 260 nm equals to 1.0 for 50 µg/ml of double stranded DNA (dsDNA) solution 
[188]. This relation is given by the following equation: 
 
 dsDNA  = 50 µg/ml   OD 260 nm   Dilution factor   [1] 
 
The DNA purity is given by the ratio between OD260 nm  and OD280 nm and for a pure sample of 
DNA, this ratio should be ~1.8 [188]. 
 
2.3.2.1.5 Evaluation of plasmid DNA through agarose gel electrophoresis 
 
The eluted fractions of plasmids DNA pAP001 and pET-21c were analysed by agarose gel 
electrophoresis in order to evaluate the three possible conformations of plasmid DNA: 
superhelical circular (form I), nicked circular (form II) and linear (form III). These three forms 
have different electrophoretic mobilities, in which form I DNA migrates faster than form III DNA, 
however the form III is a result from DNA manipulation and therefore should not appear on the 
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gel [189]. A 0.8% agarose gel was prepared by adding 0.48 g of agarose to 60 ml of TAE 1x 
buffer pH 8 (buffer denominated Tris-acetate-EDTA composed by 40mM 
tris(hydroxymethyl)aminomethane base (Tris), 20mM glacial acetic acid and 1Mm 
ethylenediaminetetraacetic acid (EDTA) and then heated 2 minutes under microwave until 
complete dissolution of agarose. Afterwards, the solution was poured in the proper container at 
room temperature for the complete solidification of agarose into a gel and with the proper comb 
with the desired number of wells. The samples preparation begins with the addition of 2 µl of 
each eluted fraction of both pAP001 and pET-21c in different microtubes and 5 µl of the sample 
buffer blue juice (buffer composed by 65% (w/v) sucrose, 10 mM Tris-HCl (pH 7.5), 10 mM 
EDTA, and 0.3% (w/v) bromophenol blue) and then well homogeneizated. The same treatment 
was performed with the DNA marker (NZYDNA ladder II).  Afterwards the samples were spin 
down and added to each well of the agarose gel. Once the samples were pipetted in each well, 
the agarose gel was run at 100 V during 60 minutes. Then, the agarose gel was staining during 
30 minutes within a container with SyBr® Safe (Invitrogen). A photograph of the gel was taken 
in an UV transilluminator by using the KODAK 1D 3.6 software. 
 
2.3.2.1.6 Hydrolysis of plasmids DNA pAP001 and pET-21c with restriction enzymes Nhe I and 
EcoR I 
 
Plasmids DNA pAP001 and pET-21c were subjected to sequential hydrolysis with two different 
restriction enzymes Nhe I and EcoR I. The enzymatic hydrolysis of plasmid pAP001 released a 
fragment with 843 bp that corresponds to RWRWRW tagged GFP encoding gene. This gene 
was used for further directional cloning into plasmid pET-21c that becomes linear (5443 bp) 
after hydrolysis with the same restriction enzymes. The double sequential hydrolysis with the 
two restriction enzymes should be carried out in a buffer where both enzymes are close to 
optimal activity. According with TAKARA supplier instructions, the buffer in which Nhe I enzyme 
presents 100% of relative activity is buffer M (100 mM Tris-HCl pH 7.5, 100 mM MgCl2, 10 mM 
Dithiothreitol (DTT) and 500 mM NaCl), while for EcoR I is buffer H (500 mM Tris-HCl pH 7.5, 
100 mM MgCl2, 10 mM DTT and 1 M NaCl). The EcoR I also presents an optimal activity with 
buffer M; however in this buffer the enzyme may display star activity, according with supplier 
instructions. In order to improve the compatibility between the reactional conditions of both 
enzymes activity, the buffer M was used and after complete digestion the enzymes were further 
inactivated. Two different microcentrifuge tubes were prepared, one for pAP001 and other for 
pET-21c. In case of pAP001, the hydrolysis with Nhe I was carried out by assemble in a 
microcentrifuge tube 13 µg substrate DNA (stock solution 425 ng/µl), 5 µl 10x restriction 
enzyme buffer M, 2 µl Nhe I (10 units/µl, Takara) and 13 µl sterilized distilled water for a final 
volume of 50 µl. The restriction enzyme was the last component added to the mixture and its 
volume should not exceed 10% of the reactional volume to avoid high glycerol concentrations. 
Then the reactional mixture was incubated at 37 ºC during 2 hours. The Nhe I hydrolysis with 
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pET-21c was carried out with the same reactional conditions as pAP001, however 43 µl of 
substrate DNA (240 ng/µl) was used and no sterilized was added for the final volume of 50 µl. 
After the first hydrolysis, an aliquot of 5 µl of both reactions was taken for further agarose gel 
electrophoresis. The restriction enzyme was then inactivated for 15 minutes at 70 ºC. 
Afterwards, 2 µl of EcoR I (12 units/µl,Takara) was added to each one of the reactional mixtures 
and then incubated at 37 ºC for 1:30 hours. Once the hydrolysis was finished, 5 µl-aliquots of 
both reactions were collected and then the enzyme was also inactivated by incubation at 60 ºC 
for 15 minutes.   
 
2.3.2.1.7 Hydrolysis evaluation by agarose gel electrophoresis 
 
The success of sequential hydrolysis was analysed through agarose gel electrophoresis. The 
0.8% agarose gel was prepared as described in § 2.3.2.1.5. The samples taken in the first 
hydrolysis corresponds to the digested DNA and those obtained from the second hydrolysis 
corresponds to double digest DNA. To each 2 µl of each sample 5 µl of the sample buffer blue 
juice was added, and then well homogeneizated. Samples (2 µl) of plasmid DNA pAP001 and 
pET-21c without any enzymatic treatment were also analysed as controls. The same treatment 
was performed with 5 µl of DNA marker (NZYDNA ladder III).  The gel was run and stained 
according with § 2.3.2.1.5. The double digested pET-21c and the insert released from the 
sequential hydrolysis of pAP001 were then purified by E-gel® CloneWell agarose gels 
(Invitrogen) for further cloning.  
 
2.3.2.1.8 Purification of the insert fragment from pAP001 and double digested pET-21c using 
the E-gel system 
 
At the end of sequential double hydrolysis the final concentration of pAP001 and pET21c was 
255 ng/µl and 206 ng/µl, respectively. In order to proceed with fragments purification through E-
gel® CloneWell agarose gel, the gel was placed in E-gel® iBase
TM 
and then a pre-run was 
performed with the comb in place by selecting the program PRE-RUN for 2 minutes. At the end 
of the run, the combs were removed and the samples were loaded. According with supplier 
instructions, the loading sample should present 20-400 ng per band in a total of 50-700 ng in a 
total sample volume of 20-25 μl per well. Regarding the hydrolysis samples, 10 µl of pAP001 
double digested was added in each well of four total wells, and then diluted with 10 µl of 
sterilized water. 10 µl of the DNA marker (NZYDNA ladder III) was added in the following well. 
Then, 10 µl of the double digested pET-21c was added in the following four well, and then 10 µl 
of sterilized water was added to each one of the wells. In the remaining empty wells, 25 µl of 
sterilized water was applied in the each one of the wells. Then E-E-gel® iBase
TM 
Power System 
was placed over a blue light transilluminator and a run CloneWell program was selected 
according with the size of band that was purified. According with the size, there is an optimal 
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time that the band takes to reach the reference line. The fragment released after the sequential 
hydrolysis of pAP001 corresponds to 843 bp and the double digested pET-21c presented 5443 
bp. This corresponds to 17-21 and 32-36 minutes, respectively. After, the time was set, the gel 
was monitorized through E-Gel® Safe Imager™ Real-Time Transilluminator. Once the band of 
interest reached the reference line, 25 µl of sterile water was added to in each empty well 
because some pre-filled water was lost during the run. From the reference line until the 
collection well, the sample took 2 and 3 minutes for fragment released from pAP001 and double 
digested pET-21c, respectively. Then, after the band of interest migrated into the well, the DNA 
was collected by pipetting. The samples were further analysed through agarose gel 
electrophoresis § 2.3.2.1.5. The DNA concentration was then estimated by comparing the 
fluorescence intensity of the bands obtained with the respective bands of the DNA marker. The 
fluorescence intensity of the marker bands corresponds to a specific amount of DNA (ng). The 
fluorescence intensity of the bands of the fragments of interest and from the marker was further 
evaluated by ImageJ software. Then by comparison it was possible to estimate the final 
concentration of the obtained fragments.  
 
2.3.2.1.9 Ligation of gene encoding RWRWRW tagged GFP (insert) and double digested pET-
21c with T4 DNA ligase 
 
The ligation reaction with T4 DNA ligase was carried out according with supplier instructions 
(NZYTech). The reaction was performed by assembling in a microcentrifuge tube, 3.8 µl of 
double digested plasmid pET-21c (8 ng/µl), 13.2 µl of 3x excess of insert (1. 03 ng/µl) , 2 µl of 
10x Reaction Buffer (660 mM Tris-HCl, pH 7.6, 66 mM MgCl2, 100 mM DTT and 660 µM ATP), 
1 µl T4 DNA ligase (5 Units/µl, NZYtech) and autoclaved Milli-Q water up to final volume of 20 
μl. The T4 DNA ligase was the last component added.  The amount of insert was determined 
according with the following equation, given by suppliers: 
 
insert  ng = 
ng of vector  kb size insert  
kb size vector 
  molar ratio 
insert
vector
 
 
Then the reactional mixture was incubated overnight at 16 ºC. 
 
2.3.2.1.10 Transformation of the ligation reaction product in NZYstar cells 
 
The ligation product was used to transform NZYstar cells according with procedure previously 
described in § 2.3.2.1.2 with the difference that the LB/ agar plates also contained 100 mg/ml of 
X-gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) and 0.5 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). A negative control was also performed, without transforming cells 
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with any ligation product or plasmid. After the overnight incubation at 37 ºC, twelve colonies 
were randomly selected and plasmid DNA was isolated.  
 
2.3.2.1.11 Isolation of plasmid DNA  
 
Twelve test tubes were prepared with 6 μl of 100 μg/ml ampicilin, 6 ml of LB medium and one 
single isolated colony from the respective freshly transformed plate (§2.3.2.1.10). In the 
negative control test tube no colony was added. Then all test tubes were incubated overnight at 
37 ºC with 210 rpm.  
The isolation and purification of plasmid DNA was performed with NZYMiniprep kit according 
with the supplier instructions, NZYTech (Portugal). The procedure and solution volumes were 
maintained equal as described in the kit instructions for the high-copy plasmid pAP001. The 
isolation of plasmid DNA from low-copy number plasmids requires double of cells and volumes 
of lysis buffers for a more effective isolation. This kit also allows a highly recovery of plasmid 
DNA through the selective adsorption of the plasmid DNA into a silica gel-based NZYTech 
plasmid spin column. This procedure involves sequential stages such as (1) bacterial cell 
harvest, (2) cell lysis, (3) clarification of lysate, (4) DNA binding, (5) silica membrane washing 
and drying and (6) elution of highly pure DNA. The procedure begins with the cell harvest after 
overnight growth, by centrifugation for 2 minutes at 7400xg in separate tubes depending on the 
plasmid used, until the end of total cells suspension. The supernatant was discarded in each 
step of centrifugation. Afterwards, already in cell lysis stage, the bacterial cell pellet obtained 
was ressuspended with 250 μl of buffer A1 (RNase A) by vigorous vortexing. 250 μl of buffer A2 
was added, mixed gently by inverting the tube several times and incubated at room temperature 
for 4 minutes. After incubation, 300 μl of buffer A3 was added and mixed softly by inverting the 
tubes several times. At the end of this stage, the tubes were centrifuged for 10 minutes at 
7400xg. The supernatant was then loaded onto a NZYTech column already placed in a 2-ml 
collection tube for the plasmid DNA binding. The column was centrifuged for 2 minutes at 
7400xg and the flow-through was discarded. The silica membrane was then washed by adding 
250 μl of buffer AY, pre warmed, onto the column and afterwards centrifuged for 2 minutes at 
7400xg. The resultant flow-through was discarded. As a last step of washing, 300 μl of buffer A4 
(with ethanol already added) was added onto the column and once again centrifuged for 2 
minutes at 7400xg. The flow-through was once again discarded. In order to proceed with elution 
of plasmid DNA, the NZYTech column was re-inserted into an empty 2-ml collecting tube and 
centrifuged for 2 minutes at 11000 rpm. The dried NZYTech column was placed into a clean 1.5 
ml centrifuge tube for the first elution step. This step was carried out by adding 30 μl of MilliQ 
water, pre-warmed at 65 ºC, into the centre part of the tube. The column was then incubated 1 
minute in a 37 ºC water bath, and centrifuged for 2 minutes at room temperature. The first 
fraction of the eluted plasmid DNA was then kept at 4ºC. For the second elution step, the 
procedure was repeated as in the first elution step however 50 μl of MilliQ water added. The 
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second eluted fraction was also kept at 4 ºC. After elution, the plasmid DNA isolated from each 
colony was subjected to sequential hydrolysis for the evaluation of success of cloning 
procedure. After this, the eluted plasmid DNA fractions were kept at -20 ºC for further use. 
 
2.3.2.1.12 Confirmation of ligation reaction by agarose gel electrophoresis and DNA sequencing 
 
The success of the cloning procedure was validated by the presence of product obtained from 
the sequential hydrolysis and evaluated by agarose gel electrophoresis. The sequential 
hydrolysis with Nhe I and EcoR I following the strategy described in § 2.3.2.1.6.  However in this 
case, the total volume of hydrolysis was 20 µl, with 10 µl of the pDNA, 2 µl 10x restriction 
enzyme buffer M, 7 µl of autoclaved Mill-Q water and 1 µl of Nhe I. After incubation and enzyme 
inactivation, 1 µl of EcoR I was added to reactional mixture, and after hydrolysis, the enzyme 
was inactivated and then the sequential hydrolysis product was evaluated by agarose gel 
electrophoresis. The agarose gel electrophoresis was performed according with §2.3.2.1.5. The 
wells that present only the presence of double digested DNA and the insert fragment without star 
activity or any unexpected fragment were selected for further DNA sequencing by StabVida 
(Portugal). 
 
2.3.2.2 RWRWRW tagged GFP small scale expression studies 
 
A positive clone, plasmid pET-21c harbouring the gene that encodes RWRWRW tagged GFP, 
was selected for small scale expression studies. These studies involved the transformation of 
cells suitable for protein expression such as E. coli BL21(DE3) with the positive clone 
Afterwards, the effect of inducer concentration at different OD600 nm on the amount of RWRWRW 
tagged GFP produced was studied by monitorization of GFP fluorescence and SDS-PAGE 
analysis. 
 
2.3.2.2.1 Transformation of E. coli BL21(DE3) competent cells with the positive clone  
 
E. coli competent BL21(DE3) cells were transformed with the positive clone as described in § 
2.3.2.1.2.  A negative and positive controls were performed without adding any plasmid and 
using 1 μl of pUC19 plasmid, respectively, and 20 μl of BL21(DE3) competent cells. 
 
2.3.2.2.2 Small scale expression tests 
 
The small scale expression studies were divided in two stages: (i) RWRWRW tagged GFP 
expression at OD600 nm 0.6-0.8 with 0.2, 0.5, 1, 1.5 and 2 mM IPTG and (ii) the protein 
expression using a constant IPTG concentration at higher OD600 nm ~2. In both cases, a pre-
inoculum was prepared by adding 6 ml LB, 6 μl of 100 μg/ml ampicilin and 1 colony of the 
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transformants (§ 2.3.2.2.1) in a sterile test tube. The culture was incubated overnight at 37 ºC 
with orbital shaking of 220 rpm. In the first studies, 100 ml LB, 100 μl of 100 μg/ml ampicilin and 
1 ml of pre-inoculum were added in 250 ml shaking flasks and incubated at 37 ºC at 220 rpm. 
The culture growth was monitorized by optical density measurements, and once reached an 
OD600 nm 0.6-0.8, the protein expression was induced with IPTG. The culture was kept at 37 ºC 
with 220 rpm overnight. Each shaking flask corresponded to a different IPTG concentration. 
After IPTG induction, the protein expression was monitored by GFP fluorescence, optical 
density measurements and SDS-PAGE analysis of the aliquots taken every two hours until 6 h 
of induction and then after overnight protein expression (22 hours). The second stage studies 
began by assembling 50 ml LB medium, 50 μl of 100 μg/ml ampicilin and 1 ml of pre-inoculum 
in a 250 ml shaking flask and then incubated at 37 ºC with 220 rpm. Once again, the culture 
growth was measured by OD600 nm and once reached a value ~2, the culture suspension was 
ready for induction. Prior induction, 50 ml of fresh LB medium and 50 μl of 100 μg/ml ampicilin 
were previously added to the culture suspension and then the IPTG was subsequently added. 
Also in this case, the protein expression was monitorized as in the first stage of studies 
.  
2.3.2.2.3 Evaluation of the amount of RWRWRW tagged GFP produced by SDS-PAGE Analysis  
 
Sample preparation 
 
In order to evaluate the amount of protein expression time course, sample volume was 
normalized. The normalization was performed according with the ratio between 1.2 and the 
respective optical density measurement of each sample.  The respective sample volumes were 
pipetted in different microcentrifuge tubes, and then centrifuged at 6800xg for 5 minutes. The 
supernatant was discarded and the pellet was ressuspended in 50 μl of sample buffer. The 
sample buffer is composed by 5 ml of 0.5 M Tris-HCl pH 6.8, 2 ml of 100% glycerol, 4 mg of 
blue bromophenol, 8 ml of 10% Sodium dodecyl sulfate (SDS), 1 ml of β-mercaptoethanol and 
distilled water up to a final volume of 20 ml. Then, the samples were spin down, and boiled for 2 
minutes. The 5 μl of low molecular weight protein marker (NZYTech) was also subjected to the 
same treatment as the samples.  After this, the samples were ready to be applied in each well 
of the 12.5% acrylamide gel. 
 
12.5% acrylamide gel preparation and blue-coomassie staining 
 
The acrylamide gel is composed by the stacking gel and running gel. The 12.5% acrylamide 
running gel was prepared by assemble in a tube 0.75 ml solution I (3M Tris Base pH 8.8), 2.08 
ml of 30% acrylamide and bis-acrylamide solution 19:1, 0.05 ml 10% SDS, 2.1 ml distilled water,  
38 µl of 10% ammonia persulfate and 2.5 µl  of 99% tetramethylethylenediamine (TEMED). 
Then the mixture was transferred to the glass plates of the casting frame. Afterwards, ~1 ml of 
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2-butanol 99% was added on the top of the gel solution to promote the formation of a 
homogeneous surface and consequently the gel was polymerized for 30 minutes. After this, the 
2-butanol solution was completely removed and the running gel was washed with distilled water. 
The 5% stacking gel was then prepared by adding 0.450 ml solution II (0.5M Tris Base, pH 7.0), 
0.3 ml of 30% acrylamide and bis-acrylamide solution 19:1, 0.018 ml 10% SDS, 0,94 ml distilled 
water, 13.5 µl 10% sodium persulfate and 2 µl of 99% TEMED in a tube. Then, the mixture was 
added on the top of the glass plates and the comb with wells was inserted. Then the gel was 
polymerized for other 30 minutes. Afterwards, the electrophoresis buffer (0.25 M Tris Base, 
1.92M Glycine, 0.1% SDS pH 8.3) was added to the tank, the glass plates containing the 
polymerized gel were introduced in the running module and 15 µl of sample were applied on 
each well. The 12.5% acrylamide gel ran at 150 V, 250 mA for 1 hour, and then transferred into 
the staining solution (1 g Coomassie blue R-250, 15 ml glacial acetic acid, 90 ml of methanol 
and distilled water up to 200 ml) for 30 minutes. Then, the gel was overnight distained with the 
distaining solution (75 ml glacial acetic acid, 450 ml of methanol and distilled water up to 1 L). 
 
2.3.2.2.4 Evaluation of the amount of RWRWRW tagged GFP produced by GFP fluorescence 
  
The fluorescence of the RWRWRW tagged GFP of each aliquot of a respective induction time 
was measured in a microplate format by adding 200 µl of each sample in each well of the black 
96-wll plates (VWR, Portugal). The fluorescence was measured by using an ʎexcitation = 485 nm 
and ʎemission = 535 nm) in microplate reader (Tecan Infinite F200).  
 
2.3.2.3 Large scale expression of RWRWRW tagged GFP 
 
According with small scale studies, the optimal condition for the production of RWRWRW 
tagged GFP was using 1 mM IPTG for the protein production at OD600 nm 0.6-0.8 during 22 h at 
37 ºC with orbital shaking of 220 rpm. Therefore, the large scale expression was conducted with 
these optimal conditions and for this was required the performance of two inocula. The first pre-
inoculum was performed in a test tube by adding 6 ml of LB medium, 6 µl of 100 ug/ml ampicilin 
and 1 colony from the transformed BL21(DE3) cells (§ 2.3.2.2.1 ) and then incubated during 6 
hours at 37 ºC at 220 rpm. Afterwards, the inoculum was performed in a 100 ml shaking flask, 
where 100 ml LB medium, 100 µl of 100 ug/ml of ampicilin and 1 ml of pre-inoculum were added 
and overnight incubated at 37 ºC with 220 rpm. After this, the large scale expression begins 
through the addition of 1 L of LB medium, 1 ml of 100 µg/ml of ampicilin and 10 ml of inoculum 
in a 2 L shaking flask and incubation at 37 ºC with orbital shaking of 220 rpm. The cellular 
growth was monitored by optical density measurements and once reached an OD 600 nm 0.6-0.8, 
the protein expression was induced. During protein expression, 5 ml aliquots of the 2, 4, 6 and 
22 hours of induction were taken and evaluated by SDS-PAGE (§ 2.3.2.2.3 )and fluorimetric 
analysis according with described in § 2.3.2.2.4. 
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2.3.2.3 1 Cellular fractionation 
 
In order to obtain the soluble crude extract containing RWRWRW tagged GFP from the large 
scale protein production, the cells were lysed and then subjected to multiple steps of 
centrifugation and a final dialysis with the binding buffer required for further screening assays. 
The amount of GFP-tagged and total protein were quantified through GFP fluorescence and 
colorimetric Bicinchoninic acid (BCA) assay, respectively.  
At the end of protein expression, the cell culture was centrifuged for 25 minutes at 4200xg at 4 
ºC. The supernatant was discarded and the pellet was ressuspended with 20 ml of Buffer A (10 
mM Tris-HCl pH 7.6) and kept in ice. The ressuspended cells were subjected to three 
freeze/thaw cycles in order to fragilize the cells to improve the cell lysis efficiency. The cell lysis 
was carried out by a mechanical process (French Press), by passing four times the sample 
800psi. After this process, DNase I was added to the lysate during 15 minutes, in order to 
reduce viscosity of the sample. Afterwards, the lysate was centrifuged for 15 minutes at at 4 ºC. 
The resultant pellet was ressuspended in 20 ml of Buffer A and the supernatant was further 
ultracentrifuged at 180000xg at 4 ºC for 1 h. Then, the pellet obtained was also ressuspended 
with 20 ml of Buffer A. The supernatant was then dialysed in the buffer required for further 
screening assays, PBS (10 mM sodium phosphate, 150 mM NaCl, pH 7.4). The supernatant 
was introduced in a dialysis membrane (MWCO of 10 kDa) and dialysed against 5 L of PBS 
during 6 hours at 4 ºC with gentle magnetic stirring. Then, a second dialysis was set overnight 
with the same operational conditions. After this, the soluble crude extract was kept at -20 ºC. 
During the fractionation, aliquots of each step were taken and evaluated through SDS-PAGE 
(§2.3.2.2.3) and fluorimetric analysis (§ 2.3.2.2.4). However, in this case the aliquots volumes 
used in SDS-PAGE analysis were normalized according to the final volume of the sample 
obtained after each step.  Afterwards, 5 µl of the sample buffer was added to the normalized 
aliquots volume from each step of fractionation and then the total volume was pipetted in each 
well of the 12.5% acrylamide gel.  
 
2.3.2.3.2 Quantification of GFP and total protein of the soluble crude extract 
 
The quantification of GFP-tagged and non-tagged and total protein was performed through GFP 
fluorescence and BCA colorimetric assay. The GFP fluorescence allowed the quantification of 
GFP proteins by measuring the intensity of fluorescence in the microplate reader using the 
respective filters ʎexcitation = 485 nm and ʎemission = 535 nm with a gain of 41. Therefore a 
calibration curve was assessed with different purer GFP concentrations within the range 10
-6
 – 
10
-1
 mg/ml. 200 µl of crude extract obtained from cellular fractionation was pipetted in triplicates 
in a black 96-well microplate and the fluorescence intensity was measured. In all cases, the 
fluorescence intensity of 200 µl of blank sample (PBS buffer (§ 2.3.2.3.1)) was also measured in 
triplicates. The total protein was quantified through the colorimetric test, BCA assay. A 
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calibration curve was made with BSA as a standard protein within the range 0.2 - 1 mg/ml. In 
order to perform the BCA assay, 25 µl of each sample (calibration curve and crude extract) was 
added in each well of a transparent 96-well microplate. Then, the BCA working reagent was 
prepared by mixing 50 parts of reagent A with 1 part of reagent B until the formation of a light 
green color. After, 200 µl of BCA working reagent was added to all wells. The microplates were 
incubated at 37 ºC for 30 minutes and the absorbance at 560 nm was measured in a microplate 
reader.  
 
2.3.2.4 Large scale expression of the remaining fusion proteins and GFP 
 
The affinity tags with the sequence WFWFWF, NWNWNW, RKRKRK and NNNNNN fused to 
GFP and non-tagged GFPwere also expressed in bacterial hosts in large scale as well as GFP 
without tagging. The expression of the GFP-tagged and non-tagged followed the same 
procedures as those already described for the expression of RWRWRW tagged GFP. The 
molecular cloning procedure of the DNA fragment that encodes the specific affinity tag fused to 
GFP and the plasmid pET-21c was carried out by Geneart
TM
 (Germany). The plasmid was also 
ressuspended in 10 µl of sterile MilliQ water. Prior to large scale expression, the cloning product 
was amplified in NZYα competent cells for further isolation and purification of plasmid DNA. 
Afterwards, competent cells BL21 (DE3) were transformed with purified plasmid DNA and the 
large scale protein expression was performed by using the optimal conditions: the protein 
expression was induced at OD600 nm 0.6-0.8 with 1 mM IPTG at 37 ºC with orbital shaking of 220 
rpm. After protein expression, cellular fractionation was also performed and the final soluble 
crude extract was quantified by GFP fluorescence and BCA colorimetric test. During the protein 
expression and the cellular fractionation, aliquots of each stage were taken and evaluated by 
SDS-PAGE and fluorimetric analysis. However, in the case of WFWFWF tagged GFP, the 
fusion protein was found in an insoluble form. At this point, no fluorescence was visualized in 
the supernatant. Therefore the pellet sample (15 µl) was analysed by fluorescence microscopy 
(objective of 100x of amplification). Three different photographs of the sample field were taken 
under bright field (to visualise the refractile bodies) and filtered light appropriate for excitation 
and emission (λexcitation= 460-490 nm and λemission = 520 IF). The images were recorded with Cell 
F software and the size of the refractile bonds was determined with Image J software.  
 
2.3.2.5 Antimicrobial assays with hexapeptide RWRWRW (RW)3 
  
Frozen E. coli K-12 (kindly provided by Dr Pedro Vidinha and Diana Garcia) at -80ºC was 
thawed on ice. From the top of the tube, a stab was taken using a sterile pipette tip. The cells 
were spread on pre-warmed LB/agar plate. The LB/Agar plate was incubated overnight at 37 
ºC. Afterwards, in a sterile test tube was added 6 mL of LB and a colony of E. coli K-12 and left 
incubated overnight at 37 ºC with 220 rpm. 
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The OD600 nm of the overnight culture was measured in a sterile transparent 96-well microplate 
and diluted to an OD600 nm of 0.045 with LB medium.  Afterwards, 1.8 ml of the diluted culture 
was pipetted in each well of an autoclaved 2 ml 96-well block, and incubated in a microplate 
incubator at 37 ºC with 500 rpm until OD600 nm reached 0.15. At this point, 200 μL of different 
concentration of (RW)3 were added to the wells, in triplicates for each condition, and then 
incubated for 7 hours at 37 ºC with 500 rpm. Each row of three wells represent a different (RW)3 
concentration. The hexapeptide concentrations used were 0, 10, 100, 500, 1000, 2500 and 
5000 µM. Samples were taken every 30 minutes, pipetted into a sterile 96-well transparent 
microplate and the OD600 nm was measured in the microplate reader to monitor cell growth. 
 
2.3.2.6. Production of RWRWRW tagged GFP in E.coli BL21(DE3) cells 
 
The production of RWRWRW tagged GFP in E. coli BL21(DE3) competent cells was performed 
according with already described in § 2.3.2.2, where after the transformation of the positive 
clone of RWRWRW tagged GFP in pET-21c, the cell growth was carried out in a 500 ml shaking 
flask with 200 ml LB, 200 µl of 100 µg/ml ampicilin and 1 ml pre-inoculum at 37 ºC at 220 rpm. 
Then the protein expression was induced with 200 µl of 1 mM IPTG at OD600 nm 0.6-0.8 and 
incubated at 37 ºC at 220 rpm. In this particular case, the monitorization was performed in a 
more extensive way because the aliquots were taken every two hours until 43 hours of 
induction. The aliquots were analyzed through optical density measurements at 600 nm and 
GFP fluorescence intensity in a 96 well microplate format (§2.3.2.2.4). Also, a cell growth assay 
was performed with only competent cells BL21(DE3). In this case, from the top of the tube of -
80ºC frozen BL21(DE3) cells, a stab was taken using a sterile pipette tip and then spread on 
pre-warmed LB/agar and 100 µg/ml ampicilin and afterwards incubated overnight at 37 ºC, in 
order to obtained individualized colonies. Then, a pre-inoculum was performed, and after this, 
the BL21(DE2) cell growth was also conducted in a 500 ml shaking flask with 200 ml LB, 200 µl 
of ampicilin 100 µg/ml and then incubated at 37 ºC with 220 rpm. In this situation, there is no 
induction with IPTG. The monitorization of the cell growth was also performed in an extensive 
way because aliquots were taken every 2 hours until 50 hours of cell growth and then evaluated 
through optical density measurements at 600 nm.  
.  
2.3.2.7. Production Inclusion bodies (IBs) with the WFWFWF-GFP system 
  
The expression of the WFWFWF tagged GFP has lead to the formation of inclusion bodies 
when using the protein expression conditions of 37 ºC and 1 mM IPTG. Due to this, the sample 
containing the protein as inclusion bodies were solubilised by using a standard procedure [190] 
and then different attempts of refolding were used. Moreover, in order to overcome the 
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formation of inclusion bodies, different culture medium conditions were employed (different 
temperatures and IPTG concentrations).  
 
2.3.2.7.1 Solubilization and Refolding Strategies 
 
The solubilization procedure was performed with the pellet sample obtained from the 
centrifugation step during cellular fractionation after cell harvest. The pellet was ressuspended 
with the buffer A (§ 2.3.2.3.1) and then the sample was centrifuged for 15 minutes at 13700xg at 
4 ºC. The supernatant was kept at -20ºC and then the resultant pellet was ressuspended in 30 
ml lysis buffer (50 mM Tris-HCl pH 7.9, 0.1 mM EDTA, 5% glycerol, 0.1 mM DTT and 0.1 M 
NaCl). Then 1% (v/v) of Triton X-100 was added to the lysate and incubated on ice for 10 
minutes, and afterwards centrifuged at 13700xg, for 15 minutes at 4 ºC. The supernatant was 
kept at -20ºC and the IB pellet was again ressuspended in 30 ml of lysis buffer with 1% (v/v) of 
Triton X-100 and incubated on ice for other 10 minutes. Again, the lysate was centrifuged at 
13700xg for 15 minutes at 4 ºC. Then the drained IB pellet was ressuspended in 30 ml of lysis 
buffer without addition of 1% (v/v) of Triton X-100 to remove the Triton and then recentrifuged 
with the same conditions. The IB pellet obtained was designated as washed IB fraction and the 
supernatant was kept at -20 ºC. The washed IB pellet was ressuspended with 30 ml denaturant 
buffer, incubated 1 hour at room temperature with gentle stirring in order to allow the 
solubilization and denaturation of the IBs. Afterwards, the mixture was centrifuged at 13700xg 
for 15 minutes to remove any insoluble material. The supernatant was then used for further 
refolding of the WFWFWF tagged GFP through multisteps of dialysis.  
 
Different attempts were performed using different denaturant buffers and denaturant 
decrements during dialysis. The first attempt was using the denaturant buffer 10 mM sodium 
phosphate, 150 mM NaCl pH 7.4 with 8 M urea and then the dialysis was performed with 2 M 
decrements from 8 M to 0 M at 4 ºC with gentle magnetic stirring. The second attempt was prior 
to addition of the denaturant buffer addition, in the washing IBs step, the ressuspended pellet 
was divided in two 15 ml lysate. After centrifugation, the two washed pellets were ressuspended 
with the same denaturant buffer as above and after solubilization and centrifugation, the 
respective supernatants, 15 ml each, followed different routes. The first route included the 
dyalisis of the 15 ml by decreasing the urea concentration from 8 M to 2 M with 2 M 
decrements, following dialysis with 1 M, 0.5 M and 0 M at 4 ºC with gentle magnetic stirring. The 
second route was performed by using the 15 ml IBs fraction ressuspended in denaturant buffer 
(10 mM sodium phoshate, 150 mM NaCl pH 7.4 with 8 M urea) in each well of 96-well block, 
where each well present a different affinity ligand and select a lead ligand that could bind to 
WFWFWF tagged GFP in denaturant conditions, so that the refolding on column could be 
performed afterwards. A third attempt was performed as the second one with dialysis as 
refolding strategy, however the denaturant buffer was 30 mM PBS, 150 Mm Nacl pH 8 with 8 M 
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of urea. The two dialysis procedures were carried out in the same way, however at two different 
temperatures (4 ºC and room temperature). A last attempt was performed by ressuspending the 
IB washed pellet with 15 ml of denaturant buffer 10 mM PBS, 150 mM NaCl pH 7.4 with 8 M 
urea and 1% (v/v) of Triton X-100 and then incubated 1 hour at room temperature and 
recentrifuged at 13700xg for 15 minutes. Afterwards, the refolding strategy was the dialysis 
carried out at 4 ºC with gentle magnetic stirring in the same away as the second and third 
attempts.  
 
2.3.2.8 Avoiding the formation of inclusion bodies 
 
The formation of inclusion bodies can be minimized by employing different protein expression 
conditions. For this, the first parameter studied on the impact of WFWFWF tagged GFP 
expression was the IPTG concentration, (0.1, 0.5 and 1 mM) added at OD600 nm 0.6-0.8 in 
cellular cultures grown at two different temperatures, 30 and 37 ºC. Then, the other parameter 
considered was the temperature of WFWFWF tagged GFP expression and four different 
temperatures were studied: 27, 30, 33 and 37 ºC and induction with 1 mM of IPTG at OD600 nm 
0.6-0.8. These experiments were performed according with what was described in § 2.3.2.2. 
However, one particularity of these studies was the fact that cell growth was always conducted 
at 37 ºC, and the temperature was only decreased after the addition of IPTG. Moreover, the 
final volume of cell growth was 150 ml. Each condition was tested in triplicates. The 
monitorization of protein expression was performed with the aliquots taken every hour after 
IPTG addition until 19 and 20 hours of induction. The aliquots were evaluated through optical 
density measurements at 600 nm, SDS-PAGE (§ 2.3.2.2.3) and GFP fluorimetric analysis (§ 
2.3.2.2.4). Afterwards, in order to evaluate if the WFWFWF tagged GFP was produced as 
soluble or insoluble form, all the stages of cellular fractionation were performed until the 
centrifugation step after cellular lysis (§ 2.3.2.3.1). The pellet and supernatant were then 
evaluated by SDS-PAGE (§ 2.3.2.2.3) and GFP fluorimetric analysis (§ 2.3.2.2.4). The pellet 
obtained was also observed under fluorescence microscopy, according with the procedure 
described in (§ 2.3.2.4). 
 
2.3.3 Screening of library based on the Ugi reaction with crude extracts containing GFP-
tagged and non-tagged 
 
Each round of screening involved regeneration, equilibration, loading, washing and elution in 
each well of the 96-well filtration block, where each well corresponds to a resin functionalized 
with a different affinity ligand in a total of 64 ligands. The steps of regeneration and equilibration 
were performed under gravitational force instead of centrifugal force as in the washing step. The 
seven targets were five different fusion proteins with different affinity tags (RWRWRW, 
WFWFWF, NWNWNW, RKRKRK and NNNNN) under physiological conditions, WFWFWF 
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tagged GFP in presence of 8M urea and with non-tagged GFP. The regeneration was 
conducted by adding 250 µl of regeneration buffer (0.1M NaOH, 30% (v/v) isopropanol) 
alternated with 250 µl of distilled water in a total of three times. Afterwards, the equilibration step 
was carried out by adding 12x 250 µl of the equilibration buffer (PBS buffer § 2.3.2.3.1). In the 
last step of equilibration, the samples were collected on a 96-well microplate UV-half area 
(VWR) and then the absorbance was measured at 280 nm, to confirm that the A280 nm reached ≤ 
0.005. Then 250 µl of the respective target (crude extract containing GFP-tagged and non-
tagged) was loaded on each well and incubated at 4ºC for 1 hour with manual shaking to ensure 
a good mixing between the resin and the target. After incubation, the flow-through was collected 
in a black 96-well microplate (Brand, VWR) by placing the microplate below the 96-well block 
and then centrifuged together at 170 xg for 1 minute. Afterwards, each well was washed with 
12x 250 µl of binding buffer and between the washes the samples were collected in a black 96-
well microplate by centrifugation at 170 xg for 1 minute. The same procedure was carried out for 
the screening with target WFWFWF tagged GFP in presence of 8M urea, however during the 
equilibration step the last 8 x250 µl were performed with PBS buffer (§ 2.3.2.3.1) with 8M urea. 
Additionally, during the washing steps after the loading, a completely urea removal was 
conducted with the following urea decrements 3x 250 µl PBS 8M urea, 3x 250 µl PBS 4M urea, 
3x 250 µl PBS 2M urea and 3x 250 µl PBS without urea in order to promote protein refolding. 
After the screening, the resins in all 96-well blocks were regenerated and stored at 0-4ºC in 
20% (v/v) ethanol. The fractions loaded and the samples collected in the black 96-well 
microplates in all washing steps were quantified by the BCA assay and GFP fluorescence 
§2.3.2.3.2.). In case of the screening with WFWFWF tagged, the loaded fractions and the 
collected washes were only possible to be quantified by GFP fluorescence as the urea 
concentrations above 3M interfered with BCA assay according to supplier instructions. 
 
2.3.4 Synthesis and re-screening of the promising lead ligands and the respective crude 
extracts containing GFP-tagged and non-tagged 
 
2.3.4.1 Synthesis of the promising lead ligands  
 
The synthesis of the promising lead ligands (Table 2.3) was also carried out on in duplicates on 
the 96-well filtration block according to 2.3.1.  
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Table 2.3 Promising lead ligands selected t from the screening between combinatorial library 
based on the Ugi reaction and the crude extracts containing GFP-tagged and non-tagged. 
 
 
PROMISING LEAD LIGANDS 
 
TARGET 
 
96-WELL BLOCK 
ROW 
A1C6; A2C4; A2C5; A2C8; A3C5; A3C6; 
A3C7; A3C8; A5C6; A6C6; A6C7; A6C8 
RWRWRW tagged GFP A 
A2C2; A2C3; A2C4; A2C5; A2C6; A3C1; 
A3C4; A3C5; A5C1; A5C6; A6C8; A7C8 
NWNWNW tagged GFP B 
A2C4; A5C4; A7C1; A7C2; A7C3; A7C4; 
A7C5; A7C6; A7C7; A7C8 
RKRKRK tagged GFP C 
A1C5; A2C4; A2C5; A3C6; A2C7; A2C8; 
A3C1; A3C6; A3C7; A3C8: A6C1 
WFWFWF tagged GFP 
(Non-denaturant conditions) 
D 
A4C5; A4C8; A8C8 WFWFWF tagged GFP 
(denaturant conditions) 
E 
A3C7; A3C8; A4C7; A4C8; A6C1; A6C4; 
A6C5; A6C6; A6C7 
Non-tagged GFP G 
 
2.3.4.2 Screening of the promising lead ligands and the respective crude extracts containing 
GFP-tagged and non-tagged 
 
The screening of the promising lead ligands and the respective targets was carried out as in 
2.3.3. However, in this case the elution step was added on the screening after the washing step 
by using a different elution condition in each 96-well block. The bound target was eluted by 
adding 5x250 µl of elution buffer, and between each addition, the samples were also collected 
in a black 96-well microplate by centrifugation at 170 xg during 1 minute. Afterwards, all the 
black 96-well microplates were also covered with aluminum foil and kept at 4ºC. The elution 
conditions used were 0.1M Glycine-HCl, pH 3 and 0.1M Glycine-NaOH, pH 11, except for the 
.WFWFWF tagged GFP screening under denaturant condition, where the last condition was 
substituted by 400 mM NaCl. After elution, the resins in each well regenerated and stored at 
4ºC in in 20% (v/v) ethanol. The fractions loaded and the samples collected in the black 96-well 
microplates in all washing and elution steps were quantified by the BCA assay and GFP 
fluorescence §2.3.2.3.2.  In case of the screening with WFWFWF tagged, the loaded fractions 
and the collected washes were only possible to be quantified by GFP fluorescence as the urea 
concentrations above 3M interferes with BCA assay according to supplier instructions. The 
enrichment of the respective target by the promising lead ligands was also evaluated by SDS-
PAGE analysis. The same evaluation was carried out with the blank agarose against all the 
fusion proteins and non-tagged GFP. 
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SDS-PAGE analysis 
 
The enrichment of the respective target was evaluated by SDS-PAGE analysis according to § 
2.3.2.2.3.  The 12.5% acrylamide gel and sample preparation was carried out in the same way, 
however the volume pipetted from each sample and sample buffer was 5 µl and 5 µl of the low 
molecular weight protein marker (NZYTech) used. The samples tested were loading sample, 
flow-through and the first elution.Gels were stained with Silver Stain Plus (Bio-Rad). The fixative 
step was carried out by placing the gel on 200 ml fixative enhancer solution (100 ml 100% (v/v) 
methanol, 20 ml 100% (v/v) glacial acetic acid, 20 ml fixative enhancer concentrated solution 
and 60 ml distilled water) for 20 minutes under gentle agitation. The solution was disposed off 
on hazardous waste. The gels were rinsed with 200 ml of distilled water for 10 minutes under 
gentle agitation. This step was repeated twice and after each rinse, the water also was 
decanted for hazardous waste. Gels were placed on the staining solution for a maximum time of 
20 minutes also under gentle agitation, and then the solution was also discarded for hazardous 
waste. The staining solution was prepared immediately before using, by adding the components 
in the following order: 35 ml of distilled water, 5 ml of silver complex solution, 5 ml of reduction 
moderator solution, 5 ml of image development reagent and 50 ml of the room temperature 
development accelerator solution. After this step, the staining reaction was stopped, by placing 
the gels in a 5% (v/v) acetic acid solution for 15 minutes, also under mild agitation. Once 
stopping the reaction, the gels were rinsed with high purity water for 5 minutes. Then, the gels 
were photographed in a UVITEC transilluminator through KODAK 1D 3.6 software. 
 
2.3.5 Optimization and characterization of the lead affinity pairs “tag-receptor” 
 
2.3.5.1 Scale-up synthesis of lead affinity ligands 
 
The required amount for the scale-up synthesis of the resins functionalized with lead ligands 
was carried out as described in § 2.3.1. However, each ligand was synthesized in 60-ml 
Nalgene bottle with a total of 20 g of moist gel (60 ml 50% (v/v)) slurry instead of 0.25 g in a 96-
well block. The lead ligands synthesized were A4C8, A3C4, A7C1 and A4C7. 
 
2.3.5.2 Screening of the lead ligands with the respective target in on-column format 
 
The screening by using the on-column format was performed in the same manner as described 
in §2.3.4.2, however in this case, 250 mg of the moist gel with the lead ligand immobilized was 
packed in 4 ml columns (0.8 x 6 cm) and the assay ran under gravitational flow, and the 
resultant fractions were collected in 1.5-ml microcentrifuge tubes, covered with aluminum foil to 
protect from the light and kept at 4ºC. The elution conditions were the same as in § 2.3.4.2.  
The screening was conducted by using the affinity pairs: WFWFWF tagged GFP-A4C7 (under 
denaturant conditions), NWNWNW tagged GFP-A3C4, RKRKRK tagged GFP-A7C1 and GFP-
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A4C8. This assay was also extended to blank agarose without any functionalization and the 
target crude extracts containing the target biomolecules. The fractions obtained were analysed 
by BCA assay, GFP fluorescence §2.3.2.3.2 and SDS-PAGE analysis (§2.3.4.2).  
 
2.3.5.3 Lead ligands selectivity 
 
The selectivity of the affinity ligands A3C4 and A7C1 was evaluated through the screening on 
column according to § 2.3.5.2 against NWNWNW tagged GFP, RKRKRK tagged GFP and GFP. 
 
2.3.5.4 Determination of the binding constants 
 
Binding affinity constants (Ka) and theoretical maximum capacity (Q max) were estimated by 
static partition equilibration studies on a 96-well filtration block. For this, 400 µl (~ 250 mg resin) 
of each functionalized resin with the lead ligand (A3C4, A7C1 and A4C7) was added in each 
well of two entire rows of the 96-well block in total of 24 wells per ligand. Then, the 72 wells 
were regenerated and equilibrated (§2.3.3) and 250 µl of the respective target loaded in each 
well and incubated overnight at 4ºC with orbital shaking at 200 rpm. The crude extracts were 
tested with several dilution factors from 1 to 10000 and this assay was run in duplicates.  
 At end of incubation, a black 96-well microplate was placed underneath the 96-well block and 
centrifuged at 170 xg for 1 minute. Then, the GFP fluorescence of the black 96-well microplate 
with the collected flow-through of all the samples was evaluated on the microplate reader 
(§2.3.2.3 .2).  
 
2.3.5.5 Optimization of the elution profile for the lead affinity pairs 
 
The optimization of the elution conditions for each affinity pair was carried in a 96-well block 
format according to § 2.3.4.4 by using two different approaches as shown in Table 2.4 and 2.5 
with a few modifications. The eluted fractions were quantified only by GFP fluorescence and 
BCA assay. The respective elution buffer was added in each well until no GFP fluorescence 
was detectable. All the elution conditions were used in duplicates. 
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Table 2.4 Elution conditions employed on the first approach of the optimization 
L
E
A
D
 A
F
F
IN
IT
Y
 P
A
IR
S
 
 
ELUTION CONDITIONS OPTIMIZATION – FIRST APPROACH 
PH INFLUENCE 
0.1 M Citrate pH 3 
0.1 M Citrate pH 4 
0.1 M Citrate pH 5 
0.1 M Citrate pH 6 
0.1 M Sodium phosphate pH 7 
0.1 M Sodium phosphate pH 8 
0.1 M Glycine-NaOH pH 9 
0.1 M Glycine-NaOH pH 10 
SALT 
INFLUENCE 
IONIC STRENGTH 
(0.010 M Sodium 
phosphate pH 7.4) 
0.15M NaCl 
0.25 M NaCl 
0.5 M NaCl 
1 M NaCl 
PHOSPHATE 
CONCENTRATION 
(pH 7.4, 0.15M NaCl) 
0.010 M Sodium phosphate  
0.1 M Sodium phosphate  
0.5 M Sodium phosphate  
1 M Sodium phosphate  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2: MATERIALS AND METHODS 
55 
 
Table 2.5 Elution conditions employed on the second approach of the optimization 
 
L
E
A
D
 A
F
F
IN
IT
Y
 P
A
IR
S
 
ELUTION CONDITIONS OPTIMIZATION – SECOND APPROACH 
NON-TAGGED 
GFP 
 
BEST ELUTION CONDITIONS 
 
(0.1 M Glycine-NaOH pH 
9 and pH 11) 
ADDITIVES 
0% (v/v) Ethylene glycol 
5 % (v/v) Ethylene glycol 
10 % (v/v) Ethylene glycol 
25 % (v/v) Ethylene glycol 
50 % (v/v) Ethylene glycol 
 
 
IONIC STRENGTH 
0 M NaCl 
0.15 M NaCl 
0.25 M NaCl 
0.5 M NaCl 
1 M NaCl 
T
A
G
G
E
D
 S
Y
S
T
E
M
S
 
N
W
N
W
N
W
 T
A
G
G
E
D
 G
F
P
 
COMPETITIVE ELUTION WITH 
TRYPTOPHAN 
MILD CONDITIONS 
(0.01 M sodium 
phosphate pH 7.4 
0.15M NaCl) 
0 M Tryptophan  
0.001 M Tryptophan 
0.005 M Tryptophan 
0.010 M Tryptophan 
0.015 M Tryptophan 
BEST ELUTION 
CONDITION  
(0.1 M Glycine-NaOH 
pH 11) 
0 M Tryptophan  
0.001 M Tryptophan 
0.005 M Tryptophan 
0.010 M Tryptophan 
0.015 M Tryptophan 
N
W
N
W
N
W
 T
A
G
G
E
D
 G
F
P
 A
N
D
 
R
K
R
K
R
K
 T
A
G
G
E
D
 G
F
P
 
BEST ELUTION CONDITION 
 
(0.1 M Glycine-NaOH pH 
11) 
ADDITIVES 
0% (v/v) Ethylene glycol 
5 % (v/v) Ethylene glycol 
10 % (v/v) Ethylene glycol 
25 % (v/v) Ethylene glycol 
50 % (v/v) Ethylene glycol 
 
 
IONIC STRENGTH 
0 M NaCl 
0.15 M NaCl 
0.25 M NaCl 
0.5 M NaCl 
1 M NaCl 
R
K
R
K
R
K
 T
A
G
G
E
D
 G
F
P
 
COMPETITIVE ELUTION WITH 
ARGININE 
MILD CONDITIONS 
(0.01 M sodium 
phosphate pH 7.4 
0.15M NaCl) 
0 M Arginine  
0.01 M Arginine 
0.1 M Arginine 
0.5 M Arginine 
0.750 M Arginine 
BEST ELUTION 
CONDITION  
(0.1 M Glycine-NaOH 
pH 11) 
0 M Arginine  
0.01 M Arginine 
0.1 M Arginine 
0.5 M Arginine 
0.750 M Arginine 
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2.3.5.6 Study of the lead affinity pairs in the automated system ÄKTA avant 25 
 
 
The screening was carried out on the ÄKTA avant 25 automated system with the lead ligands 
packed on the HiScale16/20 columns (dimensions: 16 cm inner diameter and 40 cm length). A 
volume of 50% (v/v) resin slurry in 20% (v/v) ethanol used to pack 1g of functionalized resin with 
lead ligands into the columns was determined according to: 
  (ml) = 
AC   L packed   Cf
C slurry
 
Where AC corresponds to the cross sectional area of the column, Lpacked to packed bed height 
(0.5 cm), CF to compression factor that in case of Sepharose CL-6B is 1.15, according to 
supplier instructions and Cslurry to the concentration of the slurry (50% (w/v). The volume used to 
pack 1g column was 2.3 ml of 50% (w/v) slurry functionalized with lead ligands.  
 
2.3.5.6.1 Tests with NWNWNW tagged GFP-A3C4, RKRKRK tagged GFP-A7C1 and non-
tagged GFP-A4C7 
 
The adsorbents were packed (1g) on column with a 0.3 ml.min
-1
 flow and prepared for analysis 
using an ÄKTA avant 25. Afterwards the solid support was subjected to the following steps with 
a flow rate of 1 ml.min
-1
: regeneration (regeneration buffer alternated with H2O, 10 c.v. each in a 
total of 30 c.v.), equilibration (PBS 15 c.v.) and loading (1 c.v. of 1ml of the respective target). 
Then the column was washed with binding buffer (PBS 20 c.v.), and then a step of elution with 
the respective buffer (10 c.v.) was performed and at the end other regeneration step was done 
as already described with a total of 20 c.v. (regeneration buffer 10 c.v.) alternated with H2O (5 
c.v.). All the fractions were collected from the loading in 1 ml 96-well block and kept at 4ºC. The 
fractions were then quantified by GFP fluorescence (§ 2.3.2.3.2), Bradford assay and evaluated 
by SDS-PAGE (§2.3.4.2). On SDS-PAGE analysis, the molecular weight used was Novex® 
Sharp protein standard (Invitrogen). Two different novel runs were performed for each affinity 
pair by using the two best elution conditions (Table 2.6) selected on the optimization of elution 
conditions ( §2.3.5.5). 
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Table 2.6 Best elution conditions employed on the screening between the affinity pairs on the 
ÄKTA avant 25 automated system. 
 
BEST 
ELUTION 
CONDITIONS 
ELUTION 
(A) 
ELUTION 
(B) 
 
LEAD AFFINITY PAIRS 
 
NWNWNW TAGGED GFP 
AND A3C4 
 
RKRKRK TAGGED GFP 
AND  A7C1 
 
NON-TAGGED GFP AND 
A4C7 
0.1M Glycine-NaOH 
pH 11 
PBS with 500 mM 
Arginine 
0.1M Glycine-NaOH pH 9 
0.1M Glycine-NaOH pH 
11 50% Ethylene glycol 
0.1M Glycine-NaOH 
pH 11 150 mM NaCl 
0.1M Glycine-NaOH pH 9 
50% Ethylene glycol 
 
 
Coomassie Plus (Bradford) assay kit 
 
The quantification of total protein was performed with the standard Bradford assay (Coomassie 
Plus
TM 
assay kit), a colorimetric assay that relies on a spectral shift from red (free dye) to blue 
due to the formation of the complex coomassie dye-protein. Samples to be quantified were 
added to each well of a 96-well transparent microplate (10 µl /well). Coomassie Plus protein 
assay reagent (300µl) was added to each well and mixed in an orbital shaker (30 sec, 50 rpm) 
at room temperature. The plate was left to incubate for 10 minutes at room temperature, after 
which the absorbance was read at 595nm using a microplate reader Synergy HT (BioTek). Also 
a calibration curve with standard BSA concentrations (100-15000 µg/ml) was prepared by using 
the same procedure. Controls containing the regeneration, binding and elution buffers were also 
quantified.  
 
2.3.5.6.2 Purification of GFP fusion proteins with A4C7 ligand 
 
The ligand A4C7 was used for the purification of a GFP fusion protein, in particular the fusion 
between GFP and B. megaterium spore cortex lytic enzyme SleL produced in Lactococcus 
lactis, which was kindly provided by Dr Isik Ustok, University of Cambridge. The procedure was 
carried out according to § 2.3.5.6.1. Moreover, the purification profile was also evaluated by 
Western blot analysis. 
 
Western Blot analysis 
 
Protein samples were initially resolved by SDS-PAGE, and then transferred onto PVDF 
Membranes (Life Technologies Ltd., Paisley, UK) which was prewashed with methanol for 30 
seconds and transfer buffer for 5 minutes. Transfer was performed at room temperature using a 
semi-dry blotting unit (Trans-Blot SD, Semi Dry Transfer Cell, Biorad) at 15 V for 15 minutes. 
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Following transfer and washing in water twice for 5 minutes, the membrane was blocked with 
Tris buffered saline (TBS) containing 5% BSA and 0.5% Tween-20 overnight at 4°C.  After 
blocking, the membrane was washed with buffer composed of TBS containing 0.1% Tween 20 
(TBST) for 1 minute prior to incubation with appropriate antibodies. For the detection of GFP 
fusion proteins, primary antibody (Rabbit PAb to GFP) was diluted in blocking buffer (1:2,500 
dilution) and then added to the membrane at room temperature for 1 hour with gentle shaking. 
After extensive washing, a secondary antibody (Goat PAb to Rabbit IgG;) conjugated with 
horseradish peroxidise (HRP) was diluted in TBST buffer (1:10,000 dilution) and the membrane 
was incubated with secondary antibody at room temperature for 30 minutes with gentle shaking.  
Following the final washing, excessive water was removed from the membrane which was then 
placed on an acetate paper facing upwards. The chemiluminescence reaction was conducted 
for 1 minute (Novex, HRP Chemiluminescent substrate reagent kit, Life Technologies, Paisley, 
UK) according to the manufacturer’s instructions, and signal was detected on an X-ray film (GE, 
Amersham Hyperfilm ECL) using the X-ray film developer. 
 
2.3.5.6.2 WFWFWF tagged GFP-A4C8 – Matrix-assisted refolding strategy 
 
A4C8 adsorbent was packed (1g) on column with a flow of 0.3 ml.min
-1
 and subjected to the 
following steps with a flow rate of 1 ml.min
-1
: regeneration (0.1M NaOH, 30% isopropanol (v/v) 
alternated with H2O, 10 c.v. each in a total of 30 c.v.), equilibration (10 mM sodium phosphate, 
150 mM NaCl, pH 7.4 8M urea 15 c.v.) and loading (1 c.v. of 1ml of WFWFWF tagged GFP in 
presence of 8M urea as a result of solubilization of inclusion bodies described in § 2.3.4.7.1). In 
this particular case, after the loading, a refolding step was performed by using a gradient of 1M 
NaCl in binding buffer in order to dilute the urea (250 c.v.). Afterwards, elution was proceeded 
with 0.1M Glycine-NaOH pH 11. (30 c.v.). The regeneration was done as already described with 
a total of 20 c.v. (0.1M NaOH, 30% isopropanol (v/v) (10 c.v.) alternated with H2O (5 c.v.). All 
the fractions were collected from the loading in 1 ml 96-well block in all the steps except for the 
refolding step, where the samples were collected in 50ml centrifuge tubes. The fractions were 
then quantified by GFP fluorescence (§2.3.2.3.2) and SDS-PAGE analysis (§2.3.4.2). Also, in 
this last analysis, the molecular weight used was Novex® Sharp protein standard (Invitrogen) 
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SUMMARY 
 
 
Five different expression systems were constructed each containing a different tag sequence, 
namely RWRWRW, WFWFWF, NWNWNW, RKRKRK and NNNNN. These affinity tags were 
fused to GFP as a reporter protein. Since these affinity tags present novelty on the sequence, 
the gene was designed and subcloned into an expression vector for protein expression using E. 
coli BL21(DE3) as host cells. As a proof of concept, the gene design and subcloning steps were 
accomplished for RWRWRW tagged GFP. For the remaining affinity tags, the expression 
vectors were constructed by Geneart
TM
. The expression conditions were optimized for 
RWRWRW tagged GFP and then extended to all other GFP-tagged proteins. The production of 
the affinity tags fused to GFP in bacterial cells revealed to be straightforward except for 
RWRWRW and WFWFWF tagged GFPs. In the first case, the RWRWRW peptide exhibited 
antimicrobial properties, which influenced the production of the fusion protein. The expression of 
WFWFWF tagged GFP resulted in the formation of inclusion bodies, which were subsequently 
solubilised with chaotropic agents and different attempts of protein refolding were performed. 
Moreover, different cell growth conditions, such as temperature and inductor levels, were 
studied in order to minimize the formation of inclusion bodies. The temperature has revealed to 
have a higher impact on the overall production of soluble WFWFWF tagged GFP rather than the 
inductor levels. Overall, it was possible to produce sufficient amounts of soluble GFP tagged 
proteins to be further used in affinity purification systems. 
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3.1 INTRODUCTION 
 
 
Recombinant proteins find various applications, in therapy and diagnostics as well as in 
industry.  Depending on the final application, their production can be carried out in different host 
cells and with different levels of purity. Bacterial host cells are widely used for the expression of 
heterologous proteins and Escherichia coli is the most popular system. This host presents 
several advantages, such as simplicity, well established methods for genetic manipulation, high 
products yields, rapid expression and cost effectiveness [164, 191-192]. The main 
disadvantages are related with the limitation to undertake pos-translational modifications [164, 
191-193] and the formation of insoluble aggregates. In addition, genes presenting rare or low-
usage codons, that lead to translational errors and incorrect expression of the target 
recombinant protein, cannot be expressed by E. coli [194-195]. Alternative host cells, usually 
more costly and less scalable but overcoming some of bacterial limitations, include eukaryotic 
organisms (e.g. mammalian cells, yeast, insect) and transgenic plants and animals [164, 196-
203].  
 
The production of recombinant proteins can be facilitated through the fusion with reporter 
proteins. The Green Fluorescent Protein (GFP) from jellyfish Aequorea victoria is the most 
extensively studied reporter protein and is a well-developed marker in bioprocess control and 
analysis, applied to monitor dynamic processes in cells, organisms and organs (e.g. gene 
expression, intracellular localization and protein-protein interactions studies) [164, 204-205]. 
GFP-like proteins do not require cofactors, enzymes or substrates other than molecular oxygen 
for the formation of the chromophore [166, 206]. This property makes the formation of the 
chromophore easier in live organisms, tissues and cells. Other advantages of these proteins 
include the low-toxicity and stability in a wide range of pH and solvents, the easy detection in a 
bulk cell suspension without cell disruption, and relatively small molecular weight which 
contributes to a low burden to host cells [206].  
 
In order to develop an affinity pair “tag-receptor” for the purification of fusion proteins, five 
hexapeptides, RWRWRW, WFWFWF, NWNWNW, RKRKRK and NNNNNN, were previously 
considered as potential affinity tags and chosen by presenting different properties of 
hydrophilicity/hydrophobicity and potential to establish hydrogen bonds and hydrophobic 
interactions with receptors [207-208]. This chapter focus on the production of the 
aforementioned affinity tags fused to GFP (reporter protein) in E. coli cells (Fig. 3.1). The gene 
that encodes for the tagged GFP was designed and subcloned into a commercial expression 
vector (pET-21c). The cloning step and optimization of overexpression conditions were carried 
out only for the RWRWRW tagged GFP as proof of concept. Once selected, the nucleotide 
sequences encoding for the remaining affinity tags fused to GFP were synthesized in the 
expression vector pET-21c by Geneart, and then the GFP-tagged proteins produced. After 
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protein expression, the cells were disrupted and fractionated to obtain homogenous crude 
extracts for further purification through affinity chromatography.  
 
 
Figure 3.1 Production of affinity tags fused to GFP. The production comprises three main steps: the 
design of the nucleotide sequence that encodes for the affinity tags (RWRWRW, WFWFWF, NWNWNW, 
RKRKRK and NNNNN) fused to GFP, the subcloning of this sequence in an expression vector such as 
pET-21c and then the expression of GFP-tagged by using E.coli as host cells. 
 
3.2 FRAGMENT DNA DESIGN 
 
The design of the fragment DNA was carried out by considering the nucleotide sequences 
encoding for: The reporter protein (GFP) fused to the affinity tag at the N-terminal; The affinity 
tag and the spacer of three proline residues before enterokinase specific cleavage site; several 
endonucleases restriction sites (Fig. 3.2).  
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Figure 3.2 Scheme of the (A) fragment DNA and (B) respective nucleotide sequence that encodes 
for RWRWRW tagged GFP. The fragment DNA comprises the nucleotide sequence that encodes for the 
affinity tag and the enterokinase recognition site; also the nucleotide sequence of the reporter protein 
(GFP) flanked by two polylinkers with multiple restriction sites with a total of 813 base pairs (bp).  
 
Five different GFP-tagged fragment DNA were designed, exhibiting the same nucleotide 
sequence except the tag nucleotide sequence. The major concern of the design is to avoid the 
usage of rare codons in E.coli [194] to minimize translational errors. The optimized GFP 
nucleotide sequence used in the design was based on the commercial sequence available in 
the plasmid pGFPuv (Clontech). The Nhe I restriction site was extremely important in the 
subcloning process because it allows the insertion of the GFP-tagged fragment DNA on the 
pET-21c expression vector, widely used as an expression vector for the production of 
recombinant proteins [187, 209]. The incorporation of the enterokinase recognition site was 
considered for future affinity tag removal after protein purification. The polylinkers are short DNA 
fragment with recognition sites for specific restriction enzymes and are relevant for the all 
stages of the subcloning process.  The choice of the restriction enzymes for the polylinkers was 
also careful due to the fact that the restriction enzymes cannot cleave the tag or the GFP 
nucleotide coding sequence. Therefore, all sequences were analysed with ChromasPro 
software for restriction mapping. An additional concern for the polylinker P1 was to include 
nucleotides codifying for amino acids les likely to interfere in the binding between the tag and 
the immobilised ligand on the purification step. Once designed, the fragment DNA synthesis 
was carried out on pMA vectors by Geneart
TM
.  
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3.3 MOLECULAR CLONING OF RWRWRW-GFP ENCODING GENE IN A pET-21c VECTOR 
  
The fragment DNA that encodes for the fusion protein RWRWRW-GFP was subcloned into the 
expression vector pET-21c, as a proof of concept. The remaining fragment DNA encoding for 
WFWFWF-GFP, NWNWNW-GFP, RKRKRK-GFP, NNNNNN-GFP and GFP were synthesized 
and subcloned into the expression vector by Geneart
TM
. The resulting expression vectors were 
denominated according with the tag sequence such as pAP001 (RWRWRW-GFP), pAP002 
(WFWFWF-GFP), pAP003 (NWNWNW-GFP), pAP004 (RKRKRK-GFP), pAP005 (NNNNNN-
GFP) and pAP006 (GFP). 
 
Firstly both plasmids pAP001 and pET-21c were amplified in NZY5α cells, the plasmid DNA 
was isolated using a Midiprep kit (Omega) and the final concentration and purity of DNA was 
determined by standard spectrophotometric analysis. The pAP001 was at 425 ng/µl with a purity 
of 1.73 and the pET-21c at  245 ng/µl with a purity of 1.63. Before the subcloning process, the 
hydrolysis of pAP001 and pET-21c vectors with the restriction enzymes Nhe I and EcoR I (Fig. 
3.3) was required. The fragment DNA that encodes for the tagged protein has 843 bp and the 
linear plasmid pET-21c presents 5443 bp. Double digestion of pAP001 released the fragment of 
interest with 748 bp. Afterwards both insert and double digested pET-21c vector were purified 
by gel electrophoresis (E-gel
®
 electrophoresis system).  
 
Figure 3.3 Hydrolysis with restriction enzymes Nhe I and EcoR I of (A) pAP001 plasmid that carries 
the gene encoding for RWRWW-GFPfusion protein (insert) and (B) pET-21c expression vector. Both 
plasmids were sequentially digested, first with Nhe I followed by hydrolysis with EcoR I. A 2 µl aliquot of 
each reaction was applied on the agarose gel (0.8%). After the hydrolysis, the pAP001 releases a 
fragment of 748 bp, corresponding to the insert fragment DNA and the expression vector (ddpET-21c) 
becomes linear, corresponding to a size of 5402 bp. In the first lane of each gel 5 µl of DNA Ladder III 
(NZytech) was applied as a DNA size marker. The agarose gel presents 0.8 % (w/v) agarose). 
 
 
The quantification of both DNA fragments was carried out according with Fig. 3.4. Each band of 
the ladder presented specific fluorescence intensity and corresponds to a specific amount of 
DNA. Considering this, the fluorescence intensity of the bands of interest (insert and double 
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digested pET-21c) was evaluated with Image J software and the concentration of DNA was 
estimated by comparison with the DNA mass standards of the ladder.  
 
 
Figure 3.4. DNA quantification of the insert (A) and the double digested expression vector (B) by 
agarose gel electrophoresis (0.8 % (w/v) agarose) analysis using the (C) NZYDNA Ladder III from 
Nzytech. After purification, the fluorescence intensity of the fragments was estimated using the Image J 
software and then compared with the respective band of the ladder, for an estimation of DNA 
concentration. The volume loaded into the gels of the purified fragment released from pAP001 and the 
double digested pET-21c (ddpET-21c) was 5 µl. The final concentration estimated for the fragment 
released from pAP001 was 1.2 ng/µl. Regarding the gel of pET-21c, four lanes present (lanes 1, 2, 3, 4 
from left to right) different samples of the purified ddpET-21c and according with the evaluation of the 
fluorescence intensity of the bands, the estimated concentration of ddpET-21c corresponds to 8 ng/µl in 
case of lane 1 and 2, 9.65 ng/µl to lane 3 and 4.02 ng/µl to lane 4. 
 
 
After estimating the amount of DNA, the cloning procedure was performed with the enzyme T4 
DNA ligase by using a ratio of insert:vector of 3:1. This enzyme is responsible for the single-
strand nicks repair for DNA double helix. The procedure of the subcloning procedure was based 
on a standard ligation procedure (Nzytech), where the required amount of vector is within 20-50 
nanograms. In order to calculate the suitable amount of insert to use in the ligation reaction, eq. 
4.1 was used according with the supplier’s manual.  
 
Insert amount  ng = 
ng  ector x kb Insert
kb  ector
  Insert    ector ratio molar  (Eq. 4.1) 
 
The product of ligation reaction with T4 DNA ligase was used to transform NZYSTAR competent 
cells. The transformed cells were incubated overnight in LB/agar plates containing ampicillin. 
Twelve random white colonies were selected from the LB/agar plate. The choice of the antibiotic 
was done according with the marker resistance of the expression vector, the amp
r
 gene. 
Afterwards, the twelve colonies were grown in LB medium containing ampicillin for plasmid DNA 
isolation and purification. In order to confirm the presence of positive clones, a hydrolysis with 
the same restriction enzymes Nhe I and EcoR I was performed (Fig. 3.5), and those that 
released a DNA fragment of 748 bp were positive as this would correspond to the GFP tagged 
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fragment DNA. According with Fig. 3.5, all ligation products released a fragment around 800 bp 
which corresponds to the insert of interest. Therefore, the plasmid DNA of some colonies, such 
as 3, 4 and 10, were sequenced by STABvida in order to confirm DNA sequences. Clone 4 was 
used to transform E. coli BL21DE(3) competent cells to begin the GFP tagged expression 
studies. 
 
 
 
Figure 3.5 Evaluation of the hydrolysis of pAP001 of twelve selected colonies obtained from the 
subcloning procedure with restriction enzymes Nhe I and EcoR I by agarose gel electrophoresis 
(0.8 % (w/v) agarose). A volume of 2 µl of each reaction was applied. The positive clones were identified 
by the presence of a fragment with 843 bp.  
 
 
3.4. RWRWRW TAGGED GFP SMALL SCALE  EXPRESSION STUDIES 
 
The small scale expression studies of the RWRWRW tagged GFP fragment DNA on pET-21c 
plasmid were carried out by using E.coli BL21(DE3) as host cells. The protein expression on a 
pET system requires a chromosomal T7 RNA polymerase gene, usually present in E. coli 
BL21(DE3) strain, that is controlled by the T7 lacUV5 promoter and inducible by IPTG [187, 
209-210].  
The great advantages of the pET system are the high expression levels and the versatility, as 
the presence of multicloning sites allows the insertion of different genes [187, 209-210]. 
Moreover, this system presents a reduced background expression before IPTG induction due to 
the existence of T7 lysozyme, a natural inhibitor of T7 RNA polymerase [187, 209-210]. In 
particular, pET-21c already has an AUG start codon and prokaryotic ribosome binding site 
[187]. The RWRWRW-GFP encoding fragment DNA was cloned in a proper reading frame at 
the 3’-end of the AUG start codon, which corresponds to a N-terminal methionine in the 
transcript. 
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The E coli BL21(DE3) competent cells have several important features besides the presence of 
a chromosomal copy of the T7 RNA polymerase gene. This host is protease deficient due to the 
mutations on the gene that encodes E. coli outer membrane proteases [187, 209-210], and 
these cells are compatible with most pET vectors [209].  
 
The small scale expression tests were carried out using the positive clone 4 (pAP001_pET21C), 
where at two OD600 nm (0.6-0.8 and 2), different concentrations of IPTG (0.2, 0.5, 1, 1.5 and 2 
mM) were used to induce the expression of the target protein. Cell growth was monitored by 
optical density measurements at 600 nm. The kinetic profile for the production of GFP-fusion 
proteins was carried out by fluorescence assays (ʎexcitation = 485 nm and ʎemission = 535 nm) in a 
microplate format and by SDS-PAGE.  The GFP fluorescence assay can be used as a simple, 
real time quantification method of GFP-fusion proteins produced intracellular without the need to 
perform cell lysis for further SDS-PAGE analysis. The target proteins can be quantified in a 
rapid and accurate way. Additionally, this technique is useful to monitor large scale production 
of recombinant proteins [211].  
 
During the expression of RWRWRW tagged GFP, aliquots were collected every hour between 6 
and 22 h of induction. Also, an aliquot was taken at the time of induction of gene expression 
with IPTG, representing the t=0 of the expression profile. All samples were evaluated in order to 
select the IPTG concentration and induction time leading to higher yields of GFP-tagged 
protein. As all aliquots correspond to different times of induction with different optical 
measurements of cell growth media, the amount of protein in each fraction was normalized by 
the optical density. Regarding, the SDS-PAGE evaluation, the GFP-tagged fusion protein 
presents a total weight of 31 kDa, 29 kDa corresponds to GFP and the other additional 2 kDa to 
the affinity tag.  
The results obtained for cultures induced at an optical density of 0.6-0.8 are presented in Fig. 
3.6 and 3.7, while those achieved for OD600 nm ~2 are shown in Fig.3.8 and 3.9. The best 
conditions for protein expression are those obtained with IPTG concentrations between 0.2 and 
1 mM after 22 h of induction (Fig. 3.6). However, for 1 mM IPTG a higher value of GFP-tagged 
fluorescence was obtained, corresponding to a higher yield of protein produced. 
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Figure 3.6 Quantification of RWRWRW tagged GFP by GFP fluorescence spectroscopy, produced 
by induction of gene expression at an optical density 0.6-0.8 in E. coli BL21(DE3) cultures. Each 
condition of IPTG used corresponds to unique assay of the target protein expression. The GFP 
fluorescence intensity values were normalized according with a constant optical density value (0.8). 
 
 
Figure 3.7 SDS-PAGE evaluation of the amount of RWRWRW tagged GFP produced over time, 
when using different concentrations of IPTG (A) 0.1 mM, (B) 0.5 mM, (C) 1 mM, (D) 1.5 mM and (E) 2 
mM at optical density 0.6-0.8. M corresponds to the low molecular weight marker (Nzytech); BI, is the 
sample collected at t=0 and all other lanes represent the protein profile at different times of induction (1 h, 
2 h, 3 h, 4 h, 5 h, and 22 h). The band of RWRWRW- tagged GFP is expected to have an apparent 
molecular mass of ~31 kDa and without tagging ~29 kDa. The volume of culture applied on the gel was 
normalized to a final optical density of 1.2. The protein expression was carried out at 37ºC with 220 
rpm.The gels present 12.5% of acrylamide and were stained with Coomassie Blue R-250.   
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The analysis of SDS-PAGE confirmed an increase of the amount of RWRWRW tagged GFP 
fusion protein produced with induction time (Fig. 3.6), as one can observe at the 22 h induction, 
for all the IPTG concentrations tested. In particular, the conditions that present a more intense 
GFP-tagged band are Fig. 3.7 (B), (C) and (E), corresponding to IPTG concentrations of 0.5, 1 
and 2 mM. This last one is not corroborated by the GFP fluorescence intensity values obtained. 
However, the SDS-PAGE evaluation is not conclusive on the distinction of the best condition for 
a higher yield of target protein production. Therefore, the best condition when using lower 
optical density values was mainly selected by the fluorimetric analysis. The best IPTG 
concentration for this condition (OD600 nm 0.6-0.8) was 1 mM. 
The results obtained for the production of GFP-tagged when inducing expression at higher 
optical density values did not lead to a higher yield of target protein. This conclusion is 
corroborated by the GFP fluorescence intensity values obtained for the different samples that 
are lower (Fig. 3.8) than the previous ones (Fig. 3.6). Moreover, the bands obtained for GFP-
tagged are also not as intense as those obtained in previous results. 
 
 
Figure 3.8 Monitoring of GFP Fluorescence intensity when inducing the RWRWRW tagged GFP 
expression at optical density of 2. The GFP fluorescence intensity values were normalized to a constant 
optical density value (0.8). 
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Figure 3.9 SDS-PAGE evaluation of the amount of RWRWRW tagged GFP produced over time, 
when employing different concentrations of IPTG (A) 0.1 mM, (B) 0.5 mM, (C) 1 mM, (D) 1.5 mM and 
(E) 2 mM at optical density 2. M corresponds to the low molecular weight marker (Nzytech); BI, is the 
sample collected at t=0 and all other lanes represent the protein profile at different times of induction (1 h, 
2 h, 3 h, 4 h, 5 h, and 22 h). The band of RWRWRW- tagged GFP is expected to be ~31kDa and without 
tagging ~29 kDa.. The volume used for the sample application was normalized for a final optical density of 
1.2. The protein expression was carried out at 37ºC with 220 rpm. The gels present 12.5% of acrylamide 
and were stained with Coomassie Blue R-250.   
 
 
Overall, the best condition found for the RWRWRW tagged GFP protein production was using 
an optical density of 0.6-0.8 with a concentration of IPTG of 1 mM during 22 h at 37 ºC and 210 
rpm. This condition was then used to all other systems and the GFP tagged protein production 
was also evaluated by the techniques described above.  Other aspect that should be highlighted 
from these studies is that the fluorescence techniques are useful reporters for the online 
detection of the GFP-fusion proteins. These methods allow taking measurements of the 
intracellular fusion protein production in real time and in a simple and accurate form, when 
compared with other methods as SDS-PAGE analysis. This can contribute for the optimization 
of the biochemical engineering processes. 
 
3.5. LARGE SCALE EXPRESSION OF GFP TAGGED PROTEINS 
   
3.5.1 Production of GFP tagged proteins 
 
The large scale production of each affinity tag fused to GFP was performed at the optimal 
conditions determined on the small scale studies. During the expression, the production of 
different GFP tagged proteins was monitored by fluorimetric and optical density measurements 
(Fig. 3.10 and 3.11). SDS-PAGE analysis was also performed in order to visualise the relative 
CHAPTER 3: PRODUCTION OF GFP-TAGGED PROTEINS 
70 
 
amount of protein in the various fractions. For a direct comparison of the amount produced by 
different systems, the loaded fractions at various induction times were normalized to a constant 
specific optical density value. The results obtained are shown in Fig 3.12. There is a direct 
correlation between the optical density and the GFP fluorescence intensity with increasing 
induction times (Fig. 3.10). However, for a direct comparison of the production of GFP fused to 
different tags, a normalization of the fluorescence intensity with the respective optical density 
measurements was performed and shown in Fig.3.11. This normalization allows a better 
evaluation of the GFP fluorescence intensity over time for all tags and present the following 
order in terms of GFP production: NNNNNN tagged GFP > GFP > NWNWNW tagged GFP > 
WFWFWF tagged GFP > RKRKRK tagged GFP > RWRWRW tagged GFP. The RWRWRW 
tagged GFP, is produced at a lower yield, the optical density starts decreasing after 6 h of 
induction, while in the other production systems the optical density tends to increase or 
stabilize. The other affinity tags induce lower levels of GFP expression when compared with the 
system containing the non-tagged GFP, except for the NNNNNN affinity tag. Due to the high 
hydrophilic character of this tag with the highest negative value of logP (§ 4.2), it increases the 
hydrophilicity of the fusion protein, which may increase the solubility of the fusion protein. The 
SDS-PAGE analysis also corroborates these observations regarding the GFP production with 
the different affinity tags fused to GFP. 
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Figure 3.10 Correlation between GFP fluorescence intensity and optical density measurements 
with induction time during the large-scale expression of (A) RWRWRW tagged GFP, (B) WFWFWF 
tagged GFP, (C) NWNWNW tagged GFP, (D) RKRKRKR tagged GFP, (E) NNNNNN tagged GFP and (F) 
GFP on E. coli BL21(DE3) bacterial cells. ♦ GFP fluorescence  □ OD 600 nm 
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Figure 3.11 Normalization of the GFP fluorescence intensity by the respective optical density 
measurements. The fluorescence intensity and optical density measurements were performed over time 
after addition of IPTG (0 h, 2 h, 4 h, 6 h and 22 h) through 96-well fluorimetry and spectrophotometric 
analysis, respectively.  
 
 
 
Figure 3.12 SDS-PAGE time course of large scale production of GFP tagged proteins in E. coli 
BL21(DE3). (A) RWRWRW tagged GFP; (B) WFWFWF tagged GFP; (C) NWNWNW tagged GFP; (D) 
RKRKRKR tagged GFP; (E) NNNNNN tagged GFP; and (F) GFP. M represents the low molecular weight 
marker (Nzytech); BI, is the sample collected at t=0 and all other lanes represent the protein profile at 
different times of induction (2h, 4h, 6h and 22h). The band of GFP tagged is expected to be ~31kDa and 
without tagging ~29 kDa. The volume used for the sample application was normalized for a final optical 
density of 1.2. The gels present 12.5% of acrylamide and stained with Coomassie Blue R-250.   
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Once the proteins were produced by the overexpression system, cell harvest and mechanical 
lysis with French press (4x 800 psi) were required to extract the intracellular proteins. Proteins 
were then fractionated through several steps of centrifugation to remove cell debris and 
membrane fraction. The clarified soluble extract was finally dialyzed against the buffer used in 
the affinity chromatography binding step. In all steps of protein fractionation, an aliquot of each 
sample was taken for analysis by SDS-PAGE (Fig. 3.10). After the last step of fractionation, all 
GFP-tagged proteins were quantified by GFP fluorescence and BCA assay to quantify the 
amount of GFP-tagged produced over the total protein present in soluble crude extracts. The 
results obtained are shown in Table 3.1.  
 
Analysis of all SDS-PAGE gels (Fig. 3.13) shows an intense band on the supernatant lane, 
which corresponds to soluble GFP-tagged, except in Fig. 3.13 (B). For the NWNWNW tagged 
GFP there is a significant amount of protein in the pellet and supernatant after centrifugation. 
This means that protein has been produced both in soluble and insoluble forms. The amount of 
soluble protein was enough to proceed with binding assays.  
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3.13 Cellular fractionation analyzed by SDS-PAGE of (A) RWRWRW tagged GFP (B) WFWFWF tagged 
GFP, (C) NWNWNW tagged GFP, (D) RKRKRKR tagged GFP, (E) NNNNNN tagged GFP and (F) GFP. 
(M) corresponds to the low molecular weight (Nzytech); (BI) the samples collected before induction; and 
(AI) the sample after 22 h of induction;  (FP), after lysis through a French Press; (PC) the ressuspended 
pellet after low-speed centrifugation; (SC) the supernatant after the low-speed centrifugation. This 
supernatant fraction was then ultracentrifuged, and the pellet (PU) and supernatant (SU) were obtained. 
The supernatant was dialyzed (D) against the binding buffer required for screening assays in chapter 5). 
GFP tagged proteins have an apparent molecular mass of ~31 kDa while the non-tagged GFP has ~29 
kDa. The volume used for the sample application was normalized for a final optical density of 1.2. The gels 
were 12.5% in acrylamide and stained with Coomassie Blue R-250.   
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Table 3.1 Percentage of tagged and non-tagged GFP produced over the amount of total protein 
produced by E.coli cells. The percentage of GFP was determined by GFP fluorescence intensity 
measurements and total protein through the colorimetric method BCA assay.  
 
 
Crude Extract 
 
Total Protein (mg/ml) 
 
GFP (mg/ml) 
 
% GFP 
 
RWRWRW tagged GFP 
 
 
8.55 ± 0.13 
 
0.18  
 
2 
 
WFWFWF tagged GFP 
 
 
Formation of Inclusion Bodies 
 
NWNWNW tagged GFP 
 
5.58 ± 0.03 
 
 
0.48  
 
 
9 
 
RKRKRK tagged GFP 
 
7.63 ± 0.24 
 
 
0.33 
 
 
4 
 
NNNNNN tagged GFP 
 
16.81 ± 0.53 
 
 
0.91  
 
 
5 
 
GFP 
 
4.97 ± 0.17 
 
 
0.66  
 
 
13 
 
 
The low amount of RWRWRW-GFP produced can indicate that this particular affinity tag can be 
a burden for the cell. It is known that cationic peptides with arginine-tryptophan (RW) tandem 
repeat peptide sequences are recognized as antimicrobial peptides (AMPs) [212], presenting an 
optimal antimicrobial activity when used with three repeats (RWRWRW, (RW)3) [213-214]. 
(RW)3 repetitions present bactericidal effect against different microorganisms such as S.aureus, 
S. epidermidis, E. coli, P. aeruginosa, and K. pneumonia [213]. It is thought that the mechanism 
of action of these peptides starts by the interaction with the bacterial cell membrane, by 
establishing electrostatic interaction while the cationic side chains of arginine, whereas the non-
polar side chains of the tryptophan residue might induce membrane disruption [212, 215]. 
However, the exact mode of action of these peptides is not yet fully understood and some 
models regarding membrane permeabilization and non-permeabilization have been postulated 
[215]. However, in this particular work, the AMP (RW)3 is being produced intracellularly and 
might destabilize the host cell due to its toxicity leading to cell death [216]. AMPs can be 
produced when fused to a carrier protein in order to mask their toxicity [216-217]. In this work, 
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GFP acted as the carrier protein and the potential of this system for (RW)3 production was 
further evaluated (§ 3.5.2). 
 
Regarding the production of WFWFWF tagged GFP, there is a higher amount of protein in the 
pellet sample after centrifugation, when compared with the amount of protein in the respective 
supernatant (soluble form) (Fig. 3.13), indicating that this fusion protein was produced as 
inclusion bodies (IBs) [187], which was confirmed through observation of the pellet under 
fluorescence microscope (Fig. 3.14). The images shown in Fig. 3.14 reveal bright cylinder spots 
indicating that portion of the protein is proper folded and functional.  The diameter of these 
spots was estimated with Image J, by analyzing all the spots in the image. The average 
diameter of these cylinder spots was 0.45 ± 0.09 µm, while the range of IBs which are bodies 
with diameters within the range between 0.2–0.5 µm [166, 190, 218]. In order to proceed with 
WFWFWF tagged GFP, two different approaches were carried out: the solubilization of IBs 
followed by protein refolding (§ 3.5.3.1); and the avoidance of IBs formation (§ 3.5.3.2) by using 
different conditions of protein expression such as temperature and inductor levels.  
 
 
Figure 3.14 Inclusion bodies obtained for the WFWFWF-GFP production system. The images were 
taken on the fluorescence microscope under (A) bright field filter and (B) fluorescence filter. The inclusion 
bodies are present in the pellet obtained from the low-speed centrifugation step during WFWFWF tagged 
GFP cellular fractionation. These images are representative of five images taken of the sample field with 
1000x amplification. 
 
 
All soluble crude extracts of the five affinity tags fused to GFP were then used for the screening 
with the second generation combinatorial library that contains 64 different affinity ligands 
immobilized on agarose (Chapter 5). 
 
3.5.2. Antimicrobial properties of the RWRWRW-GFP system 
 
The hexapeptide RWRWRW has been described in the literature as an AMP. In this work, 
different tests were performed to evaluate the antimicrobial behaviour of (RW)3 when incubated 
with E.coli K12 and also when produced as a fusion protein with GFP in E. coli BL21(DE3) cells. 
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3.5.2.1 Antimicrobial assays with (RW)3 
 
The antimicrobial effect of the peptide RWRWRW was conducted in a sterile 2 ml 96-well block, 
where different stock peptide concentrations were incubated with E. coli K12 in order to 
evaluate the minimum inhibitory concentration (MIC) values. This parameter is defined as the 
minimum concentration of an antimicrobial substance that inhibits the growth of a 
microorganism under specific conditions [219]. The antimicrobial assays were performed by 
using a HTS method in order to improve the variability of the conditions used and for cost-and-
time effectiveness. The monitoring of cell growth under different concentrations of the 
antimicrobial agent was conducted by optical density measurements at 600 nm every 30 min. 
The results are shown in Fig. 3.15. 
 
 
 
Figure 3.15 Antimicrobial assays between different RWRWRW concentrations and E. coli K12. 
These assays are useful for determining of minimum concentration required for RWRWRW to inhibit the 
bacterial host growth (MIC values). An overnight grown culture of E. coli K12 was diluted for an optical 
density of 0.045, while the cells were in lag phase. The diluted culture was added to each well of a 96-well 
block and then incubated at 37 ºC with stirring until optical density reached 0.1-0.15. From this point, 
different peptide concentrations were added to each well and then optical density measurements were 
taken every 30 minutes in order to monitor cell growth. The error bars corresponds to triplicates of the 
antimicrobial assays. 
 
 
When using antimicrobial agents, two types of effects can be observed: bacteriostatic and 
bactericidal effects. In the former, the antimicrobial agent only inhibits the microorganism growth 
and this latter cell death is observed [220].  The results suggest that from 2.5 mM of (RW)3 there 
is a decay of the optical density measurements suggesting the bactericidal effects of this 
peptide. For concentrations of (RW)3 between 10 and 1000 µM E. coli K12 cells tolerate the 
presence of the antimicrobial agent during growth, as curves are superimposed with the 
controls.  
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3.5.2.2. Production of RWRWRW tagged GFP in E.coli BL21(DE3) cells 
 
Small scale studies of the expression of RWRWRW tagged GFP were performed with a more 
detailed monitoring of optical density and fluorescence intensity (Fig. 3.16).  GFP has already 
been described as a possible carrier protein for the expression of AMPs masking their toxicity 
and preventing their proteolytic degradation [216-217, 221]. Previous works indicate that the 
carrier protein GFP was not efficient to mask the toxicity of AMPs in bacterial cells, leading to 
the formation of inclusion bodies [221]. This effect is possibly a host defence mechanism when 
cells produce antimicrobial peptides. 
 
Figure 3.16 Monitoring RWRWRW tagged GFP production on E. coli BL21(DE3) cells through GFP 
fluorescence intensity and optical density measurements over induction time and growth curve for 
E. coli BL21(DE3) cells. The protein expression was induced at 0.6-0.8 with 1 mM IPTG and carried out 
at 37 ºC with 220 rpm as well for E. coli BL21(DE3) cell growth . Regarding, the RWRWRW tagged GFP, 
the samples were collected after the addition of IPTG (0h – 43 h) and then quantified through 96-well 
fluorimetry and spectrophotometric analysis for the respective monitorization of GFP fluorescence intensity 
and evaluation of optical density of the cell suspension. The E. coli BL21(DE3) cell growth was also 
monitorized by spectrophotometric analysis. The time 0H corresponds to time after induction for 
RWRWRW tagged GFP expression and 8H after inoculum for E. coli BL21(DE3) cell growth. The error 
bars correspond to three assays of the expression of RWRWRW tagged GFP. 
 
 
Overall, the production of the AMP RWRWRW fused to GFP is possible to perform by using 
bacterial hosts. The use of GFP as a carrier protein seems to be efficient as there is no 
formation of inclusion bodies. The maximum fluorescence intensity is observed at 15 h and this 
should be the optimum time to achieve the highest yield in protein production. By analysing Fig. 
3.16, it is visible that OD decays approximately 41% between 25 and 35 h after induction, which 
may be related with the high toxicity provoked by the produced peptide. This is corroborated by 
E. coli BL21(DE3) growth profile on Fig. 3.17, that indicates that at this specific time, the cells 
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were still in stationary phase but not in death phase. At the same time that the OD values 
decrease, there was an increase of GFP fluorescence intensity. This can be explained by the 
release of RWRWRW tagged GFP to culture medium when cell death occurs, and GFP 
fluorescence was no longer influenced by the bacterial cell wall. In this situation, the purification 
of RWRWRW tagged GFP could be facilitated as no further steps of cell lysis were required. 
However, further studies would be necessary to corroborate this hypothesis. 
 
 3.5. 3 Production of inclusion bodies with the WFWFWF tagged GFP system 
  
 
3.5.3.1 Solubilization and Refolding Strategies 
 
The WFWFWF tagged GFP protein was produced as inclusion bodies and attempts were made 
to solubilise and refold the protein [190]. Protein solubilization was performed with chaotropic 
agents such as urea, that leads to a random coil structure and loss of secondary structure, 
therefore exposing protein hydrophobic surfaces [222]. The solubilisation buffer also includes 
other additives such as dithiothreitol (DTT), ethylenediaminetetraacetic acid (EDTA) and 
glycerol, where DTT and EDTA prevent unwanted or incorrect disulfide bonds formation and air 
oxidation during refolding, respectively [190, 222]. Glycerol is also considered an excellent 
refolding additive [190]. The solubilization was carried out at room temperature according with 
previous reports [190]. After protein solubilisation, refolding was carried out at 4 ºC through 
subsequent dialysis with small decrements of urea until complete removal of the chaotropic 
agent. Unfortunately, the fusion protein precipitated and fluorescence was lost during the last 
dialysis step. This phenomenon was reversible as GFP´s fluorophore was restored in the 
presence of the buffer with the lowest amount of urea (0.5 M urea). Since the refolding attempts 
were not successful, different solubilisation buffers were employed. These contained the same 
compounds but with higher salt concentration and slightly higher pH. In addition, the refolding 
was conducted with different temperatures namely 4 ºC and room temperature. According to the 
literature, the pH used should be at least one unit far from the isolectric point [190]. 
Furthermore, salt concentrations used should be a balance between very low concentrations 
which contribute for salting-in effects and therefore increase the protein solubility, and high 
concentration that can lead to protein precipitation [165, 190].  Regarding the refolding 
temperature, there is no optimal temperature to restore native tertiary structure of the protein, 
however in most cases, the refolding is conducted at room temperature [190, 222]. However, 
none of these strategies were successful. The last attempt was to perform the refolding on-
column, which is further described in Chapter 5 (§ 5.6.1). 
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3.5.3.2 How to avoid inclusion bodies? 
 
Considering that refolding of WFWFWF tagged GFP was not achieved, different strategies were 
explored to minimize the formation of inclusion bodies. The high level of protein expression in E. 
coli can lead to the formation of insoluble protein aggregates as inclusion bodies. These 
aggregates are formed by unfolded or highly misfolded polypeptides [165, 190]. In order to 
improve correct folding, recombinant proteins should be secreted to the periplasmic space 
through a peptide leader sequence on the N-terminal, since molecular chaperones and a 
reducing environment are found in the periplasm [165, 191, 193, 223-224]. Inclusion bodies can 
be avoided by changing growth conditions such as temperature, inducing agent levels and time, 
E. coli strain [164, 190-191, 223]. 
 
Therefore the study of the impact of different expression conditions on the overall production of 
WFWFWF tagged GFP and on the ratio between soluble GFP fusion protein and IB formation 
was carried out in two different stages. The first was characterized by the inductor levels 
influence, where different concentrations of IPTG (0.1, 0.5 and 1 mM) were used for two distinct 
temperatures (30 and 37 ºC) to which the cell cultures were subjected after the addition of 
IPTG.  After selecting the optimal level of IPTG, this condition was employed on the study of 
temperature influence (27, 30, 33 and 37 ºC) during the expression of the target protein, once 
again after IPTG addition. The production of WFWFWF tagged protein and the ratio between 
soluble and insoluble protein produced was monitored by optical density and GFP fluorescence 
intensity measurements as well as by analysis of SDS-PAGE gels.  
 
3.5.3.2.1 Inductor levels Influence 
 
The results showing the impact of IPTG levels on IB formation are shown in Figs. 3.17, 3.18 and 
3.19. Fig. 3.17 displays the evolution of GFP fluorescence intensity normalized with the 
respective optical density measurement over the induction time for different inductor 
concentrations and temperatures. There was an increase of GFP tagged production with the 
induction time, and this amount was higher when performing the expression at 30 °C (Fig. 3.17 
(A)). 
 
In order to infer on the amount of protein produced in soluble and insoluble forms, the cells were 
lysed by French press mechanical process and then centrifuged to analyse the supernatant and 
the pellet [187].  The results obtained are shown in Figs. 3.18 and 3.19. The analysis of the 
SDS-PAGE gels (Fig. 3.18), confirmed that the induction with IPTG was successful (as no GFP 
protein was visible before induction), and that the majority of the protein was produced in 
insoluble form as the GFP protein is clearly present in the pellet lanes (P). The results from Fig. 
3.19 indicate that although the amount of tagged GFP produced in insoluble form was higher, 
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the fluorescence intensity of these samples was lower when compared with that obtained from 
the soluble form. This can be explained by the fact that IBs are mostly formed by unfolded or 
highly misfolded polypeptides [166, 190] and the fluorescence intensity of GFP in IBs (pellet) is 
not representative of the real amount of protein. Quantifications of soluble protein seem more 
accurate.  
 
Overall, these studies indicate that the lowest temperature (30 ºC) is more adequate for protein 
expression and that the amount of protein produced in both forms is higher for IPTG 
concentrations of 0.5 mM and 1mM.  
 
 
Figure 3.17 Impact of IPTG concentration on the expression of WFWFWF tagged GFP at (A) 30 °C 
and (B) 37 °C. The WFWFWF tagged GFP expression was induced at OD 0.6-0.8 with three different 
concentrations of IPTG (0.1, 0.5 and 1 mM), and then carried out at different temperatures.  Samples at 
different induction times were characterised by GFP fluorescence intensity and optical density 
measurements. The error bars corresponds to triplicates of the WFWFWF tagged GFP expression assays. 
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Figure 3.18 SDS-PAGE analysis of the soluble and insoluble WFWFWF tagged GFP produced over 
the induction time for different concentrations of IPTG at (A) 30 ºC and (B) 37 ºC. The lanes in the 
“time course” correspond to  the lower molecular weight (Nzytech) (M), samples taken before induction (BI) 
and at different times of induction (1 h, 2 h, 3 h, 4 h, 5 h, 6 h and 20 h). After the expression of proteins 
(AI), the cells are lysed with French press, and then centrifuged to evaluate the soluble (S) and insoluble 
form (P). The band of GFP tagged is expected to be at ~31 kDa. The volume used for the sample 
application was normalized for a final optical density of 1.2. The gels present 12.5% of acrylamide and 
stained with Coomassie Blue R-250.   
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Figure 3.19 GFP fluorescence intensity of soluble and insoluble forms of WFWFWFW tagged GFP 
obtained after protein expression induced at 0.6-0.8 with different IPTG concentrations at (A) 30 ºC 
and (B) 37 ºC. The evaluation of soluble and insoluble form was performed after the expression of 
WFWFWF tagged protein, in particular after the steps of cellular fractionation such as cell lysis and low-
speed centrifugation. The error bars corresponds to triplicates of the WFWFWF tagged GFP expression 
assays. 
 
 
3.5.3.2.2 Temperature Influence 
 
The influence of temperature during the expression of WFWFWF tagged induced with 1 mM 
IPTG was studied by employing four different temperatures 27, 30, 33 and 37 ºC. The results 
obtained from the fluorescence intensity measurements normalized with the respective value of 
optical density are shown in Fig. 3.20. These results show that with the increase of temperature, 
there is a higher amount of protein being produced and that 30 ºC seems to be the best 
temperature condition, followed by 27 ºC, 33 ºC and 37 ºC. As previously discussed, the 
analysis of GFP fluorescence intensity might not be representative of the real amount of protein 
produced in insoluble form. Therefore, it was necessary to analyse concomitantly the 
information given from Figs. 3.20-3.22. 
 
When analysing the SDS-PAGE gels (Fig.3.21), it is clear that induction with IPTG was 
successful for all temperatures (as no GFP protein was visible before induction), and that the 
majority of the protein was produced in the insoluble form. Finally, data in Fig.3.22 clarify on the 
relative amounts of soluble and insoluble protein produced. The ratio between the fraction 
soluble and insoluble corresponds to 1.2, 2.5, 1.8 and 2.3 for the temperatures 27, 30, 33 and 
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37 ºC, respectively. The ratio between the soluble and insoluble form seems to be more 
pronounced for 30ºC. In general, at lower temperatures (27 and 30 ºC), the production of 
soluble protein is similar and more effective than at higher temperatures. The condition T=27 ºC 
seems to be more reproducible and accurate as lower error bars were obtained.  
 
 
Figure 3.20 Impact of expression temperatures on the overall productivity of WFWFWF tagged 
GFP. The WFWFWF tagged GFP expression was induced at 0.6-0.8 with 1mM of IPTG and then carried 
out at different temperatures after the induction.  The monitorization was carried out by GFP fluorescence 
intensity and optical density measurements. For a direct comparison between all samples of different 
induction times, the GFP fluorescence intensity was normalized with the respective optical density values. 
This corresponds to ratio between the fluorescence intensity and the optical density at 600 nm. The errors 
bars correspond to triplicates of WFWFWF tagged GFP expression. 
 
 
 
 
Figure 3.21 SDS-PAGE analysis of the soluble and insoluble WFWFWF tagged GFP produced over 
the induction time for different temperatures. The lanes in “time course” corresponds to: the lower 
molecular weight (Nzytech) (M), samples taken before induction (BI) and at different times of induction (1 h 
, 2 h, 3 h, 4 h, 5 h, 6 h and 20 h) . After the expression of proteins (AI), the cells are lysed with French 
press, and then centrifuged to evaluate the soluble (S) and insoluble form (P). The band of GFP tagged is 
expected to be at ~31 kDa . The volume used for the sample application was normalized for a final optical 
density of 1.2. The gels present 12.5% of acrylamide and stained with Coomassie Blue R-250.   
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Figure 3.22 GFP fluorescence intensity of soluble and insoluble forms of WFWFWFW tagged GFP 
obtained after protein expression induced at 0.6-0.8 with 1 mM of IPTG at different expression 
temperatures. The evaluation of soluble and insoluble form was carried out from the first step of 
centrifugation during protein fractionation after the expression of WFWFWF tagged protein and 
subsequent cell lysis. The ratio between the fraction soluble and insoluble corresponds to 1.2, 2.5, 1.8 and 
2.3 for the temperatures 27, 30, 33 and 37 ºC, respectively. The error bars correspond to triplicates of 
WFWFWFW tagged GFP expression assays. 
 
The samples correspondent to the pellets obtained for the various conditions were also 
visualised by fluorescence microscopy and presented in Fig.3.23. These images indicate that as 
the expression temperature increases, the formation of aggregates is more prone to occur. For 
high temperatures, the aggregates presented intense fluorescence indicating the presence of 
folded tagged GFP. However, these aggregates might interfere with the measurement of GFP 
fluorescence intensity. 
 
 
Figure 3.23. Fluorescence microscopy analysis of the insoluble form of WFWFWF tagged GFP 
produced at different temperatures with 1 mM IPTG. The insoluble form is related with the formation of 
inclusion bodies. This sample is obtained from the first step of centrifugation during protein fractionation 
after the expression of WFWFWF tagged protein and subsequent cell lysis. These images are 
representative of three images taken from the sample field and present a total amplification of 1000x.  
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Overall it is difficult to avoid the formation of inclusion bodies by controlling the temperature, for 
the WFWFWF tagged GFP protein. However it was possible to increase the amount of soluble 
protein when employing lower temperatures. The temperature seems to have a higher impact 
than the inductor levels. Still it was possible to increase the amount of soluble protein produced 
by a factor of 10 when employing 27 ºC and1 mM IPTG for induction.  
 
3.6. CONCLUDING REMARKS 
 
 
The development of novel affinity tag started with the successful subcloning of the fragment 
DNA with the nucleotide sequence encoding the affinity tag fused to GFP in pET-21c 
expression vector. The proof of concept was performed for RWRWRW tagged GFP, and can be 
extended to other hosts, expression vectors and target proteins, since the designed fragment 
DNA included two multicloning sites, for the subcloning to other commercially available 
expression vectors and also to include nucleotide sequences codifying for other proteins. The 
production of the RWRWRW tagged GFP was carried out in bacterial cells, and an optimization 
of expression conditions were performed in order to maximize the yield of protein produced. The 
production of the five different affinity tags fused to GFP in E. coli cells presented different 
expression profiles (Table 3.2). 
 
For the cases of GFP tagged to RKRKRK, NNNNN and NWNWNW protein expression is similar 
and a considerable amount of protein has been produced as soluble protein. These fusion 
proteins were produced under conditions optimized for the RWRWRW tagged GFP, and there is 
still scope to improve conditions individually for each tag system. 
 
The expression of RWRWRW tagged GFP revealed to be a burden to the host cells and due to 
its antimicrobial properties can also be lethal after long induction times. Still, it was possible to 
produce enough soluble protein to carry out further steps of screening Ugi based combinatorial 
library. However, the antimicrobial properties of this affinity tag might interfere with its main 
application studied in this work 
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Table 3.2. Expression profiles summary of each affinity tag fused to GFP.  
 
 
GFP tagged and 
non-tagged 
proteins 
Expression Profile 
Temperature 
(ºC) 
IPTG 
(mM) 
GFP 
(mg/ml) 
Total Protein 
(mg/ml) 
Properties 
H
e
x
a
p
e
p
ti
d
e
s
 
 
 
RWRWRW 
37 
1 
0.18  8.55 ± 0.13 
 
The tag presents 
antimicrobial 
properties 
WFWFWF 27 0.11 4.96 ± 0.21 
Protein produced both 
as soluble and 
insoluble form 
NWNWNW 37 0.48  5.58 ± 0.03 
Protein produced both 
as soluble and 
insoluble form 
 
RKRKRK 
37 0.33 7.63 ±0.24 Soluble protein 
NNNNNN 37 0.91 16.81 ±0.53 
Protein produced both 
as soluble and 
insoluble form 
N
o
n
-t
a
g
g
e
d
 
GFP 37 0.66 4.97 ±0.17 Soluble protein 
 
 
 
The WFWFWFW tagged GFP produced at the optimized conditions for RWRWRW tagged GFP, 
lead to the formation of IBs. As a first approach, the protein in the IBs was solubilised with 
chaotropic agents and different refolding strategies were attempted. However, no strategy was 
successful and the matrix assisted refolding was selected for further studies. IBs could be 
minimised by changing the growrh culture temperature. Lower temperatures can contribute for 
the production of higher amounts of soluble protein. The NWNWNW tagged GFP was also 
produced as both soluble and insoluble for but the total amount of soluble protein was enough 
to carry out with further studies. A common feature of the affinity tags that produce GFP protein 
as IBs is the presence of tryptophan residues on their sequences and their hydrophobic 
character.  
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CHAPTER 4 
COMBINATORIAL LIBRARY SCREENING WITH CRUDE EXTRACTS CONTAINING GFP-TAGGED AND NON-
TAGGED PROTEINS 
 
 
SUMMARY 
 
A combinatorial library comprised of 64 affinity ligands based on the Ugi reaction was prepared 
and screened for binding to five GFP tagged proteins and non-tagged GFP, from crude extracts 
of Escherichia coli production. The five GFP tagged proteins used were RWRWRW-GFP, 
WFWFWF-GFP, NWNWNW-GFP, RKRKRK-GFP and NNNNNN-GFP. The screening was 
performed using affinity chromatography in a 96-well format, and lead ligands were identified for 
the GFP -tagged and non-tagged proteins. For the GFP- tagged proteins, the lead systems “tag-
receptor” were: A4C8 for WFWFW-GFP in denaturing conditions, A3C4 for NWNWNW-GFP 
and A7C1 for RKRKRKR-GFP. The GFP tagged proteins, RWRWRW-GFP and NNNNNN-GFP 
were not selected for further studies as no lead ligands were identified. For non-tagged GFP, 
the lead ligand selected was A4C7. 
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4.1 INTRODUCTION 
 
The development of synthetic affinity ligands for the purification of a target biologic comprises 
three main stages: rational design, solid-phase synthesis and high-throughput screening. The 
rational design involves in silico tools to develop a structure that mimics the functionalities of the 
natural ligand involved in biological recognition, or can be de novo designed for increased 
complementarity with the target protein [1-2]. In order to develop an affinity pair “tag-receptor” 
for the purification of fusion proteins, two first generation libraries of affinity ligands based on the 
triazine and Ugi-scaffolds have been previously de novo designed and screened on-bead by 
fluorimetric techniques toward the five hexapeptides RWRWRW, WFWFWF, NWNWNW, 
RKRKRK and NNNNNN [207-208]. 
 
The on-bead screening was initially carried out with the potential targets labelled with the 
fluorophore FITC (fluorescein isothiocyanate) on the C-terminal, and with two proteins selected 
as controls, namely GFP and Bovine Serum Albumin (BSA) labelled with FITC. The 
fluorescence-based techniques employed were Fluorescence microscopy and 96-well 
Spectrofluorimetry, which presented several limitations, namely the fact that the former is time-
consuming, requires the individual analysis of the binding character of each agarose sample 
under the fluorescence microscope, and is difficult to implement as a HTS method; and the 
latter is associated with a high incidence of false negative results, and problems with resin 
pipetting including resin retention in the tip after dispensing, resin settling during the aliquotting 
procedure, and variability in the aliquotted slurry volume [225]. In addition, these first studies 
were performed with purified solutions of biomolecules conjugated to a fluorophore. Due to 
these limitations, this chapter focus on the selection of lead ligands by HTS affinity 
chromatography employing unlabelled and unpurified samples containing the target 
biomolecules. 
 
The use of 96-well microtiter plate formats facilitates the screening of a wide range of different 
adsorbents and the use of different binding and elution buffers, such as buffer composition, pH, 
concentration and ionic strength. Furthermore, the required amounts of resin and target 
biomolecule are much less than required for other techniques [225-226]. Besides these 
advantages, microscale affinity chromatography in a 96- well format is less time consuming, is 
cost effective and leads to an acceleration of the downstream process development [225-226]. 
The main differences between 96-well and column formats are related to binding capacity 
measurements, automation and costs [226]. The binding capacities are different because the 
96- well format is operated in batch mode, in which the target biomolecule and the resin are 
incubated under agitation; thereby generating a suspension of resin beads with the biomolecule 
feed solution. On column, this measurement is performed in a dynamic mode and is influenced 
by the flow rate [226]. Furthermore, the residence time and linear velocity are not representative 
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of industrial applications [227]. Another difference between the methods relates to the 
automation, as in the case of the 96- well format, it is essential to include a separation step to 
resolve the resin and the supernatant after incubation. This separation step may be achieved by 
vacuum filtration, pipette dispensing or by centrifugation [225]. Microscale 96-well formats have 
already been successfully employed in several applications for the purification of polyclonal 
antibodies by using a mixed mode cation exchange chromatography [226],  in protein 
purification from cell-free broths [228], in optimization of the resin and elution buffer of protein A 
for monoclonal antibodies [229] and in the development of chromatographic methods for the 
purification of α-amylase [230]. Other applications of these methods also include the purification 
of virus-like particles and the development of peptide tags using metal affinity chromatography 
[231]. All of these examples are based on the incubation of a  sample with the resin and 
Bergander et al [232] were the first to describe the microscale 96-well format for the estimation 
of the dynamic binding capacity as predictive of the behaviour of a preparative chromatography 
column [232]. Although the 96-well formats do not substitute for the use of pre-packed columns, 
they can lead to an indication of the optimal ligand candidate and chromatographic conditions, 
i.e. they can narrow the search for the conditions for the subsequent on-column studies. 
 
This chapter describes the synthesis and screening of a combinatorial library of affinity ligands 
based on the Ugi reaction against GFP-tagged and non-tagged protein using microscale affinity 
chromatography in a 96-well format. A freshly prepared combinatorial library was utilised for the 
screening with each target protein. The GFP-tagged proteins presented the tag sequence, 
which included five different tags: RWRWRW, WFWFWF, NWNWNW, RKRKRK and 
NNNNNNN. The non-tagged GFP was the same protein minus the tag. The evaluation of the 
lead ligands was determined according to Fig. 4.1. A preliminary screening was performed in 
order to evaluate the putative lead ligands by determining the enrichment factor for each affinity 
ligand and the respective target biomolecule, while comparing with the theoretical maximum 
enrichment factor for each system. Putative lead ligands were re-screened using the 96 -well 
format to select the lead ligands for each target biomolecule. In this last step of selection, the 
purity of each fraction was qualitatively determined by SDS-PAGE analysis and the binding 
percentages of GFP proteins (tagged and non-tagged) and total protein were assessed for each 
of the putative lead ligands by measurements of fluorescence intensity and colorimetric 
techniques. 
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Figure 4.1 Strategy for the selection of lead ligands. The first stage involved the selection of the 
putative lead ligands through 96-well format screening of a combinatorial library of affinity ligands based 
on the Ugi reaction and the GFP-tagged proteins. The putative lead ligands selected were those with 
higher values of enrichment factor, determined by the ratio of GFP fluorescence and the BCA total protein 
assay.  The second stage comprised the refined selection of the lead ligands, by monitoring the % of GFP 
and total protein bound and SDS-PAGE evaluation.  
 
 
4.2. SYNTHESIS OF A COMBINATORIAL LIBRARY OF AFFINITY LIGANDS 
 
The synthesis of the libraries of ligands was carried out on a solid phase in a 96-well format. 
The solid phase presents several advantages over the liquid phase as this latter requires 
multiple steps of synthesis and isolation procedures. In the solid phase, the purification process 
can be facilitated by washing off starting materials or other by-products formed by filtration and 
the amount of starting material required are less when compared with liquid phase. The main 
disadvantages of the solid phase are related to the instability of the support under the use of 
certain solvents, as well as the difficulty in characterizing and quantifying  the intermediates and 
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final products synthesized on the solid support due to the poor resolution of the available 
techniques [233].  In order to overcome the main disadvantages of the solid phase system, the 
reactions were accomplished by using an excess of starting materials to guarantee the product 
formation and compatible solvents with the solid support. Moreover, during the solid phase 
synthesis, quantitative and qualitative tests were performed in order to evaluate the amount of 
intermediates that were formed until the formation of the final products.  
 
The most conventional matrix used in affinity chromatography for purification purposes is 
agarose, which is commercially available and well established, as Sepharose CL-6B from GE 
Healthcare. Agarose is a linear polysaccharide comprised of alternating residues of D-galactose 
and 3, 6-anhydro-L-galactose and presents a hydrophilic character with a higher amount of 
primary and secondary alcohols [36]. According to the suppliers, Sepharose CL-6B is a 6% 
cross-linked agarose with fairly wide particle size distribution of 45 – 165 μm. This material 
seems to be a good matrix for purification purposes, more specifically in affinity 
chromatography, as it is a fair base for the coupling of affinity ligands and also has a higher-
degree of cross-linking that improves stability under a wide range of conditions such as pH and 
temperature.The synthesis of the combinatorial library of affinity ligands was based on the Ugi 
reaction scaffolds (Fig. 4.2, § 2.3.1). 
 
 The Ugi reaction is a multicomponent reaction (MCR) that involves an amine (primary or 
secondary), and oxo compound (aldehyde or ketone), a carboxylic acid and an isocyanide [234-
237]. This reaction presents several advantages such as simplicity, time and costs saving, since 
to create diversity between the combinatorial libraries, only a small amount of starting materials 
is required [234, 238].  Moreover, the MCRs present selectivity, because from different starting 
materials, it is possible to achieve only one product. Also MCRs are convergent, because the 
overall yield of reaction tends to be maximized as the number of step involved decrease, and in 
this case, as the reactions are one-pot synthesis, this can contribute to maximum convergence 
[238]. The mechanism of the Ugi reaction is believed to involve as first step the formation of an 
imine, i.e. a Schiff base. Afterwards, the protonation of the nitrogen atom from Schiff base by 
the carboxylic acid generates an eletrophilic iminium ion [234] Then, according to what Ugi 
postulated, the nitrogen atom of the nucleophilic isocyanide attacks the iminium ion and then a  
Mumm rearrangement occurs to form a stable Ugi product. However, other mechanisms have 
been suggested [237] and this involves the formation of a hemiaminal, an intermediate 
compound, originating from the Schiff base and the carboxyl acid group that is further attacked 
by the isocyanide. The Ugi reaction has already been described in the literature to be a 
successful strategy for the synthesis of affinity ligands in agarose for immunoglobulin 
purification [38, 68]. 
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The compounds employed to generate diversity in the first generation libraries were selected to 
maximise the complementarity with the hexapeptides and are represented in Table 2.1 and 2.2. 
The libraries was synthesized directly on the solid support by combinatorial methods and further 
screened micro-scale affinity chromatography The amines and carboxylic acids employed in the 
combinatorial library are summarized in Table 2.1 and 2.2. 
 
 
 
 
Figure 4.2 Diversity of the compounds used in the synthesis of the Ugi based combinatorial 
libraries. For the Ugi reaction, the aldehyde and the isocyanide compounds were kept constant and the 
diversity of the Ugi based ligands was originated from the different amines and carboxylic acids used. The 
list of amines and carboxylic acids utilised are summarized in Table 2.1 and 2.2 
 
4.3. SCREENING OF THE UGI BASED COMBINATORIAL LIBRARY 
 
Screening of the Ugi based combinatorial library, optimized in terms of cost and variability of 
compounds structures, was performed through micro-scale affinity chromatography using a 96-
well filtration block, where each well contained 250 mg of moist gel functionalized with a 
different affinity ligand. Crude extracts containing GFP-tagged and non-tagged proteins 
produced in E. coli, rather than pure peptide stock solutions, where utilised in the screening. 
The results obtained with the crude extracts confirmed simultaneously the affinity and selectivity 
of the lead ligands. The selectivity was investigated by observing the adsorption of proteins 
produced by E. coli, in the affinity adsorbents in comparison with the adsorption of GFP-tagged 
or non-tagged. 
Molecular recognition is the basis of the interaction between a ligand and its target biomolecule, 
which is influenced by surface complementarity, non-covalent intermolecular interactions and 
thermodynamic contributions [9, 239]. Non-covalent intermolecular interactions comprise 
hydrogen bonds, ionic interactions, van der Waals’ forces and hydrophobic interactions. Due to 
the weak character of these bonds, surface complementarity plays an important role as it allows 
a higher proximity of the atoms and increases their subsequent interaction [9]. 
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Hydrogen bonds are electrostatic attractions between a donor functional group and an atom or 
group of atoms able to accept the bond [9, 239]. A proton, covalently bonded to an 
electronegative donor group carries a partial (δ+)  charge and is thus capable of forming a 
dipole-dipole interaction with the non-bonded pair of electrons of an electronegative acceptor 
[240]. Nitrogen and oxygen atoms are those most commonly used in the hydrogen bonding, 
although sulphur and fluorine are also able to participate [9]. Depending on the functional 
groups of donor and acceptor, the hydrogen bond can present a different potential [9]. Ionic 
interactions are weaker and result from the attraction of two oppositely charged atoms (long-
range interactions) [9, 239]  an der Waals’ interactions are weaker than hydrogen bonding and 
ionic interactions and result from the attraction between temporary dipoles [9]. Hydrophobic 
interactions are dependent on surface complementarity to have an acceptable affinity  because 
this type of interaction occurs between non-polar groups such as alkyl chains and aromatic 
rings [9] 
Although these non-covalent intermolecular interactions play an important role in molecular 
recognition, there are several factors that can influence the strength of the bonds, such as the 
molecular flexibility, surrounding environment, distance between the acceptor and the donor 
and the direction of the bond [9, 239]. 
 
Crude extracts containing GFP-tagged and non-tagged proteins were incubated with 
adsorbents in order to promote the binding between the target proteins and the affinity ligands. 
The temperature was maintained low (4ºC) in order to inactivate proteases produced by the 
host, which are known to be present in the crude samples. After screening, the suspension was 
centrifuged and all the washes were collected and quantified by GFP fluorescence and the BCA 
assay. The BCA assay is a sensitive and selective colorimetric assay that allows the 
quantification of total protein through the measurement of absorbance at 560 nm, due to the 
product derived from the chelation of two molecules of BCA with one cuprous ion (Cu
+
). 
However, color development in this method is temperature- and time-dependent. Fluorimetric 
techniques are highly sensitive and require small amounts of ligand and target biomolecule 
[241]. These two techniques differ in terms of protein detection limits: the fluorescence 
technique allows quantification of micrograms of protein (0.001-100 µg/ml), whilst in the case of 
the colourimetric test it is only possible to quantify milligrams of protein (0.2-1 mg/ml). This 
difference can explain some discrepancies in the determination of the amount of GFP-tagged 
and non-tagged proteins bound and total protein bound. In order to overcome these issues, in 
situations where the percentage of total protein bound was zero, the amount of total protein 
bound was taken as the respective amount of GFP-tagged (or non-tagged) proteins determined 
by the fluorescence method.   
 
As a first approach, the screening and ligand selection were based on the enrichment factor. 
The enrichment factor is the ratio between R1 and R2. R1 corresponds to the ratio between 
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GFP-tagged (or non-tagged) protein bound and total protein bound to the affinity supports; R2 is 
the ratio between GFP-tagged (or non-tagged) protein loaded and total protein loaded. The 
enrichment aimed at assessing the specific binding between the affinity ligand and the target 
biomolecule. The enrichment factor was determined for each of the affinity ligands and the 
target biomolecule.  
As each GFP production system yields different amounts of total protein and GFP-tagged (or 
non-tagged) (see Chapter 3), it was necessary to estimate the maximum enrichment factor 
expected (Table 4.1) in each system. For this, the best case scenario was considered where 
GFP-tagged (or non-tagged) protein bound totally (i.e. 100% bound), whilst only 5% (w/w) of 
total protein bound to the affinity support. This last value was based on the minimum non-
specific adsorption calculated for plain agarose (Chapter 5 § 5.3).  
The selection of the putative lead ligands for each tag system was based on the highest values 
of enrichment factor. Moreover, promising lead ligands should present only affinity for the 
respective affinity tag and not for GFP or hosts proteins. Therefore, the screening of the 
combinatorial library of affinity ligands against GFP can be seen as a negative control and 
simultaneously will allow the search for the lead ligands displaying selectivity for GFP, which 
can also be considered as an affinity tag on its own. 
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Table 4.1 Maximum values of enrichment factor expected for GFP-tagged and non-tagged proteins. 
The maximum values of enrichment factor were based on the most promising situations possible to obtain 
in a screening: 100% of GFP protein and 5% protein of total bound.  
 
 
Crude Extract 
 
 
% GFP protein in crude 
extract (w/w) 
 
Maximum Enrichment 
Factor 
(-fold) 
 
RWRWRW-GFP 
 
2 
 
15 
 
WFWFWF-GFP (NON 
DENATURING CONDITIONS) 
 
2 
 
14 
 
NWNWNW-GFP 
 
9 
 
7 
 
RKRKRK-GFP 
 
4 
 
11 
 
NNNNNN-GFP 
 
5 
 
10 
 
GFP 
 
13 
 
6 
 
 
Therefore, it is important to understand some properties such as isolectric points (pI) and log P 
of the peptides that are being used in this work as affinity tags (Fig. 4.2). These parameters 
were estimated by using the software Marvin Beans, ChemAxon as shown in Table 4.2. 
However, the parameters were only estimates because there is no information about the 
conformation of the peptide when fused to the GFP and how these parameters can be 
influenced upon fusion. The isolectric point corresponds to the pH where the total net charge of 
the biomolecule is zero and the log P is the partition coefficient of the compound between 
octanol and water [242]. The partition coefficient is a hydrophobicity measurement that 
determines the solvent affinity of specific target biomolecule or bioactive compound [242]. The 
negative sign of the log P corresponds to a more polar hydrophilic compound whilst a positive 
relates to a more hydrophobic [242]. 
The peptides were designed to be used as affinity tags fused to the target protein such that they 
can recognize the affinity ligand immobilized on the solid support. The C-terminal of the 
peptides is linked to the linker PPP (three proline residues) and enterokinase recognition site 
that is present before the target protein to facilitate tag removal after the purification step. Thus, 
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only the N-terminal and the side chains of the peptides are available to interact with the affinity 
ligands (Fig. 4.3). 
 
 
 
 
Figure 4.3 Peptide structures used as affinity tags. The peptide structures were designed in Marvin 
Beans software, ChemAxon. These peptides present a free N-terminal and a C-terminal linked to the 
recognition site of enterokinase and to GFP protein. The GFP-tagged proteins designed were (A) 
RWRWRW-GFP, (B) RKRKRKR-GFP, (C) WFWFWFW-GFP, (D) NWNWNW-GFP and (E) NNNNNNN-
GFP. 
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Table 4.2 Properties of the peptides used as affinity tags.  The isolectric point and the logP of the 
peptides were estimated by using Marvin Beans software, ChemAxon. The estimation of these parameters 
took into the account the fact that only the N-terminal of the peptides is available to interact as the C-
terminal is linked to the recognition site of enterokinase and the GFP protein. 
 
Peptide tag 
Isoelectric Point without 
free C-terminal  
 Isoelectric point with 
free C-terminal 
LogP 
RWRWRW 13.23 12.30 -0.72 
WFWFWF 10.52 5.18 7.74 
NWNWNW 10.05 4.85 -2.94 
RKRKRK 13.35 12.35 -6.78 
NNNNNN 9.91 4.7 -12.75 
 
The peptide tags RWRWRW and RKRKRK have similar isolectric point with and without the 
COOH group available on C-terminal (Table 4.2). The pI estimated for the peptide tags 
WFWFWF, NWNWNW and NNNNNN by using the C-terminal free is different from those 
obtained without the free COOH group on C-terminal. For peptides RKRKRKR and RWRWRW, 
the existence of a protonatable COOH group does not significantly alter the pI due to the highly 
positively charged side chains. For logP no significant changes were observed when estimating 
the parameter for the peptides with and without free C-terminal because the COOH group on C-
terminal might not be significant to alter the hydrophobicity or hydrophilicity of the peptides as 
the contributions of the side chains of the aminoacids that compose the affinity tags. As shown 
in Table 5.2, the most negative value, i.e., most hydrophilic character, corresponds to the 
peptide NNNNNN whilst the most positive value is peptide WFWFWF i.e. the most hydrophobic 
character. Peptide RKRKRK also presents a negative value, and  hence has hydrophilic 
character, whilst RWRWRW and NWNWNW peptides exhibits a log P value closer to 0, 
suggesting neutral characteristics.  
 
4.3.1. Screening with RWRWRW tagged GFP crude extract  
 
The affinity tag RWRWRW display a positive charge at pH 7.4 according to Table 4.2. 
Moreover, this peptide presents a dual hydrophobic and hydrophilic behaviour and due to this, 
the interactions involved with this peptide might be electrostatic and hydrophobic interactions. 
The percentage of GFP tagged protein in the crude extract was low (~2% (w/w)) and hence the 
estimated maximum value for the enrichment factor was 15. The overall results of the library 
screening are presented in Fig 4.4, where at least 7 affinity ligands were distinguishable: A1C6, 
A2C4, A2C8, A3C6, A3C7, A3C8, A6C7 and A6C8.  
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Figure 4.4: Screening of combinatorial library for RWRWRW tagged GFP. Ugi functionalized-
Sepharose beads were synthesized in each well of the 96-well filtration blocks (250 mg of resin, c.v.: 250 
µl) and then prepared for chromatographic analysis through regeneration (0.1M NaOH, 30% (v/v) 
isopropanol alternated with H20, 3 c.v. each in a total of 6 c.v.), equilibration (PBS: 10 mM sodium 
phosphate, 150 mM NaCl, pH 7.4, 12 c.v.) prior to loading(1 c.v. of crude extract  containing GFP tagged 
protein obtained from expression of GFP tagged protein in E.coli cells) and incubation (1h at 4ºC with 
manual shaking. The flow-through (1 c.v.) and wash fractions (PBS 12 c.v.) were collected in 96 well black 
microplates. The fractions were quantified by spectrofluorimetry and BCA assays which determine the 
amount of GFP and total protein unbound, respectively. Ligand density was 20 µmol / g moist weight gel. 
Enrichment factor = R1/R2, where R1= (GFP tagged (or non-tagged) protein bound/ total protein bound) 
and R2 = (GFP tagged (or non-tagged) protein loaded / total protein loaded). 
 
 
The highest value of enrichment reached by the affinity ligands A6C7 and A6C5 was ~5. Both 
ligands possess aromatic rings, which can establish hydrophobic interactions with the 
tryptophan indole ring from the RWRWRW peptide (Fig. 4.5). It is conceivable that amine A6 is 
responsible for engaging in hydrogen bonding with the carbonyl group of the peptide backbone 
or with nitrogen atoms of the arginine side chains.  
 
 
 
Figure 4.5 Putative lead ligands structures with an enrichment factor ~ 5 for the RWRWRW tagged 
GFP. The structures were designed in ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi 
based ligand covalently linked to the solid support, agarose beads  ( ).  
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The other selected ligands A1C6, A2C4, A2C8, A3C6, A3C7 and A3C8 (Fig. 4.6) present an 
enrichment factor between 3 and 4. Common features of these ligands include amines A2 and 
A3 which infer the presence of three and two carboxylic acid groups, respectively, combined 
with aromatic rings (Fig. 4.6). Ligand A1C6 comprises a single carboxylic group and an aromatic 
ring with a hydroxyl group. It is envisaged that the carboxylic groups will interact with arginine 
residues and the aromatic moiety will interact with the indole ring of tryptophan.  
 
 
Figure 4.6 Putative lead ligands structures with an enrichment factor ~3- 4 for the RWRWRW 
tagged GFP. The structures were designed in ChemDraw, CambridgeSoft, being the aldehyde group from 
the Ugi based ligand covalently linked to the solid support, agarose beads ( ). 
 
 
Ligands presenting enrichment factors between 2 and 3 were also considered. These included 
ligands A2C5, A3C5, A5C6 and A6C6 (Fig. 4.7).  
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Figure 4.7 Putative lead ligands structures with an enrichment factor ~2- 3 for the RWRWRW 
tagged GFP. The structures were designed in ChemDraw, CambridgeSoft, being the aldehyde group from 
the Ugi based ligand covalently linked to the solid support, agarose beads ( ). 
 
 
The values of isolectric point (pI) and logP were estimated for each of the putative lead ligands 
and then correlated with the respective values of enrichment factor (Fig.4.8). Fig. 4.8 (A) 
suggests that ligands presenting a higher enrichment value (A6C7 and A6C8), also present a 
similar isolectric point (12.51 and 12.53, respectively) to RWRWRW, and therefore are also 
positively charged at pH 7.4. In these cases, electrostatic interactions might not be in the basis 
of the interaction between the ligands and the affinity tag. For the other selected ligands with 
enrichment factor below 5, pI values are lower than 7.4, indicating a negative charge of these 
ligands at the screening conditions employed. It was expected that these ligands interact with 
the affinity tag via electrostatic interactions and therefore, could have higher enrichment factors 
values. These facts might suggest that the electrostatic interactions are not dominant in the 
molecular recognition between the putative ligands and the affinity tag. On the other hand, Fig. 
4.8 (B) suggested a tendency for the ligands with higher values of enrichment factor, to present 
more positive values of Log P (a more hydrophobic character).  
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Figure 4.8 Correlation between (A) the isolectric point and (B) Log P values and enrichment factor 
value obtained for the screening with the RWRWRW tagged GFP. The values obtained for the 
isolectric point and LogP were estimated by the software Marvin Beans, ChemAxon. 
 
4.3.2. Screening with WFWFWF tagged GFP crude extract 
 
The WFWFWF peptide has a strong hydrophobic character and the production of this peptide 
fused to GFP led to the formation of inclusion bodies. Different culture conditions were selected 
in order to produce this tagged protein in a soluble form. However, as the formation of inclusion 
bodies usually allow higher amounts of protein to be expressed, purification under denaturing 
conditions and subsequent refolding on column has proven as a viable alternative. Thus, in this 
particular case, the screening was performed both under non-denaturing conditions (i.e. with the 
soluble GFP-tagged protein) and also in denaturing conditions (i.e. in the presence of 8M urea). 
 
4.3.2.1 Screening under Non denaturing conditions 
 
The WFWFWF peptide possess overall hydrophobic properties but may also engage in 
hydrogen bonds with the carbonyl group and nitrogen group of the peptide backbone and the 
indole ring of the tryptophan. As estimated in Table 4.2, the peptide has a low positive charge at 
pH 7.4. 
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The results obtained from screening WFWFWF tagged GFP under non-denaturing conditions 
are presented in Fig. 4.9; the maximum value of enrichment calculated was 14. The enrichment 
values obtained were promising, as the best affinity ligand presented in Fig 4.9 can enrich 
around ~10 times, i.e. ~70% of the maximum value of enrichment factor.  Affinity ligand A6C1 
appears to be very effective as an adsorbent for the WFWFWF tagged GFP. The ligand has a 
flexible relatively polar structure. Another promising ligand is A1C5, comprising arabic acid as 
the carboxylic compound and a tyramine as the amine compound (Fig. 4.10), with an 
enrichment factor around 5. Other putative lead ligands were selected with lower enrichment 
factors (~ 4-6). These selected promising ligands can be divided in two groups: Those 
containing amine, A2 (A2C4, A2C5, A2C6, A2C7 and A2C8) (Fig. 4.11), and those containing 
amine A3 (A3C1, A3C6, A3C7 and A3C8) (Fig. 4.12). Some of these ligands were also 
identified as putative lead ligands for RWRWRW, suggesting that they might not be selective for 
the dipeptide repetition on affinity tags, although both tags contain tryptophan.   
 
 
 
Figure 4.9 Screening of combinatorial library for WFWFWF tagged GFP under non denaturing 
conditions. Ugi functionalized-Sepharose beads were synthesized in each well of the 96-well filtration 
blocks (250 mg of resin, c.v.: 250 µl) and then prepared for chromatographic analysis through regeneration 
(0.1M NaOH, 30% (v/v) isopropanol alternated with H20, 3 c.v. each in a total of 6 c.v.), equilibration (PBS: 
10 mM sodium phosphate, 150 mM NaCl, pH 7.4, 12 c.v.) prior to loading(1 c.v. of crude extract  
containing GFP tagged protein obtained from expression of GFP tagged protein in E.coli cells) and 
incubation (1h at 4ºC with manual shaking. The flow-through (1 c.v.) and wash fractions (PBS 12 c.v.) 
were collected in 96 well black microplates. The fractions were quantified by sprctrofluorimetry and BCA 
assays which determine the amount of GFP and total protein unbound, respectively. Ligand density was 
20 µmol / g moist weight gel. Enrichment factor = R1/R2, where R1= (GFP tagged (or non-tagged) protein 
bound/ total protein bound) and R2 = (GFP tagged (or non-tagged) protein loaded / total protein loaded). 
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Figure 4.10 Structures of the putative lead ligands A6C1 and A1C5 with enrichment factors ~10 and 
5, respectively for the WFWFWF tagged GFP under non-denaturing conditions. The structures were 
designed in ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi based ligand covalently 
linked to the solid support, agarose beads ( ). 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 Structures of the putative lead ligands with enrichment factors ~2-4 that contain the 
same amine A2 for the WFWFWF tagged GFP under non-denaturing conditions. The structures were 
designed in ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi based ligand covalently 
linked to the solid support, agarose beads. 
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Figure 4.12 Structures of the putative lead ligands with enrichment factors ~2-4 that contain the 
same amine A3 for the WFWFWF tagged GFP under non-denaturing conditions. The structures were 
designed in ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi based ligand covalently 
linked to the solid support, agarose beads ( ). 
 
 
The properties isolectric point and LogP were also estimated for the promising lead ligands and 
further correlated with the respective enrichment factor as shown in Fig.4.13 
 
 
Figure 4.13 Correlation between (A) the isolectric point and (B) Log P values and enrichment factor 
value obtained for the screening with the WFWFWF tagged GFP. The values obtained for the isolectric 
point and LogP were estimated by the software Marvin Beans, ChemAxon. 
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By observing Fig. 4.13 (A) and (B), the promising lead ligand A6C1 stands out from the other 
ligands in terms of enrichment value. At the screening conditions used, this ligand is positively 
charged (pI equals to 12.43) and presents a hydrophilic character (Log P equals to -5.07); the 
peptide WFWFWF presents a positive charge and displays a highly hydrophobic character. 
Therefore, hydrophobic interactions are expectedto prevail in the molecular recognition between 
this ligand and the tag.  
 
The remaining ligands present a similar value of pI (Fig. 4.13(A)) and display a negative charge 
at pH 7.4. The Log P values are less negative, for ligands A2C8, A2C4 both with enrichment 
factor ~6 and ligands A3C7, A2C4 with enrichment factor ~ 5. The common feature of these 
ligands is the presence of at least one aromatic ring on their structures. Therefore both 
electrostatic and the hydrophobic interactions are likely to contribute for the molecular 
recognition between the tag and the ligand. 
 
4.3.2.2 Screening under Denaturing Conditions  
 
The screening under denaturing conditions was performed in the presence of 8M urea, which 
was required to solubilise inclusion bodies [190]. The crude extract was applied to the 96-well 
filtration block for further purification and refolding on-column.  However, in this case, it was only 
possible to determine the amount of GFP bound through the fluorimetric assay, since the 
colourimetric BCA assay, can only be used at urea concentrations below 3M, according with 
supplier instructions. Therefore, it was not possible to determine the enrichment factor. The 
evaluation of the lead ligands was assessed by determining the amount of bound tagged GFP 
per gram of resin, as shown in Fig. 4.14. The enrichment and selectivity of the putative lead 
ligands could be evaluated subsequently by SDS-PAGE analysis. 
 
The WFWFWF tagged GFP protein has a highly hydrophobic character and was expressed as 
inclusion bodies, which are aggregates of misfolded protein. The GFP chromophore is formed 
due to a covalent modification of three adjacent amino acids in the GFP sequence [243] and is 
located in the middle of an  α-helix structure in the centre of the β-barrel of the GFP structure 
[243]. The tertiary structure allows protection of the GFP chromophore from the aqueous 
environment. However, after solubilization of the GFP-tagged inclusion bodies with high 
concentrations of chaotropic agents such as urea, GFP loses the secondary structure exposing 
the hydrophobic surface [222], and a quenching of the GFP fluorescence [243]. The 
chromophore seems to be resistant, and only when using high temperatures in association with 
high concentrations of chaotropic agents, it is possible to observe denaturation of the GFP and 
a complete loss of fluorescence [243]. 
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The WFWFWF tagged GFP still retained some fluorescence in the solubilization buffer 
containing 8M urea, despite the high concentration of protein corroborated by the SDS-PAGE 
analysis after expression (§ 3.5.3), where an intense band of GFP-tagged can be seen. 
The screening protocol was performed manually and stepwise and consisted of the following 
steps: resin regeneration, biomolecule loading and refolding during the washing step. Proper 
folding was not likely to occur since the washes did not contain a slow reduction in the urea 
concentration, and tagged GFP precipitated. The adsorbents were washed in a total of 12 C.V., 
where 6 C.V. contained binding buffer with 4M of urea and the remaining washes only binding 
buffer. However, the principal aim at this stage was to understand which affinity ligands could 
bind to tagged GFP under these denaturing conditions. 
 
Affinity ligands displaying higher amounts of GFP tagged bound (Fig 4.9) where those 
containing amines A4 and A8 (Fig. 4.15), in particular, ligands A4C2, A4C5 and A4C8. The 
hydrophobic character of these ligands increases from A4C5 > A4C2 > A4C8 (Fig. 4.15). 
Considering the similarities between A4C2 and A4C8 and the fact that the latter displayed a 
higher binding, ligand A4C8 was considered to proceed with further studies. Ligand A4C5 was 
interesting in the sense that possess a carboxylic acid group with a very hydrophilic character 
On contrary, affinity ligand A8C8 also displaying higher binding per gram of resin presents an 
hydrophobic character with an indole ring. 
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Figure 4.14 Screening of combinatorial library for WFWFWF tagged GFP under denaturing 
conditions. Ugi functionalized-Sepharose beads were synthesized in each well of the 96-well filtration 
blocks (250 mg of resin, c.v. :250 µl) and then prepared for chromatographic analysis through regeneration 
(0.1M NaOH, 30% (v/v) isopropanol alternated with H20, 3 c.v. each in a total of 6 c.v.), equilibration (PBS: 
10 mM sodium phosphate, 150 mM NaCl, pH 7.4 12 c.v.) prior to loading(1 c.v. of solubilised inclusion 
bodies in 8M urea)  and incubation (1h at 4ºC). The flow-through (1 c.v.) and washes fractions (PBS 4M 
urea 6 c.v. and PBS 0M urea 6 c.v.) were collected in 96 well black microplates. The fractions were 
quantified by spectrofluorimetry and BCA assays which determine the amount of GFP and total protein 
unbound, respectively. Ligand density was 20 µmol / g moist weight gel). (Protein bound = (Protein 
loaded)-(sum of the amount protein in flow-through and washes). 
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Figure 4.15 Structures of the selected putative lead ligands for the WFWFWF tagged GFP under 
denaturing conditions. The structures were designed in ChemDraw, CambridgeSoft, being the aldehyde 
group from the Ugi based ligand covalently linked to the solid support, agarose beads ( ). 
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4.3.3. Screening with NWNWNW tagged GFP crude extract 
 
The maximum enrichment factor possible for the NWNWNW tagged GFP was estimated as 7. 
Through analysis of the data shown in Fig. 4.16, there were a few affinity ligands with promising 
properties, in particular, ligand A7C8 which presents an enrichment factor value around 6, i.e. ~ 
85% of the maximum. Peptide NWNWNW presents a slightly positive charge at pH 7.4 but has 
mainly an apolar character. 
  
 
Figure 4.16 Screening of combinatorial library for NWNWNW tagged GFP. Ugi functionalized-
Sepharose beads were synthesized in each well of the 96-well filtration blocks (250 mg of resin, c.v.: 250 
µl) and then prepared for chromatographic analysis through regeneration (0.1M NaOH, 30% (v/v) 
isopropanol alternated with H20, 3 c.v. each in a total of 6 c.v.), equilibration (PBS: 10 mM sodium 
phosphate, 150 mM NaCl, pH 7.4, 12 c.v.) prior to loading(1 c.v. of crude extract  containing GFP tagged 
protein obtained from expression of GFP tagged protein in E.coli cells) and incubation (1h at 4ºC). The 
flow-through (1 c.v.) and wash fractions (PBS 12 c.v.) were collected in 96 well black microplates. The 
fractions were quantified by spectrofluorimetry and BCA assays which determine the amount of GFP and 
total protein unbound, respectively. Ligand density was 20 µmol / g moist weight gel. Enrichment factor = 
R1/R2, where R1= (GFP tagged (or non-tagged) protein bound/ total protein bound) and R2 = (GFP 
tagged (or non-tagged) protein loaded / total protein loaded). 
 
 
Ligands A6C8 and A3C5 (Fig.4.17) also displayed enrichment factors around 5. However, these 
ligands were already selected as putative lead ligands for the RWRWRW tagged GFP, 
suggesting that they are relatively unselective for the specific peptides. Ligand A2C5 
(enrichment factor ~4), has the same structure as A3C5 but comprises one more carboxylic acid 
group (Figs. 4.17 and 4.18). Other relevant affinity ligands were A5C1 and A5C6; these ligands 
have enrichment factors of ~ 3 and possess similar structures containing a benzamide group, 
with the difference that A5C1 has an extra amide and A5C6 has a COOH group (Fig. 4.18). In 
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this way, both ligands present the same profile of hydrogen bonding with N-H / O-H donors and 
O-H/ C=O acceptors [240]. 
 
 
Figure 4.17 Putative lead ligands for NWNWNW tagged GFP, where ligand A7C8 presents an 
enrichment factor ~6 and ligands A6C8 and A3C5 ~5. The structures were designed in ChemDraw, 
CambridgeSoft, being the aldehyde group from the Ugi based ligand covalently linked to the solid support, 
agarose beads ( ). 
 
 
 
 
 
Figure 4.18 Promising lead ligands for NWNWNW tagged GFP, where ligand A2C5 presents an 
enrichment factor ~4 and ligands A5C1 and A5C6 ~3. The structures were designed in ChemDraw, 
CambridgeSoft, being the aldehyde group from the Ugi based ligand covalently linked to the solid support, 
agarose beads ( ). 
 
 
The other promising lead ligands fall into two categories: Those containing amines A2 and A3. 
These amines may be strongly engaged in hydrogen bonding with the affinity peptide tags, as 
already discussed for the RWRWRW peptide (§ 4.2.1).  
Ligands with amine A2 are A2C2, A2C3, A2C4 and A2C6 (Fig. 4.19). The first three ligands do 
not differ very much because all the carboxylic acid compounds contain an aromatic ring or an 
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indole ring. Thus, not surprisingly, the enrichment factors obtained for these affinity ligands are 
similar, but the one obtained for A2C2 is slightly higher as it possesses an additional hydroxyl 
group. Affinity ligand A2C6 also has the same groups but has a more flexible structure.  
The putative lead ligands with the amine A3 are A3C1 and A3C4 (Fig. 4.20). A3C4 presents a 
slightly higher enrichment factor because it contains both hydrophobic (aromatic ring) and 
hydrophilic (COOH groups) functionalities. 
 
 
Figure 4.19 Lead ligands for NWNWNW tagged GFP with a common A2 amine and enrichment 
factor ~2. The structures were designed in ChemDraw, CambridgeSoft, being the aldehyde group from the 
Ugi based ligand covalently linked to the solid support, agarose beads ( ). 
 
 
 
 
 
Figure 4.20 Lead ligands for NWNWNW tagged GFP with a common A3 amine and enrichment 
factor ~2. The structures were designed in ChemDraw, CambridgeSoft, being the aldehyde group from the 
Ugi based ligand covalently linked to the solid support, agarose beads ( ). 
 
 
The properties of the selected lead ligands such as isolectric point and LogP were also 
estimated (Fig. 4.21). Most ligands present a similar isolectric point (~2), and the same negative 
charge at pH 7.4 employed during the screening. 
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Figure 4.21 - Correlation between (A) the isolectric point and (B) Log P values and enrichment 
factor value obtained for the screening with the NWNWNW tagged GFP. The values obtained for the 
isolectric point and LogP were estimated by the software Marvin Beans, ChemAxon 
 
 
The hydrophobic contribution for the interaction between the tag and ligands seem more 
pronounced. Ligands with more hydrophobic structures (more positive LogP values) also 
present higher values of enrichment factors. Therefore this can reveals the importance of the 
hydrophobic interactions establishment between the pair. Overall, the lead ligand with the 
highest enrichment factor value (~6) was A7C8 with a likely contribution of both electrostatic 
and hydrophobic interactions between the pair. 
 
 
 
4.3.4. Screening with RKRKRK tagged GFP crude extract 
 
The results obtained from the screening of RKRKRK tagged GFP and the combinatorial library 
of affinity ligands are shown in Fig.4.22. The maximum enrichment value calculated was 11. 
However, the highest value found was 2, much lower than the theoretical expected; and was 
observed for ligand displaying amine A7, particulary A7C7 and A7C8 (Figs 4.23 and 4.24). 
Affinity ligand A7C8 was also selected as a putative lead ligand for the NWNWNW peptide 
indicating lack of selectivity. Ligands A2C4 and A5C4 (Fig, 4.25) were also selected since they 
showed values of enrichment slightly below A7 ligands.   
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Figure 4.22 Screening of combinatorial library for RKRKRK tagged GFP. Ugi functionalized-
Sepharose beads were synthesized in each well of the 96-well filtration blocks (250 mg of resin, c.v.: 250 
µl) and then prepared for chromatographic analysis through regeneration (0.1M NaOH, 30% (v/v) 
isopropanol alternated with H20, 3 c.v. each in a total of 6 c.v.), equilibration (PBS: 10 mM sodium 
phosphate, 150 mM NaCl, pH 7.4, 12 c.v.) prior to loading(1 c.v. of crude extract  containing GFP tagged 
protein obtained from expression of GFP tagged protein in E.coli cells) and incubation (1h at 4ºC). The 
flow-through (1 c.v.) and wash fractions (PBS 12 c.v.) were collected in 96 well black microplates. The 
fractions were quantified by spectrofluorimetry and BCA assays which determine the amount of GFP and 
total protein unbound, respectively. Ligand density was 20 µmol / g moist weight gel. Enrichment factor = 
R1/R2, where R1= (GFP tagged (or non-tagged) protein bound/ total protein bound) and R2 = (GFP 
tagged (or non-tagged) protein loaded / total protein loaded). 
 
 
 
 
 
 
 
Figure 4.23 Lead ligands A7C7 and A7C8 for RKRKRK tagged GFP. The structures were designed in 
ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi based ligand covalently linked to the 
solid support, agarose beads ( ). 
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Figure 4.24 Lead ligands with A7 amine, with enrichment factor ~2. The structures were designed in 
ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi based ligand covalently linked to the 
solid support, agarose beads ( ). 
 
 
 
 
Figure 4.25 Ligands A2C4 and A5C4, selected as putative lead ligands for the RKRKRK tagged 
GFP. The structures were designed in ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi 
based ligand covalently linked to the solid support, agarose beads ( ). 
 
 
When considering the properties of the ligands, they all present a negative charge at the 
screening conditions employed as the pI is below7.4 (Fig. 4.26(A)). The peptide RKRKRK has a 
positive charge at pH 7.4. Therefore, the electrostatic interaction could be in the basis of the 
molecular recognition between the affinity pairs. According to the Fig 4.26 (B), the 
hydrophobicity of the ligands varies between them, however all the ligands display at least one 
aromatic ring. These aromatic rings should contribute for enhance the rigidity of the ligands and 
therefore contribute for a better interaction with the tag, as this tag presents a flexible character. 
Due to ligands structures, also hydrogen bonding can reinforce the interaction between the 
affinity pairs. 
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Figure 4.26 Correlation between (A) the isolectric point and (B) Log P values and enrichment factor 
value obtained for the screening with the RKRKRK tagged GFP. The values obtained for the isolectric 
point and LogP were estimated by the software Marvin Beans, ChemAxon 
 
 
4.3.5. Screening with NNNNNN tagged GFP crude extract 
 
The results obtained from the screening between the combinatorial library and NNNNNN tagged 
GFP (Fig. 4.27) showed extremely low enrichment factors. The maximum factor that the affinity 
ligands could enrich tagged GFP was 10, but in fact the maximum value reached by any ligand 
was 1, i.e. only 10% of the total possible enrichment. This peptide has a negative LogP, i.e. is 
hydrophilic. Under these circumstances, no putative lead ligands were selected for further 
studies and work on this affinity tag was discontinued.  
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Figure 4.27 Screening of combinatorial library for NNNNNN tagged GFP. Ugi functionalized-
Sepharose beads were synthesized in each well of the 96-well filtration blocks (250 mg of resin, c.v.: 250 
µl) and then prepared for chromatographic analysis through regeneration (0.1M NaOH, 30% (v/v) 
isopropanol alternated with H20, 3 c.v. each in a total of 6 c.v.), equilibration (PBS: 10 mM sodium 
phosphate, 150 mM NaCl, pH 7.4, 12 c.v.) prior to loading(1 c.v. of crude extract  containing GFP tagged 
protein obtained from expression of GFP tagged protein in E.coli cells) and incubation (1h at 4ºC). The 
flow-through (1 c.v.) and wash fractions (PBS 12 c.v.) were collected in 96 well black microplates. The 
fractions were quantified by spectrofluorimetry and BCA assays which determine the amount of GFP and 
total protein unbound, respectively. Ligand density was 20 µmol / g moist weight gel. Enrichment factor = 
R1/R2, where R1= (GFP tagged (or non-tagged) protein bound/ total protein bound) and R2 = (GFP 
tagged (or non-tagged) protein loaded / total protein loaded). 
 
 
  
4.3.6. Screening with non-tagged GFP extract 
 
The library of affinity ligands was screened for binding to non-tagged GFP with two purposes: 
firstly is served as a negative control since the affinity ligand must recognize only the tag and 
not the protein; secondly, GFP itself can be regarded as an affinity tag and therefore there is 
interest in looking for specific receptors.  At present, there is no specific and selective procedure 
for the purification of GFP fusion proteins in the literature apart from immunoaffinity separations.  
GFP has an isolectric point ~ 5, indicating at pH 7.4 the protein should have an overall negative 
charge. The maximum value of the enrichment factor for GFP was determined as 6 (Fig 4.28) 
and the most promising affinity ligands such as A6C1 (Fig. 4.29) present an enrichment factor ~ 
3.  
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Figure 4.28 Screening of combinatorial library for GFP. Ugi functionalized-Sepharose beads were 
synthesized in each well of the 96-well filtration blocks (250 mg of resin, c.v.: 250 µl) and then prepared for 
chromatographic analysis through regeneration (0.1M NaOH, 30% (v/v) isopropanol alternated with H20, 3 
c.v. each in a total of 6 c.v.), equilibration (PBS: 10 mM sodium phosphate, 150 mM NaCl, pH 7.4, 12 c.v.) 
prior to loading(1 c.v. of crude extract  containing GFP tagged protein obtained from expression of GFP 
tagged protein in E.coli cells) and incubation (1h at 4ºC). The flow-through (1 c.v.) and wash fractions 
(PBS 12 c.v.) were collected in 96 well black microplates. The fractions were quantified by 
spectrofluorimetry and BCA assays which determine the amount of GFP and total protein unbound, 
respectively. Ligand density was 20 µmol / g moist weight gel. Enrichment factor = R1/R2, where R1= 
(GFP tagged (or non-tagged) protein bound/ total protein bound) and R2 = (GFP tagged (or non-tagged) 
protein loaded / total protein loaded). 
 
 
 
Figure 4.29 Lead ligand for GFP with the highest enrichment factor ~3. The structures were designed 
in ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi based ligand covalently linked to the 
solid support, agarose beads ( ). 
 
 
Ligand A6C1 was also selected as a putative lead ligand for the WFWFWF peptide tag under 
non-denaturing conditions and therefore it may be interacting not with the peptide tag but with 
GFP, although it was only detectable for the WFWFWF-GFP system. Ligands A6C4, A6C5, 
A6C6 and A6C7 (Fig. 4.30) were also presented good enrichment factors towards GFP, where 
ligands A6C6 and A6C7 were already selected for the RWRWRW tagged GFP system (§ 4.2.1).  
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Figure 4.30 Ligands selected also as putative lead ligands with enrichment factor ~1.4 -2 for GFP. 
The structures were designed in ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi 
based ligand covalently linked to the solid support, agarose beads ( ). 
 
 
 
On the other hand, ligands A6C4 and A6C5 were selected solely for non-tagged GFP protein. 
As these ligands were not rationally designed and this protein presents several hydrophobic 
patches [244], it is possible that affinity ligands comprising of hydrophobic moieties will bind to 
GFP. Affinity ligands A3C7, A3C8, A4C7 and A4C8 (Fig. 4.31) were also included for further 
studies although the enrichment factor was not high. Regarding A3C7 and A3C8, they also 
showed affinity for RWRWRW and WFWFWF (under non-denaturing conditions) peptides while 
A4C8 revealed affinity for WFWFWF tagged GFP under denaturing conditions.  
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Figure 4.31 Lead ligands for GFP with an enrichment factor ~1. The structures were designed in 
ChemDraw, CambridgeSoft, being the aldehyde group from the Ugi based ligand covalently linked to the 
solid support, agarose beads ( ). 
 
 
 
 
The isolectric point and the LogP parameters were estimated for each of the lead ligands 
selected for GFP and were correlated with the respective enrichment factors (Fig. 4.31). In 
general, ligands displaying a higher isolectric point also present higher values of enrichment 
(Fig. 4.32 (A)). At the screening conditions, the GFP displays an overall negative charge and 
the lead ligands, with pI higher than 7.4, present a positive charge.  
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Figure 4.32 Correlation between (A) the isolectric point and (B) Log P values and enrichment factor 
value obtained for the screening with non-tagged GFP. The values obtained for the isolectric point and 
LogP were estimated by the software Marvin Beans, ChemAxon 
 
 
Furthermore Fig.4.32 (B) indicates that the ligands with for high values of enrichment possess a more 
hydrophilic character. These facts might indicate that the electrostatic interactions might prevail 
over the hydrophobic interactions between the lead ligands and the GFP.  
 
4.4 SELECTION AND RE-SCREENING OF THE PUTATIVE LEAD LIGANDS 
 
Following the initial evaluation described in section 4.2, the putative lead ligands for each 
tagged- and non-tagged GFP were selected for further studies (Table 4.3).  
 
Table 4.3 Putative lead ligands selected for each of GFP-tagged and non-tagged proteins.  
 
 
GFP TAGGED AND NON-TAGGED PROTEINS 
 
PUTATIVE LEAD LIGANDS 
RWRWRW-GFP 
A1C6; A2C4; A2C5; A2C8; A3C5; A3C6; 
A3C7; A3C8; A5C6; A6C6; A6C7;A6C8 
WFWFWF-GFP (NON DENATURING 
CONDITIONS) 
A1C5; A2C4; A2C5; A2C6; A2C7; A2C8; 
A3C1; A3C6; A3C7; A3C8; A6C1 
WFWFWF-GFP (DENATURING CONDITIONS) A4C5; A4C8; A8C8 
NWNWNW-GFP A2C2; A2C4; A2C5; A2C6; A3C1; A3C4; 
A3C5; A5C1; A5C6; A6C8; A7C8 
RKRKRK-GFP 
A2C4; A5C4; A7C1; A7C2; A7C3; A7C4; 
A7C5; A7C6; A7C7; A7C8 
GFP 
A3C7; A3C8; A4C7; A4C8; A6C1; A6C4; 
A6C5; A6C6; A6C7 
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Selected putative lead ligands were re-synthesized in duplicate in 96-well filtration blocks and 
the combinatorial libraries re-screened as previously (§4.2). Two different elution conditions 
were tested: 0.1M Glycine-HCl pH 3.0 and 0.1M Glycine-NaOH pH 11.0, except for the system 
WFWFWF-GFP in denaturing conditions, where the elution at pH 11 was substituted by 400 mM 
NaCl. The loading, flow-through and elution fractions were quantified for total protein and GFP 
concentration and were also analysed by SDS-PAGE (Fig. 4.33). The gels were ran under 
denaturing conditions and revealed by silver staining, which allows the detection of nanograms 
of protein (~0.1 ng/mm
2
) according to the supplier. GFP alone has a molecular weight of 29kDa 
and the GFP-tagged protein ~31kDa. The additional 2kDa correspond to the affinity tags 
containing the hexapeptide sequences plus the cleavage sequence. Fig. 4.33 shows three 
typical examples of systems where GFP-tagged (or non-tagged), where more or less retained 
by the affinity adsorbents. 
 
 
Figure 4.33 Estimation of GFP proteins retention onto the affinity adsorbents by SDS-PAGE 
analysis. M is the molecular weight marker, L the loading, F, the flow-through and E, the elution fraction. 
This image shows typical images of different GFP protein adsorption profiles, (A) corresponds to a high 
binding, (B) medium and (C) low binding for the affinity resins. 
 
 
4.4.1. Re-Screening with RWRWRW tagged GFP crude extract 
 
The results obtained from the screening of the RWRWRW tagged GFP are shown in Figs. 4.34 
and 4.35. Putative lead ligands presented similar GFP binding percentages (40-50%) and 
enrichment factors values being these last slightly lower than those obtained in the first 
screening (Fig. 4.4). The difference between enrichment factors obtained from the two 
screening assays was more pronounced for ligands A3C6, A3C7, A3C8, A6C7 and A6C8. At a 
first glance in Fig 4.34 (A), Ligand A2C4 seemed to be the most promising ligand, presenting  a 
percentage of RWRWRW tagged GFP around 45% and the total protein < 15%, however this 
difference was not translated in a higher value of enrichment factor (Fig. 4.34 (B)). 
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Figure 4.34 (A) Binding of GFP and total protein for the putative lead ligands and RWRWRW tagged 
GFP and (B) comparison of enrichment factor values obtained from the two screening assays. The 
screening was carried out as in Fig. 4.4. The error bars were obtained from duplicates (n=2).  
 
 
From the analysis of the gels shown in Fig. 4.35, there was little evidence of an affinity ligand 
with GFP retention similar to the one presented in Fig. 4.33 (A), except for affinity ligands A5C6 
or A6C6. However, no GFP protein is observed in the elution lanes. Ligand A2C4 presented a 
medium GFP retention according to Fig. 4.33 (B), and also a small band of RWRWRW tagged 
GFP under basic elution conditions. However, the amount of tagged GFP was not possible to 
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quantify. Ligands A6C7 and A6C8 presented a small band for tagged GFP in the elution; 
however, there was also evidence of contamination with host proteins. Overall, there was little 
evidence of a promising lead ligand able to retain GFP-tagged from host proteins with a relevant 
yield of recovery. Furthermore, this tag displayed antimicrobial properties and thus might not be 
ideal for recombinant protein purification purposes. No further studies were conducted on this 
tag. 
 
 
Figure 4.35 SDS-PAGE evaluation of the screening of putative ligands for RWRWRW-GFP. The 
Loading (L), flow-through (F) and elution fractions (E) obtained from the 96-well screening were loaded 
into SDS-PAGE gels (12.5% acrylamide), ran 1h at 120V and then silver stained. Two elution approaches 
were tested (A) 0.1M glycine-HCl pH 3 and (B) 0.1M glycine-NaOH pH 11. (M=molecular weight marker).  
 
 
4.4.2. Re-Screening with WFWFWF tagged GFP crude extract 
 
4.4.2.1 Non-Denaturing Conditions 
 
From the analysis of Fig 4.36(A), all ligands showed a similar GFP binding profile. The 
enrichment factor values were maintained between the two screening assays, but with higher 
errors associated in this last screening. The first screening with the WFWFWF tagged GFP 
indicated ligand A6C1 as the most promising one, and although this ligand was not expected as 
a lead ligand due to its structure, the results obtained for A6C1 were maintained regarding the 
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enrichment factor value (10) and the GFP and total binding percentage was ~50% and 10%, 
respectively.  
Ligands A3C8 and A3C4 also presented similar binding percentages as A6C1, however with 
lower enrichment factor values. Analysis of the elution profiles at pH 3 and 11 by SDS-PAGE 
gels (Fig. 4.37) was taken into account for further lead ligand selection. Under the specified 
elution conditions, the amount of tagged-GFP eluted was ≤ 1% at pH 11, particularly for ligands 
A6C1 and A1C5. Under acidic elution conditions, there is no evidence of WFWFWF tagged 
GFP being eluted.  
 
 
Figure 4.36 (A) Binding of GFP and total protein for the putative lead ligands and WFWFWF tagged 
GFP under non-denaturing conditions and (B) comparison of enrichment factor values obtained 
from the two screening assays. The screening was carried out as in Fig. 4.9 (n=2). 
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Figure 4.37 SDS-PAGE evaluation of the screening of putative ligands for WFWFWF tagged GFP. 
The Loading (L), flow-through (F) and elution fractions (E) obtained from the 96-well screening were 
loaded into SDS-PAGE gels (12.5% acrylamide), ran 1h at 120V and then silver stained. Two elution 
approaches were tested (A) 0.1M glycine-HCl pH 3 and (B) 0.1M glycine-NaOH pH 11. (M=molecular 
weight marker).  
 
 
The SDS-PAGE gels for this GFP–tagged protein were not very promising as the flow-through 
lanes of all the affinity ligands were similar to the profile in the loading lane. Ligands A1C5 and 
A2C8 showed a band of the WFWFWF tagged GFP under basic elution conditions, and ligand 
A6C1 showed a band of GFP-tagged at acidic elution conditions (Fig. 4.37 (B)), although there 
were also a significant amount of contaminants being eluted. Thus, SDS-PAGE analysis 
indicated that selected ligands were not particularly selective for the WFWFWF tagged GFP.  
 
4.4.2.2 Denaturing Conditions 
 
Screening of the WFWFWF tagged GFP for the putative lead ligands under denaturing 
conditions in 8M urea was more promising for ligands A4C5, A4C8 and A8C8 which showed the 
best binding characteristics, confirmed by SDS-PAGE gels (Fig. 4.38 and 4.39). These affinity 
ligands presented a flow-through lane very similar to that shown in Fig. 4.33 (A), suggesting that 
these ligands are preferentially binding to the GFP-tagged over the total host proteins present in 
the crude extract. 
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Figure 4.38 Binding of GFP for the putative lead ligands and WFWFWF tagged GFP under 
denaturing conditions. The screening was carried out as in Fig. 4.14 with n=2. 
 
 
 
 
 
Figure 4.39 SDS-PAGE evaluation of the screening of putative ligands for WFWFWF tagged GFP 
under denaturing conditions. The Loading (L), flow-through (F) and elution fractions (E) obtained from 
the 96-well screening were loaded into SDS-PAGE gels (12.5% acrylamide), ran 1h at 120V and then 
silver stained. Two elution approaches were tested (A) 0.1M glycine-HCl pH 3 and (B) 0.1M glycine-NaOH 
pH 11. (M=molecular weight marker).  
 
 
 
 
Furthermore, the elution band for the GFP-tagged from ligand A4C8 in the presence of elution 
buffer containing 400mM of NaCl was significant, although these GFP-tagged proteins did not 
possess fluorescence, suggesting the elution of GFP-tagged in a denatured form. Ligand A4C8 
was selected as the lead candidate for further optimization. This selection was based on the 
higher percentage of GFP bound, i.e. the low percentage of GFP-tagged band present in the 
flow-through when compared with the loading sample. However, as these ligands bound 
selectively to GFP-tagged, the strategy suggested is to perform the refolding of GFP-tagged on-
column prior to the elution step, an approach already explored by other authors [49, 138]. These 
studies will be performed in an automatic system such that the proper negative gradient of urea 
and slow positive increments of salt can be achieved in order to enhance the likelihood of 
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proper folding (Chapter 5 § 5.6.1). It is expected that hydrophobic interactions are predominant 
for this affinity pair “tag-receptor” according to Fig4.46. Moreover, the overall charge of the 
affinity ligand is neutral and the tag seems to be slightly positive pH 7.4 (Fig. 4.46 and Table 
4.2) meaning that might not be occurring ionic interactions between the affinity system.  
 
4.4.3 Re-Screening with NWNWNW tagged GFP crude extract 
 
The screening of lead ligands for NWNWNW tagged GFP showed that the binding percentage 
were similar for all selected putative lead ligands, corresponding to ~40-50%, for GFP-tagged 
and ~20-30% for total protein (Fig. 4.41 (A)). In terms of enrichment factor (Fig. 4.40 (B)), the 
values obtained in the re-screening were lower compared with those obtained previously. 
Therefore, the evaluation of the GFP-tagged retention and respective recovery through SDS-
PAGE analysis (Fig. 4.41) might contribute for a better selection of the lead ligands. 
 
 
Figure 4.40 (A) Binding of GFP and total protein for the putative lead ligands and NWNWN tagged 
GFP and (B) comparison of enrichment factor values obtained from the screening assays. The 
screening was carried out as in Fig. 4.16.with n=2.  
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Regarding the elution at pH 3, the ligands A2C5, A2C6, A3C1, A3C4 A5C6, A6C8 and A7C8 
seemed to display a GFP-tagged band on the elution lane (Fig 4.41 (A)). However, no protein 
was detected by GFP fluorescence. Basic elution conditions were also not effective on the GFP-
tagged recovery and eluted only 0.1%, 0.03% and 0.01% for ligands A3C1, A3C4 and A6C8, 
respectively. However, purity of the eluted fractions seemed greater at pH 11 (Fig. 4.41(B)). 
From the SDS-PAGE analysis, there is a wide range of ligands binding preferentially to tagged-
GFP. 
 
 
Figure 4.41 SDS-PAGE evaluation of the combinatorial ligand screening of the putative ligands and 
NWNWNW tagged GFP. The Loading (L), flow-through (F) and elution fractions (E) obtained from the 96 
well format screening were loaded into SDS-PAGE gels (12.5% acrylamide), run 1h at 120V and then 
staining with silver staining. The screening was carried as described before but with different elution 
approaches (A) 0.1M glycine-HCl pH 3 and (B) 0.1M glycine-NaOH pH 11. (M=molecular weight marker) 
 
 
Ligands A2C2 and A3C4 present similar structures and a more promising profile in terms of 
tagged-GFP adsorption/elution at both pH values. However, at pH 11 the elution profile seemed 
to show a purer product. Affinity ligands A6C8 and A7C8 also showed a band of GFP tagged 
protein on the elution profile. For A7C8 purity in the elution fraction was low at either pH values. 
Affinity ligands A2C3 and A2C4 did not show any eluted GFP-tagged. Ligands A3C5, A2C5 and 
A2C6 present a highly flexible structure, which might explain why these were selected as 
putative lead ligands for other GFP-tagged systems as RWRWRW-GFP and WFWFWF-GFP. 
Overall, the best candidates as lead ligands were the affinity ligands A3C4 and A6C8; however, 
the elution profile for A3C4 seemed to yield a purer product and the eluted amount quantified by 
GFP fluorescence was higher. At the pH of binding (pH 7.4), the affinity tag presents a slightly 
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positive charge and the lead ligand is negatively charged. The predominant interactions 
occurred between the two entities are expected to be hydrogen bonding and hydrophobic 
interactions 
 
4.4.4 Re-Screening with RKRKRK tagged GFP crude extract 
 
The potential lead ligands for RKRKRK tagged GFP were retested for binding and eluting target 
protein. The percentage of GFP-tagged bound and the enrichment factor values were similar 
between the two screening tests, revealing reproducibility between the screening assays 
performed for the lead ligand selection. Ligands with amine A7 showed a higher percentage of 
GFP-tagged bound than other ligands such as A2C4 and A5C4 (Fig. 4.42(A)).  
 
The ligands A2C4 and A5C4, allowed the elution of GFP-tagged but only at pH 11 (Table 4.4) 
and with a yield of ~10% of bound protein. It is worth noticing that at pH 3 (Fig 4.43 (A)), the 
elution profiles showed two intense bands. In general samples eluted at pH 11 seemed to 
present a higher degree of purity. Ligands A2C4 and A5C4 presented the lowest percentage of 
GFP-tagged bound and a medium protein adsorption. 
 
In terms of purity, the elution profiles at pH 3 showed a low purity whilst at pH 11, no tagged-
GFP elution was observed. The most promising results were obtained with the ligands 
possessing amine A7, such as A7C1, A7C6, A7C7 and A7C8. Affinity ligands A7C2 and A7C3 
displayed a lower GFP band on the flow-through but the elution profile presented a higher 
amount of contaminants. Thus the best candidates for lead ligands were A7C1, A7C6 and 
A7C7, although ligand A7C7 might be too hydrophobic. Affinity ligands A7C1 and A7C6 were 
similar in terms of binding and elution. Ligand A7C8, displayed a pure eluted fraction of GFP-
tagged under basic elution conditions but it was not selectivefor this affinity tag. Therefore, the 
lead ligand selected was A7C1. Under the binding conditions, the affinity tag is highly charged 
due to the presence of the amino acids lysine and arginine. The respective lead ligand presents 
a negative charge, due to the deprotonation of the existent carboxylic acids (Fig 4.46), and the 
predominant binding interactions are electrostatic also according to Fig. 4.26 A). However, as 
the affinity tag is flexible due to the long chains of arginine and lysine aminoacids, it is 
hypothesized that the carboxylic acids of the ligand, linked to an aromatic ring, contribute for 
increased rigidity in the interaction with the affinity tag. 
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Figure 4.42 (A) Binding of GFP and total protein for the putative lead ligands and RKRKRK tagged 
GFP and (B) comparison of enrichment factor values obtained from the screening assays.The 
screening was carried out as in Fig. 4.22 with n =2. 
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Table 4.4 Elution of RKRKRK tagged GFP at pH 11.  After protein binding onto the affinity resins, 5 c.v. 
of the elution buffer (0.1M glycine-NaOH pH 11 was added in each one of the wells of the 96-well blocks 
containing the promising lead ligands. All elution fractions were then quantified by the GFP fluorescence in 
order to obtain the amount of GFP-tagged eluted.  
 
LEAD LIGANDS 
RKRKRK TAGGED GFP 
ELUTED (%) 
A7C1 3.5 
A7C2 6.1 
A7C3 6.8 
A7C4 5.9 
A7C5 0.6 
A7C6 9.5 
A7C8 8.5 
A7C8 8.5 
 
 
 
 
Figure 4.43 SDS-PAGE evaluation of the screening of putative ligands for RKRKRK tagged GFP. 
The Loading (L), flow-through (F) and elution fractions (E) obtained from the 96-well screening were 
loaded into SDS-PAGE gels (12.5% acrylamide), ran 1h at 120V and then silver stained. Two elution 
approaches were tested (A) 0.1M glycine-HCl pH 3 and (B) 0.1M glycine-NaOH pH 11. (M=molecular 
weight marker).  
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4.4.5 Re-Screening with non-tagged GFP crude extract  
 
The results obtained for the re-screening of the promising lead ligands and the non-tagged GFP 
(Fig 4.44) revealed consistency and reproducibility with those obtained in the first screening in 
terms of GFP enrichment, and also indicated that ligands with the highest GFP binding 
percentage showed the lowest enrichment factors values. 
 
GFP displays several patches of hydrophobic amino acids on its surface and can thus establish 
hydrophobic interactions with the affinity ligands. Ligands with higher hydrophobic character 
bound ~100% GFP, even if they did not present the highest enrichment factor values (Fig. 
4.44(B)). Alkaline pH appears to be the elution condition that allows a higher proportion of GFP 
to be recovered, in particular for A4C7 with ~5% of eluted protein. The remaining ligands 
presented a protein recovery below than 3%. Affinity ligands A4C7 and A4C8 displayed a small 
band of GFP in the flow-through and a highly pure band on elution (Fig. 4.45 (B)).   
Based on the flow-through of the two candidates as lead ligands, ligand A4C7 seemed to be 
more promising as this lane possesses a higher amount of unbound proteins than A4C8 and 
thus A4C7 was considered as lead ligand for GFP. Although the affinity ligand A4C7 was not 
very selective for binding to GFP under the tested conditions, presented potential for the 
selective recovery of the protein GFP (§ 5.5.3) At pH 7.4, the GFP protein is negatively charged 
according with the isolectric point of GFP around 5 [206], whereas the lead ligand presents a 
neutral charge (Fig 4.46). The aromatic and benzene ring from the ligand can behave as 
hydrogen bonding acceptor and also are available to perform hydrophobic interactions. The 
carbonyl groups and the NH groups from the ligand backbone can act as acceptor and donor, 
respectively, of hydrogen bonding [206, 245].  
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Figure 4.44 (A) Binding of GFP and total protein for the putative lead ligands and GFP and (B) 
comparison of enrichment factor values obtained from the screening assays. The screening was 
carried out as in Fig. 4.28 with n=2. 
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Figure 4.45 SDS-PAGE evaluation of the screening of putative ligands for non-tagged GFP. The 
Loading (L), flow-through (F) and elution fractions (E) obtained from the 96-well screening were loaded 
into SDS-PAGE gels (12.5% acrylamide), ran 1h at 120V and then silver stained. Two elution approaches 
were tested (A) 0.1M glycine-HCl pH 3 and (B) 0.1M glycine-NaOH pH 11. (M=molecular weight marker).  
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4.5. THE LEAD AFFINITY PAIRS “TAG-RECEPTOR” 
 
The synthesis and screening of an Ugi-library of affinity ligands with cell culture supernatants 
extracts of E. coli producing tagged and non-tagged GFP proteins yielded three potential affinity 
pairs “tag-receptor”, namely, ligand A4C8 for the tag WFWFWF under denaturant conditions, 
ligand A3C4 for the tag NWNWNW and ligand A7C1 for the tag RKRKRK. In addition, the 
synthetic ligand A4C7 presented ability for the selective recovery of non-tagged GFP (Fig. 
4.46).  
 
 
Figure 4.46 Lead ligands selected for GFP tagged proteins and non-tagged GFP. The structure of the 
lead ligands for the respective are represented at pH 7.4. The ligand was designed and then the overall 
charge was determined by using the software Marvin Beans, ChemAxon.  
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A comparison of the amount of GFP bound by each one of the lead systems is given in Fig. 
4.47. It is worth noticing that the binding conditions for each affinity system were not optimized 
in this work, as it would have involved dialysis of the E.coli crude extracts with different buffers, 
a time consuming and costly approach.  
 
 
Figure 4.47 Binding evaluation (µg bound/ g resin) of each one of the GFP tagged proteins and 
non-tagged GFP and the respective affinity ligand. The binding assay was carried out on 96 well 
format, where each one of the well presented the Ugi functionalized-Sepharose beads (250 mg of resin). 
The binding evaluation assay was conducted in several stages as: regeneration (0.1M NaOH, 30% 
isopropanol (v/v) alternated with H20, 3 c.v each in a total of 6 c.v.), equilibration with binding buffer (10 
mM sodium phosphate, 150 mM NaCl, pH 7.4 12 c.v), loading(1 c.v of the respective crude extract was 
loaded: WF-GFP in presence of 8M urea 12 µg loaded/g of resin, NW-GFP 265 µg loaded/g of resin, RK-
GFP: 150 µg loaded/g of resinand for GFP 593 µg loaded/g of resin) and then incubation (1h at 4ºC). The 
flow-through (1 c.v) and washes  fractions with binding buffer or 4M urea 6 c.v followed by 6 c.v. binding 
buffer for A4C8 were collected in 96 well black microplates. The fractions were quantified by 
spectrofluorimetry. Ligand density = 20 µmol / g moist weight gel). (Protein bound = (Protein loaded)-(sum 
of the amount protein in flow-through and washes). The errors bars presented in the graph correspond to 
the standard deviation of 36 samples except for WF-GFP (urea) that corresponds to duplicates. 
 
 
4.6 CONCLUDING REMARKS 
 
The screening of the combinatorial libraries based on the Ugi reaction led to the selection of 
three ligands, each of which displayed affinity for a tag fused to GFP, and a further lead ligand 
with affinity for GFP as shown in the Fig 4.46. The amine component of the Ugi based ligand 
seems to have a pivotal role in the molecular recognition of the tags. The 96-well screening 
format proved to be a reproducible, easy to perform and time saving protocol. 
 All three systems present different characteristics: The WFWFWF tagged GFP/A4C8 pair was 
selected in denaturing conditions, i.e. in 8M urea. This tag might be useful for protein 
purification where the proteins are produced as inclusion bodies, and is presents potential for 
on-column refolding prior to elution. The second affinity system pair corresponds to tag 
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NWNWNW/A3C4 and the third system to RKRKRK/A7C1. Both systems were selected by 
screening under physiological conditions. However, in the case of NWNWNW, this tag presents 
a more neutral character compared to the tag RRKRKRK, which is positively charged. In 
addition, an affinity ligand (A4C7) was selected for GFP, which might be useful in future for the 
purification of GFP fusion proteins. However, these preliminary results required optimization in 
terms of full characterization of the binding thermodynamics, elution conditions optimization and 
scale up in an automated system 
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CHAPTER 5 
OPTIMIZATION AND CHARACTERIZATION OF THE LEAD AFFINITY PAIRS “TAG-RECEPTOR” 
 
 
SUMMARY 
 
This chapter focus on the detailed study and optimization of the lead affinity pairs “tag-receptor”. 
For both pairs tag-receptor NWNWNW-GFP/A3C4 and RKRKRKR-GFP/A7C1, the purification 
was carried out as a standard affinity chromatography process, being the former more adequate 
for recombinant protein purification. Ligand A3C4 presented a static binding capacity of 0.34 ± 
0.59 mg of GFP-tagged per mg of resin displaying an affinity constant 7.22x10
4
 M
-1
. Ligand 
A7C1 presented slightly higher static binding capacity (0.47 ± 0.57 mg of RKRKRK tagged GFP 
per mg of resin) and displayed an affinity constant 7.45x10
5
 M
-1
. The affinity pair WFWFWF-
GFP/A4C8 was selected under denaturing conditions (e.g. presence of urea), with a 
subsequent matrix-assisted refolding stage. An affinity ligand toward GFP was also assessed 
with a static binding capacity of 1.02 ± 6.85 mg of GFP per mg of resin displaying an affinity 
constant of 2.38X10
5 
M
-1
. This was extended for the purification of GFP fusion proteins produced 
on Lactococcus lactis. Regarding the elution conditions optimization, the best elution conditions 
were competitive elution with arginine (500 mM) under mild conditions (PBS pH 7.4 150 mM 
NaCl) and under alkaline conditions such as 0.1M glycine-NaOH pH 11 with 150 mM NaCl for 
the affinity pair RKRKRK tagged GFP/A7C1. In case of non-tagged GFP/A4C7, the best elution 
conditions were also observed under alkaline conditions such as 0.1M glycine-NaOH pH 9 with 
and without 50% ethylene glycol. All the attempts used to recover NWNWNW tagged GFP were 
unaccomplished due to the extreme low amounts of protein recovery (< 3%) and low 
reproducibility of the system. In terms of the scale-up by using an automated liquid preparative 
chromatography such as ÄKTA avant 25, the systems RKRKRK tagged GFP/A7C1 and non-
tagged GFP/A4C7 revealed to be promising affinity pairs to be further used on purification of 
recombinant proteins.  
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5.1 INTRODUCTION  
 
A successful purification process based on affinity chromatography requires a highly specific 
capture step of the target protein and its full recovery with high purity [35, 246]. The capture is 
an adsorption step that relies on the specific binding between the target protein and the 
complementary affinity ligand, with a minimization of the non-specific interactions. The highly 
specific binding can be a result of the establishment of interactions such as electrostatic, 
hydrophobic, hydrogen bonding and van der Waals’ forces [9]. However, the binding efficiency 
also depends on  the kinetics of the interaction and this can be influenced  by concentration of 
the target protein, the amount of the immobilized ligand and the flow rate [34-35]. The binding 
conditions are critical for the establishment of a favourable affinity environment and this means 
that optimal components as molarity, pH and ionic strength should be taken into account [34-
36]. After the binding step, the elimination of the undesirable contaminants and unbound 
species must be assured by a washing step [36].  The following elution step consists on the 
disruption of the ligand-target protein complex [34-36, 246-247]. The choice of the eluents 
needs to be a compromise between the total recovery of the bound target protein and the purity 
and maintenance of the biological activity and integrity of the target protein [34-36, 246-247].   
 
The optimization of binding and elution conditions can be performed on a 96-well micro-scale 
format because of the great advantages of using wide range of adsorbents and different 
operating conditions [225-226, 248]. The 96-well microscale procedure is a batch process and 
because of this case the target biomolecule is incubated with the respective affinity matrix. This 
allows a better mixing between the two entities, nevertheless the flow stops after the application 
[36]. In this way, after the selection of the best binding conditions, these conditions need to be 
applied in columns where the flow rate is taken into account. In case of using small packed 
columns without an automated system driven by gravity, the flow rate will depend on the type of 
matrix and the physical dimensions of the column [36]. In this way, the parameters that 
characterize the maximum binding between the ligand and the target in small scale 
experiments, needed to be adjust on the scaling up. Moreover, the differences on the flow rate 
from small to scale up can also influence the yield of purified protein [36].  
 
The main aim of this chapter was the optimization and characterization of the lead affinity 
systems (Fig. 5.1), which involved (i) the improvement of the elution profiles, performed in a 
rational and individual manner according with the different properties of each affinity system; (ii) 
determination of the affinity constants and the static binding capacity of each affinity system and 
(iii) studies with an automated preparative liquid chromatography system AKTA
TM 
avant 25. The 
latter involved higher amounts of adsorbent bead volume, a better evaluation of the parameters 
(e.g.flow rate) and a detailed analysis of each one of the steps involved in the affinity 
chromatography process.  
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Figure 5.1-Different stages required for the optimization of the lead affinity systems.  
 
 
5.2. COMPARISON OF THE AFFINITY SYSTEMS PERFORMANCE ON 96-WELL FORMAT AND ON-COLUMN 
 
The binding evaluation for each lead ligand was initially carried out in 96-well filtration blocks 
(0.8 cm of well diameter and 3 cm well height) and in a batch mode. The same amount of 
adsorbent (0.25 mg) used in each well containing the lead ligand was packed on small columns 
(0.8 cm of diameter and 6.5 cm of height) and the assays performed under gravity. Overall, 
results obtained from 96-well format and on-column are comparable (Fig. 5.2).  
 
The main difference of the two methods was related with the incubation of the crude extract with 
the immobilized ligands, the ligand packing and the flow rate employed. In the 96-well format, 
the protein samples were incubated 1h at 4ºC with the adsorbents prior washing, the ligand was 
not packed and all the washes were performed through a centrifugation step. Regarding the 
studies on column, the affinity adsorbents were packed on the columns, the crude sample was 
not incubated with the resin, passing through the resin under a gravitational flow (0.75±0.09 
ml/min), originating a lower residence time of the sample within the resin. Although ligand 
density, adsorbent amount, and loading sample were maintained constant, it was expected that 
the binding percentage determined by the 96-well format would be higher when compared with 
those obtained on column, as the interaction between ligand and protein was promoted in the 
former (Fig 5.2). In terms of percentage of GFP bound (Fig 5.2A), there was not a significant 
decrease of binding, which further confirms the selectivity of the systems. As shown in Fig 5.2 
B, the total protein bound on column was significantly lower (less than 10%), except for the non-
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tagged system. This indicates that the on-column binding can contribute for the maintenance of 
the selectivity of the ligands but with reduced non-specific interactions. Regarding the non-
tagged system, ligand A4C7 presented a high percentage of binding for the GFP protein, and 
also for the total protein, as already observed in Chapter 4. The selectivity of this system is 
therefore based on the choice of the correct elution buffer.  The reduction of non-specific 
interactions obtained from the on-column screening with tagged affinity systems, also 
contributed for the increase of the enrichment factor (Fig 5.2(C), reaching the maximum values 
calculated for each GFP-tagged (Table 4.2). In case of non-tagged systems, the enrichment 
maintained the same value between the screening formats, revealing once again the lack of 
specificity of the binding. However, as already described, the elution step can be optimized to 
improve selective recovery of GFP.  
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Figure 5.2 Comparison of the percentage of binding of (A) GFP protein and (B) total protein and (C) 
enrichment factor for the 96-well format and on-column assays for the lead ligands. * Total protein 
bound and enrichment were not determined due to the high concentrations of chaotropic agents employed 
which interfered with the BCA assay. The screening assays were carried out in duplicates (n=2) % Bound 
= (protein bound x 100)/ (protein loaded), where the protein bound was given by protein bound = (Protein 
loaded)-(sum of the amount protein in flow-through and washes). The amounts of GFP-tagged and non-
tagged loaded on 96-well block were 3±0.09, 40 ± 0.10, 28 ± 0.76 and 134 ±4.17 µg of WFWFWF (8M 
urea), NWNWNW, RKRKRK tagged GFP and GFP. The respective amounts of total protein were, except 
for WFWFWF system, 0.71±0.03, 0.91±0.04 and 1.24±0.01 mg. Regarding the amounts of GFP tagged 
and non-tagged loaded on-column was 10±0.01, 45±0.45, 33±0.40 and 135±3.6 of WFWFWF (8M urea), 
NWNWNW, and RKRKRK tagged GFP and GFP. Also the respective amounts of total protein were 
0.87±0.01, 0.98±0.01 and 1.08±0.01mg. In all the cases, the amounts loaded were approximately the 
same and therefore, the results are comparable in terms of binding percentage.  
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The comparison of the evaluation of the binding on a 96 well format and on-column was also 
extended to the controls. The controls refer to unmodified agarose (Fig 5.3). Screening on the 
96-well format presents higher values of GFP bound (Fig 5.3A), which can be explained by the 
higher incubation times employed in the batch system enhancing non-specific interactions. In 
terms of total protein bound, the percentage of binding is similar and presents a maximum of 
binding of 15%, except for the hydrophilic tagged system RKRKRKR-GFP. This can be 
explained non-specific interactions and ionic interactions that can be occurring between the 
contaminants and the GFP tagged in crude samples and the unmodified agarose. 
 
 
Figure 5.3- Comparison of the percentage of binding of (A) GFP protein and (B) total protein for 
the 96-well format and on-column for blank agarose. * Total protein bound and enrichment were not 
determined due to the high concentrations of chaotropic agents employed which interfered with the BCA 
assay. The screening assays were carried out in duplicates (n=2) % Bound = (protein bound x 100)/ 
(protein loaded), where the protein bound was given by protein bound = (Protein loaded)-(sum of the 
amount protein in flow-through and washes) 
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5.3 LEAD LIGANDS SELECTIVITY 
 
The selectivity of the lead ligands for the NWNWNW and RKRKRK tagged GFP were evaluated 
by cross-screening ligand A3C4 against RKRKRK tagged GFP and GFP and ligand A7C1 
against NWNWNW tagged GFP and GFP in on-column format. Ligand A4C7 revealed to bound 
~100% to all GFP-tagged and non-tagged GFP proteins.  The results obtained from these 
studies are shown in Figs. 5.4, 5.5. and 5.6. 
 
 
Figure 5.4 Selectivity of the ligands A3C4 and A7C1. The screening was performed on-column in 
duplicates (n=2) with the same strategy as in 96-well format. The amount loaded of GFP was 34.68 ± 0.71, 
15.78 ± 0.95 and 0.13 ± 0.00 µg for NWNWNW, RKRKRK tagged GFP and GFP, respectively. The 
respective amount of total protein was 0.61 ± 0.05, 0.52 ± 0.04 and 0.95 ± 0.03 mg. % Bound = (protein 
bound x 100)/ (protein loaded), where the protein bound was given by protein bound = (Protein loaded)-
(sum of the amount protein in flow-through and washes). 
 
 
The results in Fig 5.4 (A) show that ligands A3C4 and A7C1 preferentially bound to their pairs 
indicating selectivity for the NWNWNW and RKRKRK tagged GFP, respectively.  Regarding Fig. 
5.4 (B), it is possible to observe a maximum 10% and 20% binding of total protein to ligands 
A7C1 and A3C4, respectively. These results were corroborated by SDS-PAGE analysis (Figs 
5.5 and 5.6). In Fig. 5.5 (A) and (B), no selective binding of the RKRKRK tagged GFP and non-
tagged GFP by ligand A3C4, and no evidence of protein eluted was observed.  
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Figure 5.5 SDS-PAGE analysis of the binding A3C4 to (A) RKRKRK tagged GFP and (B) GFP. The 
Loading (L), flow-through (F) and elution fractions (E) obtained from on-column screening were loaded into 
SDS-PAGE gels (12.5% acrylamide), ran 1h at 120V and then silver stained. Two elution approaches 
0.1M glycine-HCl pH 3 and 0.1M glycine-NaOH pH 11 were tested. (M=molecular weight marker).  
 
Figure 5.6. SDS-PAGE analysis of the binding A7C1 to (A) NWNWNW tagged GFP and (B) GFP. The 
Loading (L), flow-through (F) and elution fractions (E) obtained from on-column screening were loaded into 
SDS-PAGE gels (12.5% acrylamide), ran 1h at 120V and then silver stained. Two elution approaches 
0.1M glycine-HCl pH 3 and 0.1M glycine-NaOH pH 11 were tested. (M=molecular weight marker). 
 
 
A similar profile of low or inexistent selective binding of A7C1 was observed for NWNWNW 
tagged GFP and non-tagged GFP (Fig. 5.6 (A) and (B)). However, there was protein eluted 
under alkaline conditions that might be resultant from the non-specific binding of non-tagged 
GFP (<10%) to ligand A7C1. Overall, these results might infer about the selectivity of the lead 
ligands for their respective affinity tags.  
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5.4 DETERMINATION OF BINDING CONSTANTS 
 
The adsorption step in affinity chromatography, if a unimolecular interaction occurs, involves the 
interaction between an immobilized ligand (L) and a target protein (P) to form a complex ligand-
protein (LP). The following scheme (Fig. 5.7) and equation (5.1) describes the interaction, being 
the Ka, the association equilibrium constant and Kd the dissociation constant [34-35].   
 
Figure  5.7. Adsorption and desorption scheme between an immobilized affinity ligand and a target 
protein.  
 
Ka= 
 LP]
 L   P]
      eq.5.1 
 
For affinity purification purposes, affinity constants should be within the range 10
3
 M
-1 
-10
9
 M
-1
  
[33, 249]. The association constant should not be low otherwise the separation process will be 
inefficient; nor too high because that will limite the recovery of the protein [33]. Examples of high 
affinity constants include natural affinity partners such as glutathione- glutathione-S-transferase 
(GST) protein [250] , lectin (concanavalin A)- glycoprotein [251], staphylococcal protein A (spA) 
– IgG [77-78], avidin-biotin [113] with 10
5
, 10
5
, 10
8
 and 10
15
 M
-1
, respectively. When employing 
biomimetic ligands that mimic natural recognition, affinity constants are usually lower. Examples 
include triazine ligands 22/8 and 8/7 (artificial protein A and protein L, respectively), that bind to 
human IgG with a Ka of 10
5 
and 10
4  
M
-1
, respectively [19-20]; Ligand 11/1 (glycoprotein-binding 
artificial receptor) which binds to glycoproteins purification with a Ka of 10
4  
M
-1
 [22]. More 
recently, a new generation of biomimetic ligands based on the Ugi reaction have been 
developed for the purification of human IgG, displaying an affinity constant of 10
6 
M
-1
 [38]. 
Another system with a high affinity constant, 10
7
 M
-1
, is the complex formed between metal ions 
and poly-histidine fusion proteins as determined by surface plasmon resonance (SPR) [181]. 
 
The detailed evaluation of the interaction between the ligand and the target protein can be 
determined by different analytical methods, separative and non-separative [252]. Separative 
methods involve liquid chromatography techniques such as quantitative affinity chromatography 
[252-253]. Non-separative methods rely on the evaluation of changes on the physicochemical 
properties of the target protein or the ligand after binding. These methods can be divided in 
different categories as spectroscopic (UV visible, fluorescence, NMR, circular dichroism), 
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calorimetric (isothermal titration calorimetry and differential scanning calorimetry) or surface 
plasma resonance (SPR).  
 
Quantitative affinity chromatography presents several advantages: the matrix employed in the 
purification is also employed for the determination of the binding constants; it is a versatile 
technique that allows the characterization of a wide range of binding constants. It is possible to 
characterize from weak (10
3
 M
-1
)
 
to strong interactions (10
9
 M
-1
) by partition equilibrium 
experiments, frontal or zonal affinity chromatography [249, 253]. In this particular case, the 
binding constants were determined by static partition equilibrium studies. These studies were 
performed by the incubation of a range of different concentrations of partitioning solute (GFP-
tagged and non-tagged) with a fixed amount of immobilized ligand until the establishment of a 
chemical equilibrium [249, 253]. The correlation between the amount of protein adsorbed to the 
solid phase and the unbound protein after reaching the equilibrium is termed adsorption 
isotherm [34]. The isotherms are used to evaluate the binding  capacity of the affinity adsorbent; 
Langmuir and Freundlich isotherms are typically employed in affinity chromatography [254]. 
However, the Langmuir isotherm is the most popular model and is often described by: 
 
q= 
Qmax   Ka   C 
1+ Ka   C
     eq. 5.2 
 
where q is the bound protein per mass of support (mg/g resin)  and C corresponds to unbound 
protein in equilibrium (mg/ml) . The Qmax and Ka correspond to binding capacity and association 
equilibrium constant, respectively [34, 38, 254]. The assumptions of Langmuir isotherm include 
that all adsorption sites are identical and each one retains one target molecule; Moreover, all 
sites display uniform and independent energies of adsorption [254-255].  
 
In order to evaluate the capacity of the affinity adsorbents and the association constants, 
partition equilibrium studies were performed for all the affinity systems on a 96-well format. The 
resultant parameters were fitted by a Langmuir isotherm and the respective constants are 
shown in Fig 5.8 and Table 5.1, respectively. For the systems with NWNWNW (Fig 5.8A) and 
RKRKRK tagged GFP (Fig. 5.8B), the isotherms displayed a linear profile, explained by the 
lower concentrations of protein used on these studies, which were not sufficient to reach the 
maximum adsorption capacity [256]. Regarding the studies with non-tagged GFP protein and 
A4C7 (Fig. 5.8C), the isotherm was linear for lower concentrations, stabilising after reaching a 
maximum binding capacity. The affinity constants obtained for the affinity systems tested were 
within the range for a suitable purification process, where the RKRKRK tagged GFP/ A7C1 and 
non-tagged GFP/A4C7 presented the same order of magnitude (10
5
 M
-1
) and the NWNWNW 
tagged GFP/A3C4 presented an affinity constant with a lower magnitude of 10
4
 M
-1
 . The values 
of Qmax presented a high error associated, but in general these are low when comparing if 
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other similar affinity systems. For example, the Ugi based affinity ligands for the purification of 
immunoglobulins presented Qmax values in the order of 25 and 16 mg IgGml
−1
resin [38, 68].   
 
These partition studies were carried out with unpurified protein from crude extracts and the 
higher concentration of GFP-tagged and non-tagged required was limited by the amount of 
protein produced in E.coli host. Also the determination of unbound protein was associated with 
a larger error. In order to overcome these issues, higher concentrations of protein were needed 
by using larger volumes of cell culture, concentrating the protein after the fractionation or by 
optimizing of the culture conditions to improve protein expression. On the other hand, a 
Langmuir isotherm was assumed as the best fitting model but other models might have been 
more appropriate.  
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Figure 5.8- Binding isotherms and resulting static binding capacities for the affinity pairs (A) 
NWNWNW tagged GFP and A3C4, (B) RKRKRK tagged GFP and A7C1 and (C) GFP and A4C7. The 
Ugi-based adsorbents were incubated overnight at 4ºC under orbital agitation with several dilutions of the 
correspondent protein. Bound and unbound protein was determined by measuring GFP fluorescence. 
Then the bound protein per mass of support, q, (mg/g resin) was determined and correlated with unbound 
protein in equilibrium, C, (mg/ml). Experimental data was plotted and fitted to the Langmuir model (Q = 
(QMAX . KA . C) / (1 + KA .C)). The fittings present correlation factors (r
2
) of (A)  0.89, (B) 0.99 and (C) 0.99. 
The calculations were undertaken with OriginPro 8.0.    
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Table 5.1 Kinetic parameters obtained for each of the affinity pairs after fitting with 
Langmuir model.   
 
 
Affinity System 
 
 
Ka (M
-1
) 
 
 
Q max (mg/g) 
 
 
r
2
 
 
NWNWNW tagged GFP 
 
 
7.22E+04 
 
 
0.34 ± 0.58 
 
 
0.99 
 
RKRKRK tagged GFP 
 
 
2.45E+05 
 
 
0.47 ± 0.57 
 
 
0.99 
 
GFP 
 
 
2.38E+05 
 
 
1.02 ± 6.85 
 
 
0.89 
 
 
 
5.5 OPTIMIZATION OF THE ELUTION PROFILE FOR THE LEAD AFFINITY PAIRS 
 
The role of the elution step in affinity purification is to disrupt the interactions formed between 
the complex ligand-target protein. In order to recover the target protein, a compromise between 
high yields, purity, stability and integrity of biological activity are taken into account when 
selecting elution buffers [35, 247, 257]. The elution process can be specific (i.e. competitive 
elution) or non-specific [34]. In the former, the elution is targeted to each particular case and 
mild conditions can be employed which contribute for the maintenance of the biological activity 
and integrity of the protein [34-35, 247]. However, when using the ligand as the competitive 
agent, the free ligand should be present in higher concentrations than the immobilized ligand 
[34], which is a disadvantage from an economic point of view [247]. The non-specific elution is 
related with a change in parameters as pH, ionic strength, polarity or temperature. A difference 
in pH can influence the overall charge of the ligand and the amino acids through protonation 
and deprotonation, and consequently can contribute for the disruption of the ionic interactions. 
However, some macromolecules can suffer from denaturation due to their instability under 
extreme pH conditions. Therefore, an additional concern about pH neutralization might be 
necessary [36, 247].  The use of different salt concentration and buffer salt composition can 
contribute for differences on the ion strenght. High concentrations of salts can contribute for the 
disruption of ionic bonds but also can promote the formation of hydrophobic interactions [36, 
247-248]. A class of salts that can be used are the chaotropic salts, which increase the solubility 
of non-polar molecules in water by disrupting or minimizing the hydrogen networking of the 
water molecules [258], disrupting hydrogen bonding and dissolving the hydrophobic binding 
regions into aqueous phase [36]. Both anions and cations of the chaotropic agents are arranged 
according with the Hofmeister series (Fig. 5.10), which is related with the ion’s ability to alter the 
hydrogen bonding of water and is more pronounced for anions than for cations [36, 258-259]. 
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  Kosmotropes    Chaotropes 
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-
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-
 < SCN
- 
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   NH4
+ 
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+
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+
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+
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+
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2+
 < Ca
2+
 < Ba
+
 
 
The kosmotropes are a class of anions that are “water-structure makers” [259] as they possess 
the ability to perform hydrogen bonding with water molecules and contribute for the 
enhancement of hydrophobic interactions and salting-out effects. The chaotropic salts act by 
disordering water molecules, increasing the solubility of non-polar groups and reducing the 
hydrophobic interactions [259]. The urea, guanidine and detergents as sodium dodecyl sulphate 
(SDS) are also strong chaotropic agents [36, 258-259]. The greatest disadvantage of using 
chaotropic agents as eluents consists on the structural changes of the target protein, namely 
the loss of secondary and tertiary structure, leading to incorrect folding and denaturation, which 
require further removal after elution [34, 36, 247, 260]. The use of organic solvents also can 
affect the polarity of the affinity interaction, being the most common methanol, polyols as 
ethylene glycol (0-50%) and glycerol [247-248]. These solvents are polar reducing agents 
through the binding to hydrophobic sites of the target protein decreasing the hydrophobic 
interactions between the ligand and protein [261-262]. In general, ethylene glycol does not 
induce large conformational alterations in the protein, but high concentrations can cause ligand 
leaching [262]. The temperature and chelating substances are agents that also can improve the 
elution efficiency [34, 36]. The chelating agents such as EDTA are particular efficient in those 
affinity systems that require metals to enhance binding [36].  
 
In order to develop a successful elution strategy, the eluents choice can be a combination of the 
parameters described above. 
The optimization of the elution conditions was carried out after the binding assay, and the yield 
of the eluted fraction was monitored through GFP fluorescence. As already described, the GFP 
fluorophore is within a cylinder format with eleven beta strands around and a α-helix in both 
ends [244, 263], which confers protection to the GFP chromophore [206]. However the use of 
agents such as organic solvents and chaotropic agents can perturb the absorbance/excitation 
spectrum of native and recombinant wild-type Aequorea GFP [206]. The use of organic 
solvents, solvents with pH between 8 and 12, and solvents at high concentrations (> 60% (v/v)) 
can induce qualitative and quantitative spectral shift of GFP as previously noted [206]. The 
chaotropic agents when used in high concentrations as 8M urea and 4M guanidine ·HCl 
contribute for some loss of GFP fluorescence but when used it over longer periods and with 
higher temperatures a complete loss of fluorescence can be seen [206, 243].   
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The strategy for the optimization of elution conditions followed two different approaches in a 96-
well format (Fig 5.9). As a first approach, the parameters analysed were the pH influence by 
using different buffers with pH between 3 and 10, different ionic strengths (0.15-1 M NaCl) and 
phosphate concentrations (0.01-1M) under mild conditions (PBS, 10mM sodium phosphate, 
150mM NaCl pH 7.4). Afterwards, as second approach, the best pH that allows a better 
recovery of protein was used to evaluate the influence of different ionic strengths (0.15-1 M 
NaCl).and additives such as ethylene glycol (5-50% (v/v)). These last studies were conducted 
with two best pH conditions (pH 9 and 11) for non-tagged GFP, and for tagged systems just with 
the best pH condition (pH 11). Moreover, for the tagged systems, competitive elution also 
attempted, by using different concentrations of competitor such as tryptophan (5-15 mM) and 
arginine (10-750 mM) for the system NWWNWN and RKRKRK tagged GFP, respectively under 
mild conditions (PBS buffer) and at the best pH condition (pH 11).  
 
The optimization of elution conditions was not addressed to the system WFWFWF tagged GFP 
because refolding on column should precede elution. The attempts on the refolding and elution 
were performed in an automated system and results are shown later in this Chapter (§ 5.7.1). 
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Figure 5.9- Strategy for the optimization of the elution conditions. Two different approaches were 
attempted in a 96-well format. The first attempt comprises the evaluation of best elution pH by using 
buffers with pH between 3 and 10, and the study of different ionic strengths (0.15-1 M NaCl) and 
phosphate concentration(0.01-1M) influence under mild conditions using PBS (10mM sodium phosphate, 
150mM NaCl pH 7.4). The second approach involves the evaluation of GFP recovery with different 
ethylene glycol concentrations (5-50% (v/v)) and ionic strength (0.15-1 M NaCl) at the best pH condition, 
where a higher yield of GFP was eluted. In case of non-tagged GFP, these last studies were carried out 
with the two best pH elution conditions (pH 9 and 11) and for the tagged systems, only with one best pH 
condition (pH 11).  In case of GFP tagged systems, the competitive elution was also considered by using 
arginine and tryptophan as the competitors for the RKRKRK-GFP and NWNWNW-GFP systems, 
respectively. The competitive elution was performed by using different concentrations of competitor (5-15 
mM of tryptophan and 10-750 mM of arginine) at the best pH elution condition (pH 9) and also under mild 
conditions (PBS pH 7.4) 
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5.5.1 Affinity pair NWNWNW tagged GFP-A3C4 
 
According to the chemical structure of the tag and ligand, it was expected that the basis of the 
affinity between the pair would be both hydrophobic interactions and hydrogen bonding (Fig. 
5.10 and 5.11). The results obtained from the first approach of the elution optimization 
conditions with variation of phosphate concentration and ionic strength under mild conditions, 
indicated extremely low amounts of protein recovery (< 1%). When varying the pH, the same 
effect was also observed (< 1%), except for high alkaline conditions (pH > 11), at which the tag 
becomes negatively charged (Table 4.2). Overall, the system presented low reproducibility and 
recovery (< 3%). 
 
The second attempt on the optimization of elution involved the use of elution buffer at pH 11 
with different ionic strengths and concentrations of ethylene glycol. The competitive agent was 
tryptophan with a maximum concentration of 15 mM due to the low solubility in the buffers 
employed. Once again, the attempt to recover GFP tagged was not successful. The recovery of 
GFP tagged protein achieved a maximum of 3% in alkaline conditions with 50% ethylene glycol 
and 1% with all tryptophan concentrations at both conditions tested (PBS: 10 mM sodium 
phosphate, 150 mM pH 7.4 and 0.1M glycine-NaOH pH11). The influence of ethylene glycol in 
high concentrations seemed to recover a low amount of GFP-tagged but reproducibility was 
low. The competitive elution did not show any promising results, considering that only 1% of 
GFP tagged was eluted. In order to overcome this, more strongly agents should be tested to 
improve the efficiency of the elution. Alternatives can include chaotropic agents which disrupt 
most interactions (hydrogen-bonding, hydrophobic interactions and ionic bonds), and due to the 
harsh conditions employed, can present a higher impact on the elution of GFP tagged protein. 
Different competitors as an analogous compound of tryptophan should be used, with high 
solubility properties so that the easy dissolution on the mild conditions can be achieved. 
Considering all the conditions, the elution conditions chosen to proceed are 0.1 M Glycine-
NaOH, pH 11 with 50%(v/v)  of ethylene glycol. 
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Figure 5.10 Microspecies distribution (%) for the ligand A3C4 over the pH values between 3 and 11. 
This distribution represents the various species that the ligand A3C4 can acquire over the pH values and 
was determined by the software Marvin Beans, ChemAxon. 
 
 
  
Figure 5.11 Influence of pH on the charge of the NWNWNW peptide without free C-terminal. This 
parameter was estimated by the software Marvin Beans, ChemAxon. This estimation took into account the 
C-terminal of the tag was linked to the recognition site of the enterokinase and GFP protein 
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5.5.2 Affinity pair RKRKRK tagged GFP - A7C1 
 
The affinity system RKRKRK-GFP and A7C1 will probably interact mainly through electrostatic 
interactions and hydrogen bonding according to the structures of both affinity tag and receptor 
(Figs. 5.12 and 5.13). It was expected that an increase on ionic strength would disrupt the 
complex through the competition of the charged salts to the binding sites of the tag or the 
ligand. Variations on pH could also have a positive impact on the elution of the GFP tagged 
protein. The results obtained from the first elution tests are presented in Fig 5.14. Fig 5.14A 
shows the yield of fusion protein eluted for different phosphate and salt concentrations under 
mild conditions (PBS at pH 7.4). In terms of phosphate concentration, elution slightly decreases 
with the increase of salt concentration, being the best phosphate concentration 10 mM with a 
recovery of 20%. For the elution with varying concentrations of NaCl, the amount of fusion 
protein eluted increases from 150 to 250 mM NaCl, but there is not a significant difference from 
the concentration of 250 mM up to 1M of NaCl, corresponding to a recovery of 20%. High salt 
concentrations can break hydrogen bond networking and contribute for salting out effects of the 
protein, leading ultimately to protein precipitation and denaturation. Therefore, lower amounts of 
phosphate and NaCl in the elution buffers can be more beneficial, and a suitable buffer for mild 
elution is PBS with 10 mM of sodium phosphate and 250 mM NaCl at neutral pH. Regarding the 
effect of pH (Fig 5.14B), elution seemed to be more efficient at alkaline conditions. If the ionic 
interactions were predominant, the pH could influence the charge of the tag and the ligand by 
reducing or promoting the ionic forces. The ligand is negatively charged at pH values higher 
than 3 (Fig. 5.12), and the tag is highly positive charged until pH 8 where an accented decrease 
is observed until pH 13.35, where the charge is neutral (Fig. 5.13). Considering this, it was 
expected that from pH 8 onwards ionic interactions between the tag and the ligand would 
become weaker. The results obtained in Fig 5.14B corroborate these simulations, where pH 11 
was the best condition for fusion protein elution.   
 
.  
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Figure 5.12 Microspecies distribution (%) for ligand A7C1 over pH values between 3 and 11 
(determined by the software Marvin Beans, ChemAxon). 
 
 
 
Figure 5.13 Influence of pH on the charge of RKRKRK peptide without free C-terminaL estimated by 
the software Marvin Beans, ChemAxon. This estimation took into account the C-terminal of the tag being 
linked to the recognition site of the enterokinase and GFP. 
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5.14- Influence of the different elution buffers on the recovery of RKRKRK tagged GFP. As a first 
approach, the (A) influence of different phosphate concentrations (10mM-1M) and ionic strengths (150mM 
-1M NaCl) were studied under milder conditions with PBS (10 mM sodium phosphate , 150 mM NaCl, pH 
7.4). The (B) influence of pH was also assessed by using different buffers with pH between the 3 and 10. 
The buffers used for pH 3-6, 7-8 and 9-10 were 0.1M citrate buffer, 0.1M sodium phosphate buffer and 
0.1M glycine-HCl, respectively. The elution optimization was carried out in a 96-well format. The loading 
and washing steps were carried out as described in Fig. 5.21 with the additional elution step of addition of 
5 c.v. to each well with the respective elution buffer after washing step. The total amount of RKRKRK-GFP 
bound was 5.7 µg, corresponding to a total of 60% of the amount loaded (9.5 µg). The error bars 
corresponds to duplicates. % Eluted = (protein eluted x 100) / protein bound. 
 
 
The second approach on elution optimization was performed at pH11 in the presence of 
different concentrations of ethylene glycol and NaCl. Also competitive elution was performed by 
using arginine in PBS pH 7.4 and the buffer at pH 11. The maximum concentration or arginine 
used was 750mM due to solubilisation issues at higher concentrations (Fig 5.15). The 
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combination of the best pH and NaCl concentration improved the elution of the GFP tagged 
protein. The amount of GFP eluted appeared to be constant independently of the concentration 
of NaCl used (Fig.5.15 (A)), being the condition with the best GFP tagged recovery (30%) the 
elution buffer pH 11 with 150 mM NaCl. The effect of additives such as ethylene glycol was 
more accented with higher concentrations (Fig. 5.15 (A)).  
 
The Fig 5.15 (B) shows the results about the competitive elution by using arginine as the 
competitor agent under mild conditions (PBS pH 7.4) and at pH 11. The arginine can compete 
with RKRKRK affinity tag for the ligand binding sites. Under milder conditions, the arginine 
concentrations that allow a better recovery of the protein are 500 and 750 mM, where under 
alkaline conditions, the results revealed similar amounts within concentrations between 100 and 
750 mM. The results showed to be more promising at neutral conditions (PBS pH 7.4), and the 
arginine concentration selected was 500 mM with a protein recovery of 24%. Overall, the elution 
optimization studies contributed for an improvement of the elution being the most promising 
elution 0.1M Glycine-NaOH pH 11 with 150 mM of NaCl and the competitive elution condition as 
PBS pH 7.4 150 mM NaCl with 500 mM Arginine. The selected elution conditions can 
corroborate the selectivity between the affinity tag RKRKRK and ligang A7C1. 
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Figure 5.15- Second approach for the optimization of the elution conditions for the recovery of 
RKRKRK tagged GFP. The second approach for the elution optimization involves the evaluation of (A) 
different concentrations (v/v) of ethylene glycol (0-50%) and ionic strengths (0-1M NaCl) by using the best 
pH elution condition (0.1M Glycine-NaOH pH 11) determined on the first attempt of elution optimization. 
The competitive elution with arginine as competitor agent was evaluated by employing (B) different 
concentrations (0-750mM) under milder conditions (PBS, 150 mM NaCl, pH 7.4) and at pH 11 (0.1M 
Glycine-NaOH pH 11). The elution optimization was carried out in a 96-well format. The loading and 
washing steps were carried out as described in Fig. 5.21 with the additional elution step of addition of 5 
c.v. to each well with the respective elution buffer after washing step. The total amount of RKRKRK-GFP 
bound was 20 µg, corresponding to a total of 60% of the amount loaded (32 µg). The error bars 
corresponds to duplicates. % Eluted = (protein eluted x 100) / protein bound. 
 
 
5.5.3 Affinity pair GFP-A4C7 
 
The main interactions involved in the affinity complex GFP and A4C8 were evaluated according 
to the structure of the lead ligand and GFP properties (Fig. 5.16 and 5.17). The optimization of 
the elution conditions might also give some indications about the interactions that have been 
established. Ligand A4C7 shows a highly hydrophobic structure with aromatic rings, which can 
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engage into hydrophobic interactions and as an acceptor of hydrogen bonding. No protein was 
eluted when using mild conditions as neutral phosphate buffers with different phosphate 
concentrations and ionic strengths. These parameters enhance hydrophobic interactions, and if 
these are the basis of the molecular recognition, the use of high concentrations of NaCl and 
sodium phosphate would contribute for a stronger interaction rather than disruption. When 
studying the influence of pH, it was observed that at pH 9, there was a recovery of 40% of 
bound GFP protein (Fig.5.15). At this pH value the overall charge of the protein is negative. The 
side chains of the amino acid present different pKa’s of the ionisable groups. The pKa values 
can be shifted due to the influence of different factors as protein conformation and the 
polarizability of the solvent and protein [264]. Moreover, the binding of the ligand to the target 
protein can also affect the pKa values of the ionisable groups due to the transfer of the protons 
[265] . However if a shift on the pKa of the ionisable groups of the side chains of specific amino 
acids such as cysteine (pKa ~ 8), lysine (pKa ~ 10), tyrosine (pKa ~ 10), and arginine (pKa ~ 
12) occurred, these groups could be deprotonated at pH 9. If these amino acids are interacting 
with the ligand via hydrogen bonding, at pH 9 these interactions should be reduced and the 
elution of the protein could be achieved. The protein can be interacting with ligand via hydrogen 
bonding considering that over the pH, the ligand presented a neutral charge eliminating the 
possibility of the establishment of the ionic interactions. However, in order to corroborate this 
hypothesis, it was necessary to understand if these amino acids are present in the surface of 
the GFP protein. The GFP sequence used on this work was based on the commercial sequence 
available in the plasmid pGFPuv (Clontech). The crystal structure used was the 1QYO from 
protein data bank (Fig.5.18). This structure is the one that presents a higher identity (more than 
90%) with the GFP sequence used experimentally. By using the software Pymol, all the 
aminoacids whose pKa’s of the side chains are close to 9 (lysine, tyrosine, arginine and 
cysteine) were selected to understand their position within the protein. All the aromatic residues 
were also selected in order to understand if they are available on surface to perform 
hydrophobic interactions. 
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Figure 5.16- -Influence of the different elution buffers on the recovery of GFP. As a first approach, 
the nfluence of pH was also assessed by using different buffers with pH between the 3 and 10 (B). The 
buffers used for pH 3-6, 7-8 and 9-10 were 0.1M citrate buffer, 0.1M sodium phosphate buffer and 0.1M 
glycine-HCl, respectively. The elution optimization was carried out in a 96-well format. The loading and 
washing steps were carried out as described in Fig. 5.27 with the additional elution step of addition of 5 
c.v. to each well with the respective elution buffer after washing step, except for the condition 0.1M 
Glycine-NaOH pH 9, where 25 c.v. were added until GFP concentration reaches 0 mg/ml. The total 
amount of GFP bound was 111 µg, corresponding to a total of 99% of the amount loaded (112 µg). The 
error bars corresponds to duplicates. % Eluted = (protein eluted x 100) / protein bound. 
. 
 
 
 
 
Figure 5.17- Microspecies distribution (%) for the ligand A4C7 over pH values between 3 and 11. 
This distribution represents the various species that the ligand A4C7 can acquire over the pH values and 
was determined by the software Marvin Beans, ChemAxon. 
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According to the Fig 5.18, a significant number of these residues are at the surface of the 
protein. Moreover, Fig 5.18 presents also a considerable number of aromatic residues (tyrosine, 
phenylalanine and tryptophan) mostly within the cylinder barrel (phenylalanine residues) and 
some present in higher amounts at the surface (tyrosine). 
Overall, the best elution conditions found out from the first approach of the elution optimization 
were pHs 9 and 11. At pH 11, the total amount of GFP protein eluted is only 12%. Considering 
this, the second approach for the optimization of the elution buffers was performed and the 
results are shown in Fig 5.19.  
  
 
 
Figure 5.18- Crystal structure of GFP protein (1QYO). The surface of the GFP protein presents several 
aminoacids involved in different type of interactions such as lysines (blue), tyrosines (red), arginines 
(yellow), cysteines (orange) and aromatic residues (white) as tryptophan and phenylalanines. 
 
 
The increase of ethylene glycol concentration increased the amount of GFP eluted, which 
corroborates the weight of hydrophobic interactions (Fig. 5.19(A)). As already discussed, 
ethylene glycol induces some perturbations in the fluorescence of GFP. This effect was 
observed as the percentage of GFP recovery corresponded to 150% when using pH 9 with 50% 
of ethylene glycol. In the case of pH 11 with 50% of ethylene glycol this corresponded to 99%. 
Even if the use of ethylene glycol inflated the results of the amount of GFP eluted, these two 
conditions seemed to be more promising. The combination of pH 9 and the use of 50% ethylene 
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contributed for the maximization of the disruption of more than one type of interactions. Other 
issue that was taken into account due to the higher percentages of GFP eluted, was ligand 
leaching. Ligand A4C7 presents a fluorescent amine with the same adsorption and emission 
wavelengths than GFP. Therefore, if ligand was leaching it could also be accounted in the 
quantification of the GFP protein. However, the SDS-PAGE analysis and the BCA assay 
confirmed the presence of protein during the elution. 
 
 
Figure 5.19 Second approach for the optimization of the elution conditions for the recovery of GFP 
The second approach for the elution optimization involves the evaluation of (A) different concentrations 
(v/v) of ethylene glycol (0-50%) and ionic strengths (0-1M NaCl) by using the two best pH elution 
conditions (0.1M Glycine-NaOH pH 9 and 11) determined on the first attempt of elution optimization. Also 
the influence of (B) of different ionic strength (0-1M NaCl) was evaluated in the two best pH elution 
conditions (0.1M Glycine-NaOH pH 9 and 11).  The elution optimization was carried out in a 96-well 
format. The loading and washing steps were carried out as described in Fig. 5.27 with the additional 
elution step of addition of 5 c.v. to each well with the respective elution buffer after washing step, except 
for the conditions 0.1M Glycine-NaOH pH 9 with 5, 10, 25 and 50% ethylene glycol (v/v), where 18 c.v. 
were added until GFP concentration reaches 0 mg/ml. The total amount of GFP bound was 149 µg, 
corresponding to a total of 99% of the amount loaded (150 µg). The error bars corresponds to duplicates. 
% Eluted = (protein eluted x 100) / protein bound. 
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The results shown in Fig 5.19 revealed that different ionic strengths did not contribute for the 
disruption of interactions between the affinity complex. If the predominant interactions were 
involved were hydrophobic and hydrogen bonding, the results obtained can corroborate this 
hypothesis. Overall the best elution conditions selected to proceed were 0.1mM Glycine-NaOH 
pH 9 with and without 50% of ethylene glycol. These conditions might present selectivity on 
GFP recovery due to total amount of total protein also eluted that is below 13% as determined 
by BCA colorimetric analysis. 
 
 
5.6 SCALE UP OF THE AFFINITY PAIRS  
 
The scale-up of the affinity systems involved the use of higher amounts of the affinity 
adsorbents (~1g) in an automated preparative liquid chromatography system (AKTA
TM
 avant 
25). Therefore, it was possible to perform cycles of affinity purification at controlled flow rate, 
with 1ml/min as a first approach. The choice of this flow rate was the best approximation of the 
gravitational flow rate (0.75±0.09 ml/min) obtained on-column screening, presented as the most 
suitable flow rate according to affinity based protein purification manuals [266] and was also the 
best flow compared to others (0.3 and 0.5 ml/min) to prevent resin damage. Two separate 
cycles of binding, elution and regeneration were performed for the affinity pairs RKRKRK 
tagged GFP/A7C1, NWNWNW tagged GFP/A3C4 and non-tagged GFP/A4C7 using E.coli 
protein extracts. The system GFP/A4C7 was also employed in the purification of a GFP fusion 
protein, produced in a different host (Lactococcus lactis). The affinity system WFWFWF-
GFP/A4C8 was subjected to a cycle with an additional step of on column refolding after binding 
under denaturing conditions and prior to elution. Samples obtained in each step of the 
purification process were analysed by GFP fluorescence and total protein measurements as 
well as SDS-PAGE analysis for purity evaluation. 
 
5.6.1 Affinity pair WFWFWF tagged GFP - A4C8 under denaturing conditions 
 
The affinity pair WFWFWF tagged GFP/A4C8 presented different properties from the other 
systems, as the extremely hydrophobic tag induced the formation of inclusion bodies. In this 
case, as ligand A4C8 binds to the tagged protein in the presence of the chaotropic agent (urea), 
it was interesting to explore the potential of this system for on-column refolding of the protein 
prior to elution. The protocol for the refolding on column was based on other cases presented in 
the literature [49, 138, 190], and involved simultaneously a decreasing gradient of urea and an 
increasing gradient of the ionic strength up to 1M NaCl to avoid non-specific interactions [49]. 
During the refolding process (Fig. 5.20), one important aspect is the flexibility of the affinity tag 
to allow the proper protein structure folding while the interaction between the tag and the 
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immobilized ligand is maintained. Therefore, the refolding yield and rate are dependent on each 
target protein [165].  
If the refolding is successfully achieved, the protein will acquire the correct folding and the 
fluorescence of chromophore can be observed. As the optimization studies (§ 5.6) were not 
performed for this affinity system due to impossibility to have an accurate quantification of GFP 
fluorescence and total protein, it was expected that, by removing urea, the fluorescence of 
WFWFWF tagged GFP could be slowly restored. As a first approach, the refolding on-column 
was conducted with 50 c.v. of PBS with 1M NaCl to dilute the 8M urea presented in the binding 
buffer prior to elution step. However, after the refolding process, the WFWFWF tagged GFP did 
not restore the proper folding due to inexistence of fluorescence obtained on the elution and 
regeneration samples. A longer refolding time with a gradient of PBS 8M urea: PBS 1M NaCl 
from 100:0 to 0:100 in 250 c.v.was used to improve the protein folding kinetic (Fig.5.20) and all 
the stages were monitored for GFP fluorescence. However, no GFP fluorescence was again 
observed. The SDS-PAGE gel of the samples collected confirmed that the affinity ligand bound 
to the GFP-tagged, when comparing the loading and flow-through lanes (Fig. 5.21). However, it 
is unlikely that GFP refolding occurred as despite the bands of GFP in the elution and 
regeneration lanes, no fluorescence was detected by spectrofluorimetry. During the first steps of 
refolding there was a small amount of tagged GFP being washed out. Still, as there was 
evidence of WFWFWF tagged GFP on the elution and regeneration lanes, there was still protein 
bound to the affinity matrix during refolding. This might be related with the fact that high salt 
concentrations can improve hydrophobic interactions between the ligand and the tag and 
therefore influence the renaturation process [165]. The elution step was conducted by a drastic 
change in the pH conditions. If a rational selection was performed, maybe the use of ethylene 
glycol that disrupts the hydrophobic interactions, could improve the recovery of GFP-tagged. 
The used strategy was just performed once as a first approach and therefore some efforts 
should be done in future so that a total refolding of the GFP could be achieved. 
 
 
Figure 5.20 Strategy used for the refolding of the WFWFWF tagged GFP on A4C8 functionalized 
matrix performed on the AKTA
TM
 avant 25 with the expected chromatogram. The refolding strategy 
was based on the dilution of the binding buffer PBS 8M urea with 250 c.v. of PBS with 1M Nacl, prior to the 
elution step with 0.1M glycine-NaOH pH 11.  
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Figure 5.21- SDS-PAGE analysis of the samples from the purification of WFWFWF tagged GFP by 
ligand A4C8 under denaturing conditions. A4C8 adsorbent was packed (1g) on column with a flow of  
0.3 ml.min
-1
 and prepared for analysis using an AKTA 
tm
 avant 25. Afterwards the solid support was 
subjected to the following steps with a flow rate of 1 ml.min
-1
: regeneration (0.1M NaOH, 30% isopropanol 
(v/v) alternated with H2O, 10 c.v. each in a total of 30 c.v.), equilibration (10 mM sodium phosphate, 150 
mM NaCl, pH 7.4 15 c.v.) and loading (1 c.v. of 1ml of WFWFWF tagged GFP with 12 µg loaded/g of resin. 
In this particular case, after the loading, a refolding step was performed by using a gradient of 1M NaCl in 
binding buffer in order to dilute urea (250 c.v.). The elution was proceeded with 30 c.v. of the 0.1M 
Glycine-NaOH pH 11. The regeneration was done as already described with a total of 20 c.v. (0.1M NaOH, 
30% isopropanol (v/v) (10 c.v.) alternated with H2O (5 c.v.). All the fractions were collected from the 
loading in 1 ml 96-well block in all the steps except for the refolding step, where the samples were 
collected in 50ml centrifuge tubes. The GFP fluorescence was then evaluated. The ligand density 
corresponded to ~ 20 µmol per gram of moist gel. The gel was 12.5% acrylamide, ran 1h at 120V and was 
silver stained. 
 
 
 
5.6.2 Affinity pair NWNWNW tagged GFP-A3C4 
 
The affinity pair NWNWNW tagged GFP and ligand A3C4 showed a poor performance in an 
automated system according with the results shown in Figs. 5.22, 5.23 and 5.24.  The 
adsorption step revealed less than 10% of GFP-tagged binding, much lower from those 
obtained with 96-well format (Table 5.2). This was also corroborated by the SDS-PAGE 
analysis, where there was no evidence of GFP-tagged enrichment in the flowthrough (Fig.5.23). 
This can indicate that higher residence times and incubation in batch with orbital agitation were 
promoting the interaction between adsorbent and protein (Table 5.2) 
Regarding the elution step, the conditions used were not effective on the recovery of the low 
amounts of NWNWNW-GFP bound to the affinity matrix. The conditions employed in the 
regeneration step, were also not strict enough to remove the protein bounded.  
Overall, the affinity system NWNWNW-GFP/A3C4 was considered not suitable for affinity 
purification purposes, under the conditions employed in this study. The affinity constant of the 
pair was acceptable for purification processes; the estimated Qmax value was extremely low. 
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An effort on the binding and elution conditions for this affinity system can be an alternative to 
increase its performance. Otherwise, a better evaluation of the promising lead ligands for 
NWNWNW-GFP should be performed in order to find out other potential affinity ligand. 
 
 
 
Figure 5.22- Percentages of NWNWNW tagged GFP bound, eluted and regenerated from affinity 
adsorbent containing A3C4. Two different elution conditions were tested (A) 0.1M Glycine-NaOH pH 11 
and (B) 0.1M Glycine-NaOH pH 11 50% ethylene glycol.  A3C4 adsorbent was packed (1g) on column with 
a flow of 0.3 ml.min
-1
 and prepared for analysis using an AKTA 
tm
 avant 25. Afterwards the solid support 
was subjected to the following steps with a flow rate of 1 ml.min
-1
: regeneration (0.1M NaOH, 30% 
isopropanol (v/v) alternated with H2O, 10 c.v. each in a total of 30 c.v.), equilibration (10 mM sodium 
phosphate, 150 mM NaCl, pH 7.4 15 c.v.) and loading (1 c.v. of 1ml of NWNWNW tagged GFP of (A) 20 
µg and 5.5 mg and (B) 58 µg and 25 mg of GFP-tagged and total protein, respectively. Then the column 
was washed with binding buffer (20 c.v.), and then a step of elution with the respective buffer (10 c.v.) was 
performed and at the end other regeneration step was done as already described with a total of 20 c.v. 
(0.1M NaOH, 30% isopropanol (v/v) (10 c.v.) alternated with H2O (5 c.v.). All the fractions were collected 
from the loading in 1 ml 96-well block and were quantified by GFP fluorescence and Bradford assay. The 
ligand density corresponds to ~ 20 µmol per gram of moist gel. The percentage of protein bound was 
determined according to % Bound = (protein bound x 100)/ (protein loaded), where the protein bound was 
given by protein bound = (Protein loaded)-(sum of the amount protein in flow-through and washes).  
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Figure 5.23- Chromatograms obtained for the purification of NWNWNW tagged GFP with affinity 
ligand A3C4 when using the elution conditions (A) 0.1M Glycine-NaOH pH 11 and (B) 0.1M Glycine-
NaOH pH 11 50% ethylene glycol. The chromatograms were obtained from the purification of NWNWNW 
tagged GFP in Äkta avant 25 by using the conditions employed in Fig. 5.21, with the monitorization of 
NWNWNW tagged GFP through GFP fluorescence and the total protein by absorbance at 595 nm 
according to Bradford assay. FT- Flow-through  
 
 
 
 
Figure 5.24 SDS-PAGE analysis of the samples from the purification of NWNWNW tagged GFP by 
the ligand A3C4 when using (A) 0.1M Glycine-NaOH pH 11 and (B) 0.1M Glycine-NaOH pH 11 50% 
ethylene glycol. The gel present 12.5% acrylamide ran 1h at 120V and silver stained.The purity of the 
eluted fractions was not estimated as there is no evidence of any amount of eluted protein. 
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Table 5.2. Comparison of the results obtained for the affinity pair NWNWNW tagged GFP/A3C4 in all 
chromatographic steps for the screening formats used: 96-well block, on-column and on a preparative 
liquid chromatographic system ÄKTA avant 25 system. The binding step was carried at physiological 
conditions (PBS pH 7.4 150 mM NaCl) and the elution conditions used where the two best conditions 
obtained by elution tests. The error bars correspond to duplicates, except for the binding on 96-well block 
that corresponds to an average of 16 samples obtained from the binding assays on the elution optimization 
studies. The individual runs performed on ÄKTA AVANT 25 were from different crude extracts containing 
different amounts of tagged GFP and total protein. Therefore the amounts on loading and binding 
corresponds to the conditions (A) 0.1M glycine-NaOH pH 11 and (B) 0.1M glycine-NaOH pH 11 50% 
ethylene glycol.  * The binding of total protein was 0%, in the cases where GFP tagged was eluted, due to 
limitations on detection using colorimetric assay, BCA. ** The run was just conducted once. 
 
 
CHROMATOGRAPHIC STEPS 
 
96-WELL BLOCK 
 
ON COLUMN 
 
ÄKTA AVANT 25 
 
RESIN AMOUNT (G) 
 
0.25 
 
0.25 
 
1 
Loading 
 
NWNWNW tagged GFP 
(µG) 
 
66.4 ± 7.2 
 
45.25 ± 0.45 
 
(A) 20 ** 
(B) 58 ** 
 
 
Total Protein (mg) 
 
 
1.9 ± 0.1 
 
0.87 ± 0.01 
 
(A) 5.55 ** 
(B) 25.00 ** 
 
Binding 
 
NWNWNW tagged GFP 
(µG bound / g resin) 
 
 
156.1 ± 12.5 
(60%) 
 
48.44 ± 11.01 
(27%) 
 
(A) 0.1 (1%) ** 
(B) 8 (14%) ** 
 
 
Total Protein 
(mg bound / g resin) 
 
0.6 ± 0.2 
(38%) 
 
 
0.07 ± 0.11  
(2%) 
 
(A) 2 (33%) ** 
(B) 0.8 (3%) ** 
 
Elution 
Condition (A) 
 
0.1M Glycine-
NaOH pH 11 
 
NWNWNW tagged GFP 
(mg eluted /g bound) 
 
 
31± 37 
 (1%) 
-  
0 
(0%) ** 
 
Total Protein 
(mg eluted /g bound) 
 
 
0 
 (0%)* 
-  
0 
(0%) ** 
Regeneration 
(Elution 
Condition a) 
 
NWNWNW tagged GFP 
(mg regenerated / g bound) 
 
- 
 
-  
0  
(0%) ** 
 
Total Protein 
(mg regenerated / g bound) 
 
- -  
0  
(0%) ** 
Elution 
Condition (B) 
 
0.1M Glycine-
NaOH pH 11 50% 
Ethylene glycol 
 
NWNWNW tagged GFP 
(mg eluted /g bound) 
 
 
31.9 ± 33 
 (3%) 
-  
0  
(0%) ** 
 
Total Protein 
(mg eluted /g bound) 
 
 
354.1 ± 12.6  
(35%)  
-  
365.6  
(38%) ** 
Regeneration 
(Elution 
Condition B) 
 
NWNWNW tagged GFP 
(mg regenerated/ g bound) 
 
- -  
0  
(0%) ** 
 
Total Protein 
(mg regenerated/ g bound) 
- -  
0 
(0%) ** 
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6.6.3 Affinity pair RKRKRK tagged GFP-A7C1   
 
The results obtained for the affinity pair RKRKRK-GFP/A7C1 when employing a flow rate of 
1ml/min are shown in Figs. 5.25, 5.26 and 5.27. Under the tested conditions, the adsorbent 
bound approximately 50% of loaded GFP (22.5 µg bound/g resin).  The chromatograms 
obtained 
 
(Fig. 5.26) revealed a large peak in the flowthrough fraction for the total protein. The 
peak correspondent to RKRKRK-GFP is lower when compared with the maximum of 
fluorescence of the y-axis that is correlated with the fluorescence of the sample loaded. The fact 
that some amount of RKRKRK-GFP is being washed out can be related with limited binding 
capacity of the adsorbent at the flow rate and packing conditions tested. In terms of protein 
recovery, the two best elution buffers selected in section § 5.6 were tested. The best elution 
condition obtained in the scale-up studies was when using arginine as a competitor with 12% of 
GFP-tagged bound recovered with an estimated purity of 45%. The purity of RKRKRK-GFP 
eluted with condition B, as determined by densitometry analysis of SDS-PAGE gels in Fig 5.27, 
indicated a slightly higher value of 50%. It was also attempted to elute the protein with the PBS 
buffer with 500 mM lysine or 500 mM lysine: 500 mM arginine, but no protein was verified in the 
elution.  
Regarding the regeneration step, it was not effective for the desorption of the remaining protein 
bound to the affinity matrix.  
As a proof of concept, the affinity pair RKRKRK-GFP/A7C1 worked in an automated preparative 
liquid chromatography, but the results obtained on GFP binding and elution showed lower 
efficiency than 96-well block and on-column format. Moreover, the parameters used including 
flow rate were selected as a first approach and require further optimization to promote the 
efficiency on adsorption and desorption of GFP-tagged. The results obtained in the automated 
liquid chromatography differ from those obtained previously (Table 5.3). 
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Figure 5.25- Percentages of RKRKRK tagged GFP bound, eluted and regenerated from affinity 
adsorbent containing A7C1. Two different elution conditions were tested (A) 10mM Naphosphate 150 
mM NaCl pH 7.4 with 500mM Arginine and (B) 0.1M Naphosphate 150 mM NaCl pH 7.4. A7C1 adsorbent 
was packed (1g) on column (0.3 ml.min
-1
) and prepared for analysis using AKTA 
tm
 avant 25 system. 
Afterwards the solid support was subjected to the following steps at a flow rate of 1 ml.min
-1
: regeneration 
(0.1M NaOH, 30% isopropanol (v/v) alternated with H2O, 10 c.v each in a total of 30 c.v.), equilibration (10 
mM sodium phosphate, 150 mM NaCl, pH 7.4, 15 c.v) and loading (1 c.v of 1ml of RKRKRK tagged GFP: 
44 µg of GFP-tagged and 12 mg  of total protein). The column was washed with binding buffer (20 c.v.), 
and then a step of elution with the respective buffer (10 c.v.) was performed and at the end other 
regeneration step was done as already described with a total of 20 c.v. (0.1M NaOH, 30% isopropanol 
(v/v) (10 c.v.) alternated with H2O (5 c.v.). All the fractions were collected from the loading in 1 ml 96-well 
block and were quantified by GFP fluorescence and Bradford assay. The ligand density was ~ 20 µmol per 
gram of moist gel. The percentage of protein bound was determined according to % Bound = (protein 
bound x 100)/ (protein loaded), where the protein bound was given by protein bound = (Protein loaded)-
(sum of the amount protein in flow-through and washes).  
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Figure 5.26 – Chromatograms obtained for the purification of RKRKRK tagged GFP with affinity 
ligand A7C1 when using the elution conditions (A) PBS pH 7.4 150 mM NaCl with 500mM Arginine and 
(B) 0.1M PBS pH 7.4 150 mM NaCl The chromatograms were obtained from the purification of RKRKRK 
tagged GFP in Äkta avant 25 by using the conditions employed in Fig. 5.21, with the monitorization of 
NWNWNW tagged GFP through GFP fluorescence and the total protein by absorbance at 595 nm 
according to Bradford assay. FT- Flow-through 
 
 
 
 
Figure 5.27 SDS-PAGE analysis of the samples  from the purification of RKRKRK tagged GFP by 
the ligand A7C1 when using A) PBS pH 7.4 150 mM NaCl with 500mM Arginine and (B) 0.1M PBS pH 7.4 
150 mM NaCl.  The gel presents 12.5% acrylamide, ran 1h at 120V and silver stained. The purity of the 
eluted fractions was estimated with the software Image J revealing a purity of 45% for elution condition (A) 
and 50 % for elution condition (B). 
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Table 5.3 Comparison of the results obtained for the affinity pair RKRKRK tagged GFP/A7C1 in all 
chromatographic steps for the screening formats used: 96-well block, on-column and on a preparative 
liquid chromatographic system ÄKTA avant 25 system. The binding step was carried at physiological 
conditions (PBS pH 7.4 150 mM NaCl) and the elution conditions used where the two best conditions 
obtained by elution tests. The error bars correspond to duplicates, except for the binding on 96-well block 
that corresponds to an average of 16 samples obtained from the binding assays on the elution optimization 
studies. * The binding of total protein was 0%, in the cases where GFP tagged was eluted, due to 
limitations on detection using colorimetric assay, BCA. ** The run was just conducted once. 
 
 
CHROMATOGRAPHIC STEPS 
 
 
96-WELL BLOCK 
 
ON COLUMN 
 
ÄKTA AVANT 25 
 
Resin amount (g) 
 
 
0.25 
 
0.25 
 
1 
Loading 
 
RKRKRK tagged GFP (µG) 
 
37.00 ± 1.11 
 
33.00 ± 0.49 
 
46 
 
 
Total Protein (mg) 
 
 
1.55 ± 0.25 
 
0.98 ± 0.01 
 
12 
Binding 
 
RKRKRK tagged GFP 
(µG bound / g resin) 
 
 
77.45 ± 4.07 
(52%) 
 
55.00 ± 5.20 
(42%) 
 
22.5 ± 0.71 
(49%) 
 
Total Protein 
(mg bound / g resin) 
 
 
0.49 ± 0.06 
(46%) 
 
0.35 ± 0.03  
(9%) 
 
2.10 ± 0.56 
(18%) 
Elution 
Condition (A) 
 
PBS with 500 
mM Arginine 
 
RKRKRK tagged GFP 
(mg eluted /g bound) 
 
 
235 ± 25.75 
(30%) 
-  
111  
(12%) ** 
 
Total Protein 
(mg eluted /g bound) 
 
 
15.72 ± 5.46 
(2%) 
-  
214.28  
(19%) ** 
Regeneration 
(Elution 
Condition a) 
 
RKRKRK tagged GFP 
(mg regenerated / g bound) 
 
- 
 
-  
0 
(0%) ** 
 
Total Protein 
(mg regenerated / g bound) 
 
- -  
80.95  
(10%) ** 
Elution 
Condition (B) 
 
0.1M Glycine-
NaOH pH 11 150 
mM NaCl 
 
RKRKRK tagged GFP 
(mg eluted /g bound) 
 
 
290.67 ± 30.63 
(24%) 
-  
4  
(0.5%) ** 
 
Total Protein 
(mg eluted /g bound) 
 
 
0 
(0%) * 
-  
228.57  
(27%) ** 
Regeneration 
(Elution 
Condition B) 
 
RKRKRK tagged GFP 
(mg regenerated/ g bound) 
 
- -  
0  
(0%) ** 
 
Total Protein 
(mg regenerated/ g bound) 
 
- -  
22.85  
(9%) ** 
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5.6.4 Affinity pair non-tagged GFP- ligand A4C7  
 
For the affinity pair GFP/A4C7, the results obtained with the automated system are in 
agreement with those obtained in the 96-well format and on-column (Table 5.4) (Figs. 5.28, 5.29 
and 5.30). In both formats, the binding percentage was ~100%. The immobilized ligand seemed 
to bind strongly to GFP independently of the format used. Moreover, it was possible to recover 
almost the total amount of GFP bound, although results for elution B (pH 9 with 50% of ethylene 
glycol) might have some error due to the presence of ethylene glycol. Consequently the mass 
balances are affected due to the increase of fluorescence. In order to confirm that the GFP 
fluorescence was being influenced just by the 50% of ethylene glycol and not by ligand 
leaching, a column run was performed in the ÄKTA avant 25 with the ligand and 50 c.v of the 
0.1M glycine-NaOH 50% ethylene glycol and then 1ml fractions were collected in a 96-well 
block. As the ligand and GFP absorbs and emits fluorescence at equal wavelengths, the 
fractions were quantified as GFP fluorescence. The results obtained revealed no fluorescence 
in all fractions, indicating that the ligand was not being leached from the column during the 
elution step.   
 
 
 
Figure 5.28- Percentages of GFP bound, eluted and regenerated from affinity adsorbent containing 
A4C7. Two different elution conditions were tested (A) 0.1M Glycine-NaOH pH 9 and (B) 0.1M Glycine-
NaOH pH 9 50% ethylene glycol.  A3C4 adsorbent was packed (1g) on column with a flow of  0.3 ml.min
-1
 
and prepared for analysis using an AKTA 
tm
 avant 25. Afterwards the solid support was subjected to the 
following steps with a flow rate of 1 ml.min
-1
: regeneration (0.1M NaOH, 30% isopropanol (v/v) alternated 
with H2O, 10 c.v. each in a total of 30 c.v.), equilibration (10 mM sodium phosphate, 150 mM NaCl, pH 7.4 
15 c.v.) and loading (1 c.v. of 1ml of GFP with 104 µg of GFP-tagged and 9 mg of total protein for both 
conditions. Then the column was washed with binding buffer (20 c.v.), and then a step of elution with the 
respective buffer (10 c.v.) was performed and at the end other regeneration step was done as already 
described with a total of 20 c.v. (0.1M NaOH, 30% isopropanol (v/v) (10 c.v.) alternated with H2O (5 c.v.). 
All the fractions were collected from the loading in 1 ml 96-well block and were quantified by GFP 
fluorescence and Bradford assay. The ligand density corresponds to ~ 20 µmol per gram of moist gel. The 
percentage of protein bound was determined according to % Bound = (protein bound x 100)/ (protein 
loaded), where the protein bound was given by protein bound = (Protein loaded)-(sum of the amount 
protein in flow-through and washes).  
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The flow rate used in the automated system seemed to be effective on binding, however the 
elution conditions used seemed to display different peaks on the GFP elution according with the 
chromatograms presented in Fig. 5.29.  
 
 
 
Figure 5.29 -Chromatograms obtained for the purification of GFP with affinity ligand A4C7 when 
using the elution conditions (A) 0.1M Glycine-NaOH pH 9 and (B) 0.1M Glycine-NaOH pH 9 50% ethylene 
glycol. The chromatograms were obtained from the purification of non-tagged GFP in Äkta avant 25 by 
using the conditions employed in Fig. 5.27, with the monitorization of GFP through GFP fluorescence and 
the total protein by absorbance at 595 nm according to Bradford assay. FT- Flow-through 
 
 
By analysing both chromatograms, the elution on Fig. 5.29(A) shows a broad elution peak. On 
the subsequent regeneration step, there was a high amount of protein regenerated; indicating 
that elution A is not so effective to completely dissociate the affinity complex. The 
chromatogram on Fig. 5.28(B) shows a better profile on the elution, revealing a more 
accentuated peak, inferring about elution efficiency. On the regeneration step, there was no 
evidence of GFP only total protein presented on crude extract. 
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These results were also corroborated by SDS-PAGE analysis (Fig. 5.30), and the purity of GFP 
eluted was quantified by the software Image J. The purity of GFP eluted corresponded to 94% 
on elution (A) and 66% to elution (B), although more protein was recovered in the latter. 
In this way, a compromise should be done between the amount and the higher yields, and 
therefore the elution condition A is preferably. 
 
 
 
Figure 5.30- SDS-PAGE analysis obtained from the chromatographic assays from the purification 
of GFP and the ligand A4C7 when using (A) 0.1M Glycine-NaOH pH 9 and (B) 0.1M Glycine-NaOH pH 9 
50% ethylene glycol. The gels present 12.5% acrylamide on its composition and were run 1h at 120V and 
then stained with silver. The purity of the eluted fractions were estimated with the software Image J 
revealing a purity of 94% for condition (A) and 67 % for condition (B).   
 
 
 
Overall, these results indicate that the affinity ligand A4C7 althouh non specific for binding to 
GFP, allowed a significant amount of protein recovered with high yields of purity.  
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Table 5.4. Comparison of the results obtained for the affinity pair non-tagged GFP/ ligand A4C7 in 
all chromatographic steps for the screening formats used: 96-well block, on-column and on a preparative 
liquid chromatographic system ÄKTA avant 25 system. The binding step was carried at physiological 
conditions (PBS pH 7.4 150 mM NaCl) and the elution conditions used where the two best conditions 
obtained by elution tests. The error bars correspond to duplicates, except for the binding on 96-well block 
that corresponds to an average of 16 samples obtained from the binding assays on the elution optimization 
studies. 
1
 The elution was higher than 100% duo the interference of 50% of ethylene glycol* The binding of 
total protein was 0%, in the cases where GFP tagged was eluted, due to limitations on detection using 
colorimetric assay, BCA. ** The run was just conducted once. 
 
 
CHROMATOGRAPHIC STEPS 
 
 
96-WELL BLOCK 
 
ON COLUMN 
 
ÄKTA AVANT 25 
 
Resin amount (g) 
 
 
0.25 
 
0.25 
 
1 
Loading 
 
GFP (µG) 
 
148.30 ± 10.47 
 
135.82 ± 3.60 
 
104.00 ± 9.89 
 
 
Total Protein (mg) 
 
 
2.81 ± 0.33 
 
1.08 ± 0.01 
 
9 
Binding 
 
GFP 
(µG bound / g resin) 
 
 
590.72 ± 2.70 
(99%) 
 
512.00 ± 6.02 
(94%) 
 
103.50 ± 9.19 
(99%) 
 
Total Protein 
(mg bound / g resin) 
 
 
11.00 ± 0.07 
(98%) 
 
4.14 ± 0.21  
(95%) 
 
8.53 ± 0.33 
(98%) 
Elution 
Condition (A) 
 
0.1M Glycine-
NaOH pH 9 
 
GFP 
(mg eluted /g bound) 
 
 
382.24 ± 27.52 
(40%) 
-  
888.00 
(94%) ** 
 
Total Protein 
(mg eluted /g bound) 
 
 
16.62 ± 0.04 
(2%) 
-  
445.22 
(43%) ** 
Regeneration 
(Elution 
Condition a) 
 
GFP 
(mg regenerated / g bound) 
 
- 
 
-  
338.16 
(36%) ** 
 
Total Protein 
(mg regenerated / g bound) 
 
- -  
316.34  
(31%) ** 
Elution 
Condition (B) 
 
0.1M Glycine-
NaOH pH 9 50% 
Ethylene glycol 
 
GFP 
(mg eluted /g bound) 
 
 
1493.55 ± 68.00 
(150%)
1
 
-  
1217.39 
(113 %) 
1
** 
 
Total Protein 
(mg eluted /g bound) 
 
 
129.49 ± 9.66  
(13%) * 
-  
651.43  
(62%) ** 
Regeneration 
(Elution 
Condition B) 
 
GFP 
(mg regenerated/ g bound) 
 
- -  
0  
(0%) ** 
 
Total Protein 
(mg regenerated/ g bound) 
 
- -  
1054.48  
(9%) ** 
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5.6.5 Purification of GFP fusion proteins with A4C7 ligand 
 
In order to show the suitability of ligand A4C7 to purify GFP fusion proteins, GFP was fused to a  
B. megaterium spore cortex lytic enzyme SleL and then produced in Lactococcus lactis [267] 
with a total molecular weight of 78 KDa. This GFP fusion protein also presented a histidine tag 
after the GFP sequence. Besides using a real GFP fusion protein, this one was produced in a 
different host from E.coli. The results obtained in Fig.5.31 were promising; revealing highly 
percentages of binding ~90%, indicating that the affinity ligand still recognized GFP, even when 
fused to other protein. However, in terms of elution, condition (A), where only a displacement of 
pH was used, was not effective to recover the bound protein. The GFP-fusion protein is eluted 
only during the regeneration step. These results were corroborated by the chromatogram on 
Fig.5.32 and SDS-PAGE analysis on Fig. 5.33. The elution condition B seemed more promising 
with ~50% of recovery. This indicates that not only a displacement of pH was effective for 
desorption of the complex but the presence of an agent such as ethylene glycol disrupted 
hydrophobic interactions.  
 
 
Figure 5.31- Percentages of GFP fusion protein bound, eluted and regenerated from affinity 
adsorbent containing A4C7. Two different conditions were tested (A) 0.1M Glycine-NaOH pH 9 and (B) 
0.1M Glycine-NaOH pH 9 50% ethylene glycol.  A4C7 adsorbent was packed (1g) on column with a flow of 
0.3 ml.min
-1
 and prepared for analysis using an AKTA 
tm
 avant 25. Afterwards the solid support was 
subjected to the following steps with a flow rate of 1 ml.min
-1
: regeneration (0.1M NaOH, 30% isopropanol 
(v/v) alternated with H2O, 10 c.v. each in a total of 30 c.v.), equilibration (10 mM sodium phosphate, 150 
mM NaCl, pH 7.4 15 c.v.) and loading (1 c.v. of 1ml of GFP with 13 µg of GFP and 9 mg of total protein in 
both situations. Then the column was washed with binding buffer (20 c.v.), and then a step of elution with 
the respective buffer (10 c.v.) was performed and at the end other regeneration step was done as already 
described with a total of 20 c.v. (0.1M NaOH, 30% isopropanol (v/v) (10 c.v.) alternated with H2O (5 c.v.). 
All the fractions were collected from the loading in 1 ml 96-well block and were quantified by GFP 
fluorescence and Bradford assay. The ligand density corresponds to ~ 20 µmol per gram of moist gel.The 
percentage of protein bound was determined according to % Bound = (protein bound x 100)/ (protein 
loaded), where the protein bound was given by protein bound = (Protein loaded)-(sum of the amount 
protein in flow-through and washes).  
 
 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
Bound Eluted Regenerated Bound Eluted Regenerated 
Elution A Elution B 
%
 
GFP  TOTAL PROTEIN 
CHAPTER 5: OPTIMIZATION AND CHARACTERIZATION OF THE LEAD AFFINITY PAIRS “TAG-
RECEPTOR” 
 
183 
 
The results were in accordance with the chromatogram from Fig. 5.33, that shows a peak of the 
GFP fusion protein on the elution. The respective results obtained on SDS-PAGE analysis for 
the eluted fractions were not as conclusive as just only a faint band appeared on the gel. 
Western blot analysis was performed with anti-GFP antibodies in order to detect the GFP-fusion 
proteins. The western blot was revealed by chemiluminescence reactions and the results are 
shown in Fig. 5.34 (B). 
 
 
Figure 5.32 -Chromatograms obtained for the purification of GFP fusion protein with affinity ligand 
A4C7 when using the elution conditions (A) 0.1M Glycine-NaOH pH 9 and (B) 0.1M Glycine-NaOH pH 9 
50% ethylene glycol. The chromatograms were obtained from the purification of RKRKRK tagged GFP in 
Äkta avant 25 by using the conditions employed in Fig. 5.27, with the monitorization of GFP fusion protein 
through GFP fluorescence and the total protein by absorbance at 595 nm according to Bradford assay.  
FT- Flow-through 
 
 
Figure 5.33-SDS-PAGE analysis of the samples from the purification of GFP fusion protein by the 
ligand A4C7 when using 0.1M Glycine-NaOH pH 9. The gel presents 12.5% acrylamide, ran 1h at 120V 
and silver stained. The purity of the eluted fractions was not assessed as there is no evidence of the 
elution of the GFP fusion protein. 
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The detection method of the western blot used presents the greatest sensitivity of any available 
detection method according the supplier instructions. Due to this, it was possible to visualize the 
correspondent bands of the GFP-fusion protein on the elution and regeneration steps. The 
bands on the elution were not so evident on the SDS-PAGE analysis and therefore the purity 
evaluation was not assessed. 
 
 
Figure 5.34 SDS-PAGE analysis obtained of the samples from the purification of GFP fusion 
protein by the ligand A4C7 when using 0.1M Glycine-NaOH pH 9 50% ethylene glycol, where (A) 
corresponds to SDS-PAGE analysis and (B) western blot.  The gels present 12.5% acrylamide ran 1h at 
120V. After, one gel was silver stained and the other was used for further western blot analysis. The 
western blot was performed by using anti-gfp antibodies that only recognized gfp. 
 
 
These preliminary results indicate that the affinity ligand A4C7 might be effective on the 
purification of GFP fusion proteins, inferring about the selectivity for the GFP. In this particular 
case, the elution condition that indicates to be more effective was the buffer B, which includes 
high pH and 50% ethylene glycol. Moreover, this elution condition can also indicates the 
establishment of strong hydrophobic interactions between the pair. Overall, this affinity ligand 
seems to be a promising strategy for a novel purification method for GFP-fusion proteins. 
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5.7 CONCLUDING REMARKS 
 
The optimization of chromatographic conditions on a 96-well block was effective on narrow to 
search of the most promising conditions for the binding and elution steps. This platform seems 
to be reliable, cost- and time-effectiveness. The results obtained from the 96-well block were 
comparable with those obtained by an automated liquid chromatography system the main 
difference being flow-rate and resin packing. This influences the performance of the adsorption 
and desorption processes between the affinity pair.  
 
As a proof of concept, the development of an affinity pair “tag-receptor” was successfully 
achieved with the pair RKRKRK tagged GFP and ligand A7C1. The pair presented an affinity 
constant on order of 10
5
 M
-1
 but the maximum binding capacity low. The binding and elution 
conditions used on an automated system still need further optimizations, mainly the flow-rate 
and residence time, in order to improve the adsorption and desorption steps. This affinity pair 
can be similar to an ion-exchange chromatography but with increased selectivity. The recovery 
of the RKRKRK tagged GFP was not possible with a pH displacement but when using arginine 
as a competitor.  
 
Regarding the affinity pair NWNWNW tagged GFP and ligand A3C4, this pair revealed poor 
ability on the binding and elution of the target protein. Despite the tag the neutral character of 
the tag can facilitate the purification of challenging proteins, some studies should be performed 
in the future by using other putative lead ligands selected on Chapter 4.  
 
The affinity ligand A4C8 bound preferentially to WFWFWFW tagged GFP in presence of urea., 
which is promising for proteins are expressed as inclusion bodies. Although the renaturation 
and the proper folding of the protein were not achieved, further studies are highly required to 
promote refolding. These studies should be performed on an automated liquid chromatography 
system and the use of other additives (e.g. arginine) should be considered for a matrix-assisted  
protein refolding [138].  
 
An affinity ligand for the purification of GFP fusion proteins was successfully accomplished. 
Ligand A4C7 seemed highly specific for GFP and its selectivity was maintained when using a 
proper GFP fusion protein produced in other hosts.   
Overall, the development of an affinity pair for the purification of recombinant proteins was 
accomplished but some efforts are still required for the adjustment of binding and elution 
conditions to improve the kinetics of the affinity pair. Other important parameter when applied 
this system in a commercial view is the matrix reuse. In other words, the immobilized ligand 
should also hold different cycles of cleaning-in-place, so that can be further used for the 
purification of tagged proteins without compromising its activity. 
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The proof of concept was made with two GFP proteins, one non-tagged and a fusion protein, 
but the ligand must be challenged in the future with other GFP fusion proteins. 
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CHAPTER 6 
CONCLUDING REMARKS 
 
 
The work presented in this thesis aimed at the development of new affinity pairs “tag-receptor” 
for the purification of recombinant proteins, which combined the best of small peptide tags with 
the best of synthetic affinity ligands.  
 
Five promising hexapeptides with different hydrophobic / hydrophilic characters were previously 
selected as potential affinity tags, and the respective complementary binding partners based on 
the one-pot multicomponent Ugi reaction were de novo designed in silico [207]. This work 
served as inspiration for the synthesis of a combinatorial library comprising 64 Ugi-based affinity 
ligands in solid phase (aldehyde-activated agarose), and diversity was introduced through the 
variation of the amine and carboxylic acid compounds, whereas the isocyanide functionality was 
kept constant.  
 
In order to improve the selection of the best affinity ligands to target the tag peptides, the latter 
were genetically fused to Green Fluorescent Protein (GFP) and produced in Escherichia coli (E. 
coli). As a successful proof of concept, the DNA fragment that codifies for the RWRWRW 
tagged GFP was cloned on the expression vector pET21c for further expression on E.coli cells 
(BL21 (DE3)). A particularity of this DNA fragment is that GFP is within two multicloning sites 
and this vector could be extended for the production of other proteins. Moreover, a nucleotide 
sequence between the tag and the protein was designed to codify for the enterokinase 
recognition site, useful for future tag removal. The production of GFP fused to the affinity tags 
NWNWNW, RKRKRK and NNNNNN was straightforward leading to a production of mostly or 
totally soluble protein, with a percentage of GFP-tagged in the crude extract of 9, 4 and 5% 
(w/w), respectively for 1L of culture medium. Regarding the production of GFP tagged with 
RWRWRW and WFWFWF, the percentage of soluble tagged protein was as low as 2% (w/v) in 
1L of culture. In addition, the RWRWRW peptide presented antimicrobial properties with a 
minimum inhibitory concentration of 2.5mM for E.coli K12. The production of this peptide fused 
to GFP was found to be a burden for bacterial cells, and the fusion with GFP worked as a 
limited mask for peptide toxicity. For these reasons, the RWRWRW peptide was not considered 
as suitable affinity tag to be used in bioseparation. The WFWFWF tagged GFP was produced 
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as inclusion bodies, and different culture conditions such as temperature and inductor levels 
were studied to improve the amount of soluble protein. Therefore, the screening with this affinity 
tag was performed in both denaturant and non-denaturant conditions. 
 
The bacterial extracts containing GFP-tagged proteins were further screened for binding to a 
solid phase second generation combinatorial library based on the Ugi reaction comprising of 64 
affinity ligands. Screening was performed on a 96-well batch mode by micro-scale affinity 
chromatography as it allows testing a wide range of adsorbents under different binding/elution 
conditions [226]. As a first approach, the selection of the putative lead ligands was possible for 
all affinity tags, except for NNNNNN tagged GFP, which was not used for further studies. The 
putative lead ligands were then re-screened for binding to GFP-tagged proteins and recovered 
samples were analysed by SDS-PAGE, where selective binding was estimated on the basis of 
the loading and flow-through samples. The overall analysis led to the selection of three lead 
affinity pairs tag-receptor: WFWFWF tagged GFP – ligand A4C8 (in denaturant conditions), 
NWNWNW tagged GFP – ligand A3C4 and RKRKRK tagged GFP – ligand A7C1. Ligand A4C8 
bound 11±0.5 µg of WFWFWF tagged GFP per gram of resin (90%), ligand A3C4 bound 
156±12 µg of NWNWNW tagged GFP per gram of resin (58%) and ligand A7C1 bound to 77 ±4 
µg of RKRKRK tagged GFP per gram of resin (50%). As a negative control, the second 
generation library was also screened against GFP extracts from E. coli . The affinity ligand 
A4C7 was found to bind ~100% GFP (590 ± 3 µg of GFP per gram of resin (99%)), all tagged-
GFP proteins and most host proteins. Despite the apparent lack of selectivity the affinity pair 
A4C7-GFP was taken into account for further optimizations. Partition equilibrium experiments 
fitted to Langmuir isotherm with good correlation factors were performed to estimate affinity 
constants (Ka) and binding capacity (Qmax) for the lead affinity systems, although limited by the 
amount of unpurified protein produced by the bacterial cells. The Ka values obtained for the 
affinity pairs NWNWNW tagged GFP-A3C4 and RKRKRK tagged GFP-A7C1 were in order of 
7.22x10
4 
M
-1 
and 2.45x10
5
 M
-1
,respectively. The Qmax values obtained were apparently low with 
high errors associated.  
 
 The four affinity systems (i) WFWFWF tagged GFP-A4C8 (denaturant conditions), (ii) 
NWNWNW tagged GFP-A3C4, (iii) RKRKRK tagged GFP-A7C1 and (iv) GFP-A4C7 were 
selected for further studies in terms of selectivity, optimization of elution conditions, binding 
kinetics and further use on an automated chromatographic system The affinity systems (i) to (iii) 
were mainly developed to be used as an affinity pair “tag-receptor”, where (i) might be 
employed as matrix-assisted refolding strategy. The affinity system (iv) was interesting to 
explore for the purification of GFP fusion proteins.  
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The affinity pair WFWFWF tagged GFP- A4C8 might be an alternative matrix-assisted refolding 
strategy considering that the A4C8 ligand was found to selectively bind to WFWFWF tagged 
GFP in presence of 8M urea. Hydrophobic interaction is expected to prevail on the molecular 
recognition between WFWFWF tagged GFP and A4C8. The preliminary attempts performed for 
proper on-column refolding of protein prior to elution were not successful. Still, the optimization 
of this system could represent an alternative for refolding strategies, specially for those based 
on structural ligands such as ion-exchange resins and metal chelate ligands with the respective 
binding partners Zbasic [48-49] and His-tag [134]. Ion-exchange resins are cost-effective, 
however charge-charge interactions can lead to protein aggregation [8]. The His-tag is 
compatible with denaturant conditions, but metal leaching can occur and the imidazoyl side 
chain groups of histidine interfere with protein folding [74]. 
 
The affinity pair NWNWNW tagged GFP-A3C4 showed very low binding capacity (less than 
10% of loaded protein) and protein recovery (elution yields of 3%) when employing the 
automated liquid chromatography system, which points toward system optimization. Another 
alternative could be to further optimize other potential lead candidates.   
 
The affinity pair RKRKRK tagged GFP-A7C1 revealed to be promising for the purification of 
fusion proteins, as it showed a reproducible and consistent binding profile, although the amount 
of GFP-tagged per gram of resin has slightly decreased when applying an automated system 
(Table 5.3 § 5.7.3). However, this can be improved by an adjustment of the flow rate and 
residence time. Regarding the optimization of elution conditions carried out on a 96-well format, 
the most promising were the competitive elution with 10mM PBS, 500 mM arginine and 0.1M 
Glycine-NaOH pH 11, 150 mM NaCl, with a protein recovery of 30 and 24%, respectively. Both 
conditions when applied to automated liquid chromatography system led to a purity of 50% and 
protein recovery of 30%. The affinity pair RKRKRK- A7C1 represents increased selectivity when 
compared with a common IEX based process, as the elution process is more complex, 
indicating mixed modes of interaction. Also, the novel RKRKRK tag is recognised by a robust 
and inexpensive synthetic ligand. An overview and comparison of the affinity pair performance 
with currently established platforms is shown in Table 6.1.  
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Table 6.1 Comparison of the RKRKRK affinity tag with similar tags commercially 
available 
 
Affinity 
tag 
Size Resin Ka (M
-1
) Method 
 
Dynamic binding capacity  
(mg/ml) 
Strep-tag 
II 
8 aa StrepTactin
TM 
1.4x10
4
 
ITC
1
 [101] 
-6 mg/ml (GE Healthcare) 
-9 mg/ml (QIAGEN) 
FLAG tag 8 aa 
-ANTI-FLAG M1 
-ANTI-FLAG M2 
-ANTI-FLAG antibody 
magnetic beads 
2.4x10
6
 
 
SPR
2
 [268] 
 
-0.6 mg/ml (ANTI-FLAG M1, M2) 
(SIGMA-ALDRICH) 
-1.3 mg/ml (magnetic beads) 
(Clontech) 
His-tag 6 aa 
-Ni-IDA Sepharose 
-HisPur Ni-NTA 
-HisPur Cobalt 
-His60 Ni (Ni-IDA) 
-Ni-NTA 
10
7 
SPR
2
 [181] 
- 40mg/ml (GE Healthcare) 
- 20 mg/ml (Piercenet) 
-20 mg/ml (Piercenet) 
-60 mg/ml (Clontech) 
-5-10 mg/ml (Invitrogen) 
 
RKRKRK 
 
6 aa 
 
A7C1 (Ugi based 
ligand) 
2.5x10
5
 
Static 
partition 
equilibrium 
-0.5 mg/g
3 
1 
ITC - isothermal titration calorimetry; 
2
 SPR - surface Plasmon resonance; 
3
 Static binding 
capacity. 
 
 
A novel strategy for the purification of GFP fusion proteins was also developed based on Ugi-
based ligand A4C7. Although the affinity constant Ka (2.38x10
5
 M
-1
) was suitable for affinity 
based chromatography processes, the binding capacity is still low. Despite the low selectivity in 
binding, the fine tuning of elution conditions allowed the selective GFP recovery (92-100%) with 
a purity of 94% and 66% for the conditions 0.1M glycine-NaOH pH 9 and 0.1M glycine-NaOH 
pH 9 with 50% ethylene glycol, respectively. The affinity ligand A4C7 was also employed on the 
purification of GFP fused to a  B. megaterium spore cortex lytic enzyme SleL produced in 
Lactococcus lactis [267] with a total molecular weight of 78 KDa. Adsorbents containing ligand 
A4C7 bound a high binding percentage (90%) of GFP, with a 50% recovery. This work sets the 
ground for a deeper exploitation of ligand A4C7 for purification of GFP fusion proteins. To date, 
there is no selective synthetic affinity ligand towards GFP and the purification of GFP fusion 
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proteins is often cumbersome (Table 6.2.) with single or multiple chromatographic steps 
needed. Immunoaffinity chromatography which requires the use of biological ligands such as 
monoclonal antibodies is the most popular strategy. The novel affinity adsorbent based on 
A4C7 can yield similar results in terms of recovery and purity and can overcome the limitations 
of the described methods. 
 
Table 6.2 Purification methods used on the purification of green fluorescent protein (GFP) 
 
GFP source Purification Method 
 
Yield (% 
Recovery) 
 
Purity 
(%) 
Reference 
E.coli cell lysate Organic extraction 60 90 [269] 
E.coli cell lysate Chromatofocusing 60 80 [270] 
E.coli cell lysate Two IMAC steps
1
 80-66 n.a. [271] 
E.coli cell lysate ATPE
2
 + IMAC
1 
32-81 n.a. [272] 
E.coli cell lysate Three phase partitioning
3 
78 n.a. [273] 
E.coli cell lysate (NH4)2 SO4 Precipitation + HIC 74-80 97 [274] 
Culture tobacco 
cells lysate 
Multiple step
4
 95 80 [275] 
E.coli cell lysate Immunoaffinity 90 97 [276] 
E.coli cell lysate Novel Affinity chromatography 
based on A4C7 affinity ligand 
92 94 - 
1
The immobilized metal affinity chromatography (IMAC) was performed by using histidine residues 
available on the surface of GFP without the use of a histidine tail; n.a: data not available; 
2 
aqueous two-
phase extraction (ATPE) 
3
 the method involves a combination of ammonium sulphate and tert-butanol 
precipitation methods; 
4 
the multiple step chromatography purification method involved the methods 
ammonium sulphate precipitation, hydrophobic interaction chromatography (HIC) and ion-exchange 
chromatography (IEX) 
 
 
The novel affinity pair RKRKRK tagged GFP-A7C1 seems to combine increased selectivity with 
the cost-effectiveness of structural ligands, representing an interesting alternative to explore 
fusion protein production, purification and immobilization.  The synthetic ligand A4C7 shows 
interesting selectivity on the recovery of bound GFP protein, and therefore can serve as a 
capturing agent for GFP alone or GFP fusion proteins, with a wide range of applications in the 
bioseparation and diagnostic fields. 
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